{
    "nodes": [
        {
            "ix": "6-456_v1_0",
            "content": "Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions",
            "ntype": "article-title",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_1",
            "content": "Abstract",
            "ntype": "abstract",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_2",
            "content": "There are more and more data concerning the role of cellular metabolism in innate immune cells, such as macrophages or conventional dendritic cells. However, few data are available currently concerning plasmacytoid dendritic cells (PDC), another type of innate immune cells. These cells are the main type I interferon (IFN) producing cells, but they also secrete other pro-inflammatory cytokines (e.g., tumor necrosis factor or interleukin [IL]-6) or immunomodulatory factors (e.g., IL-10 or transforming growth factor-\u03b2). Through these functions, PDC participate in antimicrobial responses or maintenance of immune tolerance, and have been implicated in the pathophysiology of several autoimmune diseases. Recent data support the idea that the glycolytic pathway (or glycolysis), as well as lipid metabolism (including both cholesterol and fatty acid metabolism) may impact some innate immune functions of PDC or may be involved in these functions after Toll-like receptor (TLR) 7/9 triggering. Some differences may be related to the origin of PDC (human versus mouse PDC or blood-sorted versus FLT3 ligand stimulated-bone marrow-sorted PDC). The kinetics of glycolysis may differ between human and murine PDC. In mouse PDC, metabolism changes promoted by TLR7/9 activation may depend on an autocrine/paracrine loop, implicating type I IFN and its receptor IFNAR, explaining a delayed glycolysis. Moreover, PDC functions can be modulated by the metabolism of cholesterol and fatty acids. This may occur via the production of lipid ligands that activate nuclear receptors (e.g., liver X receptor [LXR]) in PDC or through limiting intracellular cholesterol pool size (by statins or LXR agonists) in these cells. Finally, lipid-activated nuclear receptors ( i.e ., LXR or peroxisome proliferator activated receptor) may also directly interact with pro-inflammatory transcription factors, such as NF-\u03baB. Here, we discuss how glycolysis and lipid metabolism may modulate PDC functions and how this may be harnessed in pathological situations where PDC play a detrimental role.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_3",
            "content": "1. Introduction",
            "ntype": "title",
            "meta": {
                "section": "1",
                "sec-type": "intro",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_4",
            "content": "More and more data are available concerning the role of cellular metabolism in innate immune cells, such as macrophages or conventional dendritic cells (cDC) <REF-1> \u2013 <REF-3> . However, few data are available currently concerning plasmacytoid dendritic cells (PDC). PDC belong to the family of dendritic cells (DC) and possess specific features that distinguish them from cDC. PDC represent the main type I interferon (IFN) secreting cells and play a critical role in antimicrobial immune responses. The involvement of PDC through IFN-\u03b1 secretion has also been reported in several autoimmune diseases (see section 2.4). Furthermore, PDC release other pro-inflammatory cytokines, as well as immunoregulatory factors. In these ways, they may exert pro-inflammatory functions or, on the contrary, participate in tolerance mechanisms. In this Review article, based on recent publications <REF-4> \u2013 <REF-6> , we will discuss how the innate immune functions of PDC may be modulated by or dependent on the glycolytic pathway (also known as glycolysis) and lipid metabolism, including the metabolism of cholesterol and fatty acids. Before that, we will describe the innate functions of PDC. PDC also have the capacity to present antigens to T cells and to polarize CD4 + helper T cell responses, as well as those interacting with B cells <REF-7> . These functions will not be discussed in this article, since no sufficient data are available concerning the impact of metabolism on the capacity of PDC to interact with the adaptive immune system. Although the \u201cimmunometabolism\u201d (as defined in Ref# <REF-2> ) includes six metabolic pathways (glycolysis, the tricarboxylic acid [TCA] cycle, the pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis and amino acid metabolism) that influence immune cell effector functions <REF-2> , this article will focus on glycolysis and lipid metabolism (extended to the cholesterol metabolism). Concerning amino acid metabolism, PDC innate functions have been shown to be modulated by mammalian target of rapamycin (mTOR) signaling. This central metabolic regulator, mTOR can sense amino acid sufficiency in lysosomes, and promotes mRNA translation and lipid synthesis to support cell growth and proliferation <REF-2> . Furthermore, mTOR, through its association with regulatory-associated protein of mTOR (RAPTOR), constitutes the mTOR complex 1 (mTORC1), which is connected with other metabolic pathways (see section 3.1). This will be discussed briefly, since the role of mTOR in innate immune cell functions has been reviewed recently <REF-3> , <REF-8> . Finally, concerning amino acid metabolism, PDC are able to sense amino acid deficiency through their expression of GCN2 (general control nonderepressible 2) serine/threonine kinase. Indeed, the suppression of interleukin (IL)-6 production in PDC by indoleamine 2,3-dioxygenase (IDO) involves GCN2 kinase <REF-9> (see section 2.3).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_5",
            "content": "What are the main roles of the immunometabolism in immune cells? First of all, this is a way to provide energy. Cells need energy to execute cellular functions, such as survival, proliferation or cytokine secretion. This energy is provided as adenosine triphosphate (ATP) by several pathways. The first is glycolysis, which involves the conversion of glucose to pyruvate in the cytosol. The second pathway is the TCA cycle (also called the Krebs cycle), which donates electrons to the electron transport chain located in the mitochondria to fuel oxidative phosphorylation or respiration (OXPHOS). This OXPHOS process generates ATP in the mitochondria. Other substrates, such as fatty acids via \u03b2-oxidation (also called fatty acid oxidation [FAO]), can replenish the TCA cycle to fuel OXPHOS <REF-10> . In addition to substrates used for energy production and de novo biosynthesis, mitochondrial metabolic pathways (such as the TCA, FAO, or OXPHOS) provide substrates for epigenetic modifications of DNA and histones <REF-11> , <REF-12> . This is the case, for instance, of acetyl-CoA for histone acetylation, which is associated with active transcription <REF-11> . This connects mitochondrial metabolism to epigenetic regulation <REF-12> . This specific aspect will be briefly discussed in the Conclusions of this article.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_6",
            "content": "2. The innate immune functions of plasmacytoid dendritic cells",
            "ntype": "title",
            "meta": {
                "section": "2",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_7",
            "content": "PDC belong to the DC family and possess specific features that distinguish them from cDC <REF-13> . These features include: the capacity to rapidly and massively produce type I IFN ( i.e ., IFN-\u03b1/\u03b2), the expression of a particular set of pathogen-recognition receptors (PRR), leading to the recognition of specific pathogen-associated molecular pattern (PAMP) and damage-associated molecular pattern (DAMP) molecules, as well as a preferential localization in lymphoid organs <REF-7> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_8",
            "content": "PDC were firstly identified in human as the major IFN-\u03b1 producing cells, and thus initially called IPC (IFN-\u03b1 producing cells) <REF-14> , <REF-15> . After this characterization in human, its murine PDC counterpart was then isolated <REF-16> \u2013 <REF-19> . Human PDC are usually identified as CD4 + , CD303 + (previously known as BDCA-2), and CD123 high , whereas mouse PDC are CD11c int , B220 + , SIGLEC-H + , and CD317 + <REF-7> . Despite the difference in phenotypes of human and mouse PDC, PDC from both species exhibit a conserved genetic signature with some common genes (e.g., tlr7 ) <REF-20> . Moreover, PDC exhibit specific transcription factors, such as the transcription factor E2-2 (also known as TCF4) or SPIB <REF-7> . A differentiation/ontogeny process distinct from those of cDC has been reported <REF-7> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_9",
            "content": "2.1. PDC ontogeny and localization",
            "ntype": "title",
            "meta": {
                "section": "2.1",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_10",
            "content": "Development of PDC from hematopoietic stem cells occurs in the bone marrow. As mentioned above, PDC-defining transcription factors have been identified, such as E2-2 (TCF4) or SPIB <REF-7> . After differentiation in the bone marrow, PDC are released into the bloodstream for homing to different lymphoid tissues <REF-21> . Thus, PDC isolated from blood of healthy donors or patients consist in PDC migrating to these tissues <REF-7> . In steady state, PDC reside mainly in T cell-rich areas in lymph nodes and secondary lymphoid organs <REF-7> . Localizations of PDC in other lymphoid organs, such as Peyer\u2019s patches of the gut <REF-22> , and tonsils <REF-23> , have been reported. PDC residing in non-lymphoid tissue \u2013 such as the airways <REF-24> and the liver <REF-25> \u2013 exert a critical role in steady state by regulating mucosal immunity and maintaining tolerance to inhaled or ingested antigens <REF-26> . Finally, PDC are also present in the thymus during homeostatic conditions, where they play a role in central tolerance <REF-27> \u2013 <REF-29> . In contrast, during infections or autoimmune diseases, PDC migrate to inflamed lymph nodes <REF-14> or inflamed epithelia <REF-14> , <REF-23> , <REF-30> . The microenvironment in which PDC are present may influence oxygen and nutrient availability, which impacts on metabolic pathways (see section 3).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_11",
            "content": "2.2. Type I IFN and pro-inflammatory cytokines secreted by PDC",
            "ntype": "title",
            "meta": {
                "section": "2.2",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_12",
            "content": "PDC constitute a DC subset, specialized in antimicrobial immune responses. This occurs mainly through a rapid type I IFN (IFN-\u03b1/\u03b2) production <REF-7> , <REF-31> , <REF-32> . Selective depletion of PDC by genetic approaches supports the critical role of PDC for early IFN-\u03b1 production after microbial infections <REF-33> \u2013 <REF-35> . The type I IFN response is triggered by Toll-like receptor (TLR) signaling after PAMP recognition.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_13",
            "content": "Compared to cDC, PDC express a limited number of PRR. TLR 7/9 are expressed by both human and mouse PDC <REF-7> , <REF-36> . These two endoplasmic TLRs allow PDC to recognize cytosine-phosphate guanosine (CpG)-rich unmethylated DNA from bacteria and DNA viruses, <REF-7> , <REF-31> , <REF-37> , as well as viral single-stranded RNA (ssRNA), <REF-31> , <REF-38> , <REF-39> , respectively. In addition, PDC are able to recognize via TLR7/9 mammalian nucleic acids <REF-40> , in particular when these nucleic acids are complexed or associated with antimicrobial peptides (e.g., LL37) <REF-41> , <REF-42> . Once PDC have sensed pathogens or DAMP through endoplasmic TLR, signaling is mediated via MyD88 (myeloid differentiation factor 88), a docking protein for IRAK1\u20444 (IL-1R-associated kinase 1/4), and the ubiquitin ligase TRAF6 (tumor necrosis factor [TNF] receptor-associated factor 6). IFN-regulatory factor 7 (IRF7) is then phosphorylated and translocates into the nucleus to induce type I IFN gene and IFN-inducible gene transcription ( Figure 1 ) <REF-43> . This is true for human PDC <REF-36> . Concerning mouse PDC, other intermediates may participate in type I IFN mRNA transcription in the TLR-dependent IRF7 signaling pathway. This involves a complex, associating TRAF3, IRAK1, osteopontin, PI3K (phosphatidylinositol 3-kinase) and IKK\u03b1 (I\u03baB kinase-\u03b1) <REF-36> . A critical role of PI3K has also been reported for type I IFN production by human PDC <REF-44> . In addition, in TLR7- or TLR9-activated human PDC, TRAF6 can also recruit TAK1 (transforming growth factor [TGF]-\u03b2-activating kinase; also known as MAP3K7 for mitogen-activated protein kinase kinase kinase 7) to trigger the synthesis of pro-inflammatory cytokines via NF-\u03baB activation <REF-36> . In mouse PDC, TAK-1/MAP3K7 activates the mitogen-activated protein kinase (MAPK) pathway that upregulates costimulatory molecule expression (e.g., CD40, CD80 or CD86) <REF-36> . Both human and mouse PDC have been shown to secrete TNF-\u03b1 <REF-4> \u2013 <REF-6> , <REF-45> , <REF-46> , IL-6 <REF-4> \u2013 <REF-6> , <REF-45> , <REF-46> , IL-8 <REF-45> \u2013 <REF-47> or granulocyte macrophage colony-stimulating factor (GM-CSF) <REF-45> . This TLR-induced cytokine synthesis is regulated in PDC by the translocation of NF-\u03baB, p38 MAPK and c-Jun N-terminal kinase (JNK) into the nucleus. In human PDC, the association of NF-\u03baB p65 and p50 subunits with IRF5 appears to be the master inducer of IL-6 mRNA transcription <REF-36> . Depending on the TLR9 ligand used, the cytokine response can be different. For instance, type A CpG-containing oligonucleotide (CpG-ODN) (CpGA) induces mainly type I IFN production, whereas type B CpG-ODN (CpGB) induces pro-inflammatory cytokine secretion and upregulation of co-stimulatory molecules <REF-48> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_14",
            "content": "Figure 1.",
            "ntype": "label",
            "meta": {
                "id": "f1",
                "caption": "The main signaling pathways in plasmacytoid dendritic cells that promote metabolic changes or are modulated by metabolic pathways. This figure summarizes different signaling pathways described in the literature to promote metabolic changes or to be modulated by immunometabolism in plasmacytoid dendritic cells. This includes: endosomal TLR 7 and TLR9, membrane IL-3 receptor (associating CD131 to CD123), GM-CSF receptor (associating CD131 to CD116), and IFN-\u03b1 receptor (IFNAR associating IFNAR1 and IFNAR2). Only the main pathways with main effector molecules are depicted. For more details, please refer to the main text. Abbreviations (not defined in the main text): IFIG , IFN-I-induced genes; nf\u03baB1 , NF-\u03baB gene.",
                "uri": "https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure1.gif",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_15",
            "content": "<fig xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" fig-type=\"figure\" id=\"f1\" position=\"float\"> <caption> <title>The main signaling pathways in plasmacytoid dendritic cells that promote metabolic changes or are modulated by metabolic pathways.</title> <p>This figure summarizes different signaling pathways described in the literature to promote metabolic changes or to be modulated by immunometabolism in plasmacytoid dendritic cells. This includes: endosomal TLR 7 and TLR9, membrane IL-3 receptor (associating CD131 to CD123), GM-CSF receptor (associating CD131 to CD116), and IFN-&#945; receptor (IFNAR associating IFNAR1 and IFNAR2). Only the main pathways with main effector molecules are depicted. For more details, please refer to the main text. Abbreviations (not defined in the main text): <italic>IFIG</italic>, IFN-I-induced genes; <italic>nf&#954;B1</italic>, NF-&#954;B gene.</p> </caption> <graphic xlink:href=\"https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure1.gif\"/> </fig>",
            "ntype": "fig",
            "meta": {
                "id": "f1",
                "caption": "The main signaling pathways in plasmacytoid dendritic cells that promote metabolic changes or are modulated by metabolic pathways. This figure summarizes different signaling pathways described in the literature to promote metabolic changes or to be modulated by immunometabolism in plasmacytoid dendritic cells. This includes: endosomal TLR 7 and TLR9, membrane IL-3 receptor (associating CD131 to CD123), GM-CSF receptor (associating CD131 to CD116), and IFN-\u03b1 receptor (IFNAR associating IFNAR1 and IFNAR2). Only the main pathways with main effector molecules are depicted. For more details, please refer to the main text. Abbreviations (not defined in the main text): IFIG , IFN-I-induced genes; nf\u03baB1 , NF-\u03baB gene.",
                "uri": "https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure1.gif",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_16",
            "content": "In addition to virus or pathogen-expressing TLR7/TLR9 ligands or synthetic ligands, PDC can be activated to release cytokines by other stimuli, including DAMP. PDC express RAGE (receptor for advanced glycation end products), a PRR that recognizes high-mobility group box-1 (HMGB1) <REF-49> , <REF-50> , a nuclear DNA-binding protein released from necrotic cells <REF-51> . PDC can also be activated by neutrophil extracellular traps (NET), released by dying or activated neutrophils. These NET contain DNA fibers, histones, as well as a large amount of LL37 and HMGB1 <REF-52> , <REF-53> . Human PDC can also be activated by CD154 from activated platelets <REF-54> or endothelial-derived microvesicles <REF-6> , <REF-46> . Other PRR are present in the cytoplasm of PDC and dedicated to RNA virus recognition. This is the case of retinoic acid-inducible gene (RIG)-I-like receptors, DHX9 or DHX36 <REF-55> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_17",
            "content": "2.3. Regulatory or immunosuppressive factors expressed by PDC",
            "ntype": "title",
            "meta": {
                "section": "2.3",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_18",
            "content": "In addition to type I IFN and pro-inflammatory cytokine production, PDC have regulatory and immunosuppressive functions <REF-26> . This has been demonstrated by in vivo PDC depletion studies <REF-24> , <REF-56> . For instance, PDC exert immunoregulatory functions in the lung, preventing deleterious asthmatic reactions <REF-24> . Moreover, PDC may express immunosuppressive factors that confer tolerogenic properties <REF-26> . One major factor is the enzyme IDO <REF-26> , <REF-57> , <REF-58> . This enzyme is involved in the catabolism of the essential amino acid, tryptophan, and the synthesis of kynurenines. Tryptophan is required for T cell proliferation and kynurenines have immunosuppressive properties. Engagement of several receptors, including CD80/CD86, or TLR9 <REF-59> , participates in active IDO induction. Amino acid withdrawal resulting from IDO enzymatic activity, stimulates the GCN2 kinase in PDC and then prevents IL-6 secretion by PDC <REF-9> . Moreover, IDO exerts a regulatory function independently of its catabolic activity by participating in TGF-\u03b2-signaling pathway <REF-60> . Receptors expressed by PDC, such as immunoglobulin-like transcript 7 <REF-61> or CD303 <REF-62> may also inhibit TLR7/9-mediated type I IFN production. In addition, PDC can produce, under certain circumstances, high levels of immunosuppressive cytokines, such as IL-10 <REF-19> , <REF-25> or TGF-\u03b2 <REF-56> , <REF-63> . In addition, PDC participate in the maintenance of immune tolerance via the induction and/or expansion of regulatory T cells (please refer to Refs# <REF-7> , <REF-63> ; this is out of the scope of this review).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_19",
            "content": "When one evokes cellular metabolism, cell survival has to be discussed. IL-3 has been identified as a critical factor for the development and survival of PDC <REF-64> , <REF-65> . This cytokine interacts with the IL-3 receptor associating two chains, the common chain CD131 and the IL-3R\u03b1 chain (CD123) that is highly expressed by PDC. Signaling through this receptor involves Janus kinase 2 (JAK2), Src kinases, transcription factors STAT3/STAT5 (signal transducer and activator of transcription 3/5) and Akt ( Figure 1 ) <REF-66> . Another cytokine that shares the common chain CD131 and influences PDC survival with nearly the same signaling pathway is GM-CSF ( Figure 1 ) <REF-65> . Finally, PDC express IFNAR, the membrane receptor for type I IFN (IFN-\u03b1 or IFN-\u03b2) that consists of two subunits, IFNAR1 and IFNAR2. Engagement of this receptor by its ligand activates JAK1 (associated with IFNAR1) and tyrosine kinase 2 (associated with IFNAR2) that phosphorylate and activate STAT1 and STAT2, respectively ( Figure 1 ) <REF-66> , <REF-67> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_20",
            "content": "2.4. Implications of PDC in diseases",
            "ntype": "title",
            "meta": {
                "section": "2.4",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_21",
            "content": "Before discussing the role of immunometabolism, the role of PDC in beneficial and detrimental immune responses will be briefly detailed. As type I IFN producing cells, PDC play a major beneficial role in antimicrobial immune responses <REF-7> . However, uncontrolled IFN-\u03b1 production in acute viral infection may be detrimental to the host. Moreover, high levels of type I IFN released by PDC may be detrimental in chronic inflammatory or autoimmune diseases <REF-7> , <REF-54> , <REF-68> \u2013 <REF-71> . This is the case of systemic lupus erythematosus (SLE) <REF-52> \u2013 <REF-54> , type 1 diabetes <REF-69> , and psoriasis <REF-41> , <REF-71> . Furthermore, PDC may participate in inflammatory autoimmune disorders ( i.e ., systemic sclerosis <REF-70> or autoimmune vasculitis <REF-72> ) via the secretion of other pro-inflammatory cytokines than type I IFN <REF-72> or chimiokines <REF-70> . Since PDC infiltrate inflamed tissues, they may release pro-inflammatory factors participating in the amplification of diseases. Therefore, PDC have been reported to infiltrate acute graft- versus -host disease lesions, including gastro-intestinal <REF-73> and cutaneous <REF-74> lesions. PDC emerge as cells present in atherosclerotic plaques and may play a role in atherosclerosis <REF-66> , <REF-75> . Atherosclerotic plaques are enriched in lipids. This may modify the lipid metabolism of infiltrated PDC by the uptake of lipid-enriched lipoproteins or oxidized lipoproteins, and subsequently PDC functions (see section 3.3.3). Finally, insufficient or exhausted production of IFN-\u03b1 during chronic viral infections (e.g., chronic hepatitis C virus or HIV) has also been reported <REF-76> , <REF-77> . Thus, the metabolism of PDC may be pharmacologically modified in order to restore type I IFN production.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_22",
            "content": "3. The influence of the metabolism on innate immune functions of plasmacytoid dendritic cells",
            "ntype": "title",
            "meta": {
                "section": "3",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_23",
            "content": "3.1. PDC innate immune functions and mTOR signaling",
            "ntype": "title",
            "meta": {
                "section": "3.1",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_24",
            "content": "The kinase mTOR is a key regulator of different biological processes, including metabolism <REF-8> . This is a serine/threonine protein kinase that senses and integrates signals (such as nutrients and oxygen) originating from the extracellular milieu, as well as intracellular signals <REF-78> . In fact, mTOR is the catalytic subunit of two different complexes, mTORC1 and mTORC2. As mentioned briefly in the Introduction, mTORC1 is connected with several metabolic pathways. Indeed, mTORC1 promotes glycolysis through hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) <REF-8> , as well as cholesterol and fatty acid synthesis using TCA cycle intermediates through a pathway involving sterol regulatory element-binding proteins (SREBP) and the nuclear receptor, peroxisome proliferator-activated receptor (PPAR) \u03b3 <REF-8> . Cholesterol and fatty acids are used as \u201cbuilding blocks\u201d <REF-8> for complete maturation of endoplasmic reticulum (ER) and Golgi apparatus. Both organelles can promote the transport of pro-inflammatory cytokines within the cell that precedes their secretion <REF-8> . In addition, mTORC1 can have a negative effect on mitochondrial OXPHOS by inducing the expression of type I IFN and production of nitric oxide, which subsequently promotes aerobic glycolysis <REF-8> . This has been well described in macrophages <REF-8> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_25",
            "content": "Concerning PDC innate immune functions, mTOR plays an important role in type I IFN production <REF-79> . The TLR9 ligand, CpGA, stimulates the rapid phosphorylation of mTOR and its downstream targets, the p70 ribosomal S6 kinase 1 and the eukaryotic translation initiation factor 4E-binding protein (4E-BP) <REF-79> . Thus, mTOR is involved in the TLR9-induced type I IFN signaling pathway ( Figure 2 ). Using the mTORC1 inhibitor rapamycin, the same authors demonstrated that TLR7/9-mediated production of type I IFN is inhibited in both human and mouse PDC <REF-79> . These data have been confirmed in vivo using live attenuated viral yellow fever vaccine <REF-79> . The virus responsible for yellow fever is an ssRNA virus and TLR7 recognizes ssRNA <REF-38> . Rapamycin may act at two levels: i ) by inactivating via the inhibition of 4E-BP phosphorylation the nuclear translocation of IRF7 required for type I IFN gene transcription; and ii ) by blocking the formation of the TLR9-MyD88 complex via the p70 ribosomal S6 kinase 1 <REF-78> . In addition to type I IFN production, the inhibition of mTORC1 reduces TLR7/9-induced TNF and IL-6 production by human and mouse PDC <REF-79> . Overall, mTOR signaling is involved in the TLR9-induced type I IFN signaling pathway and blocking mTORC1 inhibits TLR7/9-stimulated secretion of pro-inflammatory cytokines ( i.e., type I IFN, TNF and IL-6) by PDC. Thus, the use of mTOR inhibitors may block the detrimental pro-inflammatory functions of PDC in inflammatory disorders, but may also prevent the beneficial antimicrobial response of PDC.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_26",
            "content": "Figure 2.",
            "ntype": "label",
            "meta": {
                "id": "f2",
                "caption": "Metabolic changes in plasmacytoid dendritic cells (PDC) providing energy and affecting their innate immune functions: glycolysis versus fatty acid oxidation coupled with OXPHOS. ( A ) The endosomal TLR7 pathway in human blood-derived PDC promotes early glycolysis (within minutes following TLR7 triggering; green font and green arrows), as attested by increased ECAR (extracellular acidification rate; a reflection of lactate excretion). This implicates the HIF-1\u03b1 molecule that increases the GLUT1 glucose transporter allowing extracellular glucose entry and stimulates some enzymes involved in glycolysis (HK or PFK). Glycolysis in human PDC is required for TLR7-induced type I IFN production. A potential link with the activation of the mTORC1 complex can be seen, since this complex is activated by both endosomal TLR7 and TLR9 pathway in mouse and human PDC. Inhibitors of mTORC1 (RAP), of TLR7 signaling (chlor.), and of glycolysis (2-DG) are written in blue font. ( B ) The TLR9 pathway in mouse bone marrow-derived PDC promotes late glycolysis (after 24 hours) (grey font and grey arrows) via a type I IFN/IFNAR loop. This pathway also promotes fatty acid synthesis, FAO coupled with OXPHOS to generate ATP in a PPAR\u03b1-dependent mechanism (violet font and violet arrows). This TLR9 pathway implicates the activation of mTORC1 in both mouse and human PDC. Specific inhibitors of fatty acid synthesis (C75), pyruvate entry in the mitochondrion (UK5099), TCA cycle (TOFA) or FAO (etoxomir) are written in blue font and have been used to demonstrate the promotion of fatty acid synthesis, FAO and OXPHOS inTLR9-induced type I IFN production. For more details, please refer to the main text. Abbreviations (not defined in the main text): HK, hexokinase; PFK, phosphofructokinase; RAP., rapamycin; chlor., chloroquine.",
                "uri": "https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure2.gif",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_27",
            "content": "<fig xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" fig-type=\"figure\" id=\"f2\" position=\"float\"> <caption> <title>Metabolic changes in plasmacytoid dendritic cells (PDC) providing energy and affecting their innate immune functions: glycolysis <italic>versus</italic> fatty acid oxidation coupled with OXPHOS.</title> <p>( <bold>A</bold>) The endosomal TLR7 pathway in human blood-derived PDC promotes early glycolysis (within minutes following TLR7 triggering; green font and green arrows), as attested by increased ECAR (extracellular acidification rate; a reflection of lactate excretion). This implicates the HIF-1&#945; molecule that increases the GLUT1 glucose transporter allowing extracellular glucose entry and stimulates some enzymes involved in glycolysis (HK or PFK). Glycolysis in human PDC is required for TLR7-induced type I IFN production. A potential link with the activation of the mTORC1 complex can be seen, since this complex is activated by both endosomal TLR7 and TLR9 pathway in mouse and human PDC. Inhibitors of mTORC1 (RAP), of TLR7 signaling (chlor.), and of glycolysis (2-DG) are written in blue font. ( <bold>B</bold>) The TLR9 pathway in mouse bone marrow-derived PDC promotes late glycolysis (after 24 hours) (grey font and grey arrows) <italic>via</italic> a type I IFN/IFNAR loop. This pathway also promotes fatty acid synthesis, FAO coupled with OXPHOS to generate ATP in a PPAR&#945;-dependent mechanism (violet font and violet arrows). This TLR9 pathway implicates the activation of mTORC1 in both mouse and human PDC. Specific inhibitors of fatty acid synthesis (C75), pyruvate entry in the mitochondrion (UK5099), TCA cycle (TOFA) or FAO (etoxomir) are written in blue font and have been used to demonstrate the promotion of fatty acid synthesis, FAO and OXPHOS inTLR9-induced type I IFN production. For more details, please refer to the main text. Abbreviations (not defined in the main text): HK, hexokinase; PFK, phosphofructokinase; RAP., rapamycin; chlor., chloroquine.</p> </caption> <graphic xlink:href=\"https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure2.gif\"/> </fig>",
            "ntype": "fig",
            "meta": {
                "id": "f2",
                "caption": "Metabolic changes in plasmacytoid dendritic cells (PDC) providing energy and affecting their innate immune functions: glycolysis versus fatty acid oxidation coupled with OXPHOS. ( A ) The endosomal TLR7 pathway in human blood-derived PDC promotes early glycolysis (within minutes following TLR7 triggering; green font and green arrows), as attested by increased ECAR (extracellular acidification rate; a reflection of lactate excretion). This implicates the HIF-1\u03b1 molecule that increases the GLUT1 glucose transporter allowing extracellular glucose entry and stimulates some enzymes involved in glycolysis (HK or PFK). Glycolysis in human PDC is required for TLR7-induced type I IFN production. A potential link with the activation of the mTORC1 complex can be seen, since this complex is activated by both endosomal TLR7 and TLR9 pathway in mouse and human PDC. Inhibitors of mTORC1 (RAP), of TLR7 signaling (chlor.), and of glycolysis (2-DG) are written in blue font. ( B ) The TLR9 pathway in mouse bone marrow-derived PDC promotes late glycolysis (after 24 hours) (grey font and grey arrows) via a type I IFN/IFNAR loop. This pathway also promotes fatty acid synthesis, FAO coupled with OXPHOS to generate ATP in a PPAR\u03b1-dependent mechanism (violet font and violet arrows). This TLR9 pathway implicates the activation of mTORC1 in both mouse and human PDC. Specific inhibitors of fatty acid synthesis (C75), pyruvate entry in the mitochondrion (UK5099), TCA cycle (TOFA) or FAO (etoxomir) are written in blue font and have been used to demonstrate the promotion of fatty acid synthesis, FAO and OXPHOS inTLR9-induced type I IFN production. For more details, please refer to the main text. Abbreviations (not defined in the main text): HK, hexokinase; PFK, phosphofructokinase; RAP., rapamycin; chlor., chloroquine.",
                "uri": "https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure2.gif",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_28",
            "content": "Lastly, mTORC1 stimulates glycolysis in innate immune cells, at least via HIF-1\u03b1 induction, but also through the increased expression of the glucose transporter 1 (GLUT1) at the cell surface ( Figure 2 ) <REF-8> . GLUT1 enhances glucose uptake from the extracellular milieu <REF-8> . Thus, the implication of mTOR signaling pathway in the response of PDC to TLR9 ligand <REF-79> suggests that glycolysis may be triggered in the cells. This will be discussed in the next section.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_29",
            "content": "3.2. PDC innate immune functions and glycolysis",
            "ntype": "title",
            "meta": {
                "section": "3.2",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_30",
            "content": "The glycolytic pathway (also known as glycolysis) involves the uptake of extracellular glucose ( i.e ., present in the microenvironment) and its conversion in the cytosol to generate pyruvate <REF-2> . Most pyruvate is then excreted from the cells as lactate after a process called aerobic glycolysis. This is a relatively inefficient pathway for the generation of energy ( i.e ., cellular ATP) compared to the TCA cycle coupled to OXPHOS <REF-80> . The preferential use of glycolysis versus the TCA cycle and OXPHOS depends on oxygen availability <REF-2> , <REF-80> . Glycolysis is favored during hypoxia, a situation encountered, for instance, in joints during rheumatoid arthritis or in the inflamed colon during Crohn\u2019s disease <REF-80> - PDC can be present in both inflamed tissues ( i.e ., the synovial fluid <REF-81> \u2013 <REF-83> and the colon <REF-73> , <REF-84> ). This energy provided by glycolysis may represent the resources necessary for cytokine secretion, since PDC does not proliferate in the same way as adaptive cells ( i.e ., T cells). However, PDC become highly secretory upon activation <REF-7> . Finally, growth factors triggering PI3K and MAPK in their signaling pathway promote, in theory, the cellular use of glycolysis <REF-2> . This may be the case when PDC are stimulated by TLR7/9 ligands (see previous section).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_31",
            "content": "The exposure of human PDC to two different ssRNA viruses, influenza virus (Flu) and Rhinovirus (RV) \u2013 triggering the TLR7 pathway via ssRNA recognition <REF-38> \u2013 activates HIF-1\u03b1 <REF-4> , a major regulator of metabolism ( Figure 2A ). Indeed, HIF-1\u03b1 is critical for glycolysis to generate ATP, since it induces the expression of different glycolytic enzymes, such as hexokinase and phosphofructokinase <REF-80> . In addition to HIF-1\u03b1 activation, the TLR7 agonist gardiquimod, as well as Flu and RV, induces early glycolysis (within minutes) in human PDC, as attested by elevated extracellular acidification rate (ECAR; a reflection of lactate secretion in extracellular milieu, an indicator of glycolysis in real time) and elevated rates of lactate production <REF-4> . Moreover, the inhibition of glycolysis by 2-deoxyglucose (2-DG; a glycolytic inhibitor) impairs ssRNA virus- or TLR7 ligand-induced type I IFN by PDC, as well as the upregulation of HLA-DR, CD80 and CD86 at PDC cell surface <REF-4> . Furthermore, 2-DG inhibits the increase of IFNA , CD80 and CD86 mRNA induced by exposure to Flu <REF-4> . This suggests that glycolysis induced by the TLR7 pathway regulates these genes at the transcriptional level. The involvement of the TLR7 pathway in glycolysis was supported by the use of chloroquine, known to disrupt endosomal acidification required for TLR7 signaling <REF-85> . Chloroquine treatment inhibits the lactate production by PDC in response to Flu or gardiquimod <REF-4> . Overall, ssRNA viruses enhance glycolysis in human PDC via the TLR7 pathway ( Figure 2A ). This finding was confirmed in vivo , since viral infection using live attenuated influenza vaccine increases glycolysis in ex vivo isolated human PDC and correlates with IFN-\u03b1 production by these cells <REF-4> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_32",
            "content": "These data contrast with a recent report showing that mouse PDC activation in response to the TLR9 ligand, CpGA, is not accompanied by a rapid change in ECAR ( i.e ., during the first 150 minutes). This contrasts with data obtained in the same experiments using cDC \u2013 as a control of PDC \u2013 stimulated by either lipopolysaccharide, Poly(I:C) or CpGA <REF-5> . However, glycolysis is detected late (24 hours) in TLR9-stimulated mouse PDC <REF-5> . Moreover, the authors also studied the role of the TLR7 pathway in mouse PDC, but not extensively. Again, they found a delayed activation of glycolysis after stimulation of mouse PDC with the TLR7 agonist imiquimod <REF-5> . Thus, whether the origin of PDC (human <REF-4> versus mouse <REF-5> ) or their source (sorted from peripheral blood mononuclear cells <REF-4> versus sorted from FLT3-stimulated ligand-bone marrow cultures <REF-5> ) may explain this discrepancy remains to be determined. Another difference between these two studies lies in the direct effect of IFN-\u03b1 on PDC metabolism. Treatment of human PDC with IFN-\u03b1 is not sufficient to induce PDC lactate efflux ( i.e ., glycolysis) and IFN-\u03b1/\u03b2 receptor (IFNAR) blockade does not affect PDC lactate efflux induced by Flu infection <REF-4> . This suggests that type I IFN does not regulate in an autocrine/paracrine manner Flu-induced early glycolysis in human PDC. In contrast, this autocrine/paracrine loop involving type I IFN and its receptor may play a significant role in TLR-induced glycolysis in mouse PDC ( Figure 2B ) <REF-5> . Nevertheless, all these data support that glycolysis plays a role as a source of energy in the production of type I IFN, pro-inflammatory cytokines (IL-6 and TNF) and costimulatory molecule upregulation by PDC in response to TLR7/9 activation. The modulation of this metabolic pathway may limit uncontrolled pro-inflammatory cytokines by PDC in pathological situations or may restore type I IFN production in chronic infectious diseases.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_33",
            "content": "3.3. PDC innate immune functions and lipid metabolism",
            "ntype": "title",
            "meta": {
                "section": "3.3",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_34",
            "content": "In this section, we will discuss fatty acid metabolism, including fatty acid oxidation (FAO; also known as mitochondrial \u03b2-oxidation) and fatty acid synthesis, as well as cholesterol metabolism. Lipid metabolism is regulated by many key enzymes. Some of these enzymes involved in de novo lipid synthesis are controlled by lipid-activated nuclear receptors, such as liver X receptor (LXR) or PPAR. The genes coding for these enzymes are thus called LXR or PPAR target genes, respectively. Among these LXR or PPAR target genes, one may cite FASN coding for fatty acid synthase <REF-86> \u2013 <REF-88> . These LXR or PPAR target genes code not only for enzymes involved in lipid metabolism, but also for transcription factors and transporters, and regulate also to glucose or amino acid metabolism. This is the case of the transcription factors, SREBP, or of glucose or cholesterol transporters involved in nutrient entry (e.g., the GLUT1 glucose transporter) or efflux, such as ATP binding cassette (ABC) transporters A1 and G1 (ABCA1 and ABCG1, respectively) involved in cholesterol efflux <REF-2> , <REF-86> , <REF-87> , <REF-89> , <REF-90> . PPAR and LXR are both mainly found associated with retinoid X receptor (RXR) to form a heterodimer. Considered as permissive heterodimer receptors, they can be activated by the ligands of each partner (e.g., PPAR or RXR ligands; LXR or RXR ligands) <REF-88> , <REF-90> . While the involvement of these nuclear receptors in innate immune responses is well described for macrophages and cDC <REF-90> , few data are available for PDC. Here, we will discuss how lipid metabolism modulates PDC innate immune functions and how PDC activation by TLR ligands or other stimuli modifies lipid metabolism.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_35",
            "content": "3.3.1. Fatty acid oxidation . The FAO pathway allows the conversion of fatty acids into numerous products in the mitochondria. These products, such as acetyl-CoA, NADH (nicotinamide adenine dinucleotide dehydrogenase) and FADH <REF-2> (the fully reduced form of flavin adenine dinucleotide [FAD]), can be used in the TCA cycle and the electron transport chain to generate energy <REF-2> . As discussed before, normoxia supports the TCA cycle and OXPHOS, while hypoxia via HIF-1\u03b1 activation followed by the induction of glycolytic enzymes leads to glycolysis <REF-2> , <REF-80> . The TCA cycle coupled to OXPHOS is the major metabolic pathway used by most quiescent or non-proliferating cells <REF-2> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_36",
            "content": "A recent well-received manuscript reports that FAO and mitochondrial OXPHOS play a critical role in murine PDC activation by the TLR9 pathway ( Figure 2B ) <REF-5> . This is particularly well demonstrated for type I IFN production by these cells <REF-5> . Mouse PDC stimulated by the TLR9 ligand, CpGA, exhibit an increase of basal oxygen consumption rate (OCR) and spare respiratory capacity (SRC) <REF-5> . Both increased basal OCR and SRC are indicators of FAO. To directly demonstrate that CpGA increases FAO, the authors used etomoxir, an irreversible inhibitor of carnitine palmitoyl transferase I <REF-2> . This enzyme is responsible for the entry of activated fatty acids ( i.e ., medium-chain and long-chain fatty acids conjugated with carnitine) into mitochondria for FAO <REF-2> . Etomoxir inhibits both the increase of basal OCR and SRC induced by TLR9 ligand stimulation. Moreover, etomoxir limits the production of IFN-\u03b1 and pro-inflammatory cytokines (TNF-\u03b1 and IL-6) by PDC in response to CpGA stimulation. This inhibition of TLR9 activation by etomoxir also prevents the upregulation of CD86 expression at PDC cell surface <REF-5> . Overall, TLR9-induced mouse PDC activation is accompanied by an increased FAO, and stimulation of this metabolic pathway is required for pro-inflammatory cytokine secretion and PDC maturation ( i.e ., CD86 upregulation).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_37",
            "content": "An increase of basal OCR and SRC attesting for FAO has also been observed after the activation of mouse PDC by the TLR7 agonist imiquimod. Treatment of mouse PDC by etomoxir inhibits imiquimod-induced IFN-\u03b1 production <REF-5> , suggesting that FAO is also required for type I IFN production in response to TLR7 ligand. Implication of FAO in vivo was assessed using etomoxir and mice infected with the ssRNA lymphocytic choriomeningitis virus (LCMV). Etomoxir-treated and LCMV-infected mice exhibit reduced circulating IFN-\u03b1 3 days after infection and significantly more LCMV are detected in the liver and spleen of etomoxir-treated versus untreated infected mice <REF-5> . This demonstrates the in vivo relevance of these data.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_38",
            "content": "Changes in basal OCR are not detected at early time points after murine PDC activation by CpGA, but this requires new gene transcription. This may suggest that IFN-\u03b1 production and IFNAR signaling induced by CpGA stimulation may be responsible for these changes in PDC metabolism. Indeed, treatment with IFN-\u03b1 alone is sufficient to induce increased FAO in mouse PDC <REF-5> . Thus, increased FAO induced by CpGA stimulation in mouse PDC are therefore the results of an autocrine or paracrine loop involving the type I IFN signaling pathway.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_39",
            "content": "One goal of the FAO pathway is to generate energy, by the production of a high number of ATP molecules <REF-2> . This occurs in fact by fueling OXPHOS <REF-2> . To definitively demonstrate the implication of energy provided by FAO coupled to OXPHOS in type I IFN-induced mouse PDC activation, ATP was quantified in response to IFN-\u03b1 and different inhibitors were used <REF-5> . Metabolic reprogramming of mouse PDC induced by IFN-\u03b1 leads to enhanced ATP availability <REF-5> . The quantity of ATP in response to CpGA activation is significantly reduced by the inhibition of either FAO (using etomoxir), pyruvate import into mitochondria required for the TCA cycle (using UK5099) or fatty acid synthesis (using tall oil fatty acid [TOFA]) <REF-5> . This confirms that type I IFN stimulation of mouse PDC generates significant amounts of ATP via the FAO pathway. This pathway fuels OXPHOS in this setting and is itself fueled by fatty acid synthesis, as demonstrated by the use of the inhibitor TOFA ( Figure 2B ).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_40",
            "content": "The pathways responsible for the changes in metabolism induced by type I IFN in mouse PDC were studied by an unbiased RNA-seq based approach <REF-5> . This analysis shows that OXPHOS is the major network induced by type I IFN, and FAO is connected to this network. Furthermore and surprisingly, this analysis reveals also a PPAR\u03b1 gene signature <REF-5> . While PPAR\u03b3 is expressed in macrophages and cDC <REF-90> , the PPAR\u03b1 isoform is mainly and highly expressed in metabolic active tissues, such as the liver or brown adipose tissues <REF-88> . After having confirmed that the PPAR\u03b1 isoform is expressed by bone marrow-derived and splenic mouse PDC, a PPAR\u03b1 antagonist, GW6471 was used <REF-5> . GW6471 blocks both IFN-\u03b1 production and the increase of basal OCR in response to CpGA activation. Furthermore, increased basal OCR and SRC in mouse PDC are observed after incubation with a PPAR\u03b1 agonist gemfibrozil, as well as with the combined PPAR\u03b1 and PPAR\u03b3 agonist, muraglitazar <REF-5> . Overall, this indicates that PPAR\u03b1 is involved in FAO and OXPHOS induced by CpGA activation ( Figure 2B ). This PPAR\u03b1 pathway in PDC functions will be discussed later in this review together with the other lipid-activated nuclear receptor, LXR (see the following two sections).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_41",
            "content": "3.3.2. Fatty acid synthesis . The fatty acid synthesis pathway allows cells to generate lipids that are necessary for cellular growth and proliferation <REF-2> . Fatty acid synthesis is performed in the cytosol, and it uses citrate from the TCA cycle and exported from the mitochondria into the cytosol to generate fatty acids ( Figure 2B ). As mentioned above, de novo fatty acid synthesis is dependent on key enzymes, such as FASN, that are controlled by either the mTOR signaling pathway <REF-8> , LXR <REF-86> , <REF-87> or SREBP-1c <REF-2> , <REF-91> . Fatty acids generated by this synthesis can be used to fuel mitochondrial FAO <REF-2> , to activate PPAR nuclear receptors <REF-89> , or can be condensed with glycolysis-derived glycerol to produce triacylglycerol and phospholipids <REF-2> . These latter two are key components of many cellular structures, such as the cell membrane, ER or Golgi apparatus <REF-2> , <REF-8> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_42",
            "content": "The inhibition of the fatty acid synthesis using two different inhibitors (TOFA, an inhibitor of acetyl-CoA carboxylase; C75, an inhibitor of FASN) <REF-2> prevents the increase of IFN-\u03b1, TNF-\u03b1, and IL-6 production by mouse PDC in response to CpGA stimulation <REF-5> . As previously demonstrated for FAO and OXPHOS, fatty acid synthesis induced by the TLR9 pathway implicates a type I IFN/IFNAR loop <REF-5> . Moreover, using the TOFA inhibitor before measuring both the quantity of ATP in response to CpGA activation and the expression of PPAR\u03b1 target genes, Acadl and Pltp in CpGA-activated mouse PDC <REF-5> allowed the authors to conclude that fatty acid synthesis induced in mouse PDC rather fuels FAO and OXPHOS than provides lipid ligands for PPAR\u03b1 activation. It is well described that the natural ligands of PPAR\u03b1 include different fatty acids, as well as numerous fatty acid derivatives and compounds with structural resemblance to fatty acids, such as acyl-CoAs, or oxidized fatty acids <REF-89> . Here in PDC, fatty acids synthetized in response to the TLR9 signaling pathway do not seem to directly stimulate PPAR\u03b1 by providing PPAR\u03b1 ligands. One may hypothesize that, as reported for lipid-activated nuclear receptors <REF-86> , <REF-88> , activation of PPAR\u03b1 by TLR9 ligand may interfere with transcription factors <REF-3> , <REF-88> that are critical for pro-inflammatory cytokine secretion by PDC (see section below).",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_43",
            "content": "3.3.3. Cholesterol metabolism . Cholesterol is one of the major constituents of lipid rafts together with glycosphingolipids <REF-92> . Cellular cholesterol content results from cholesterol uptake and biosynthesis through the mevalonate pathway, while its elimination from cells is mediated by cholesterol efflux. Cholesterol uptake involves plasma lipoproteins (mainly low density lipoprotein [LDL] and very low density lipoprotein [VLDL]) after interactions with their specific receptors, LDLR and VLDLR, respectively. Cholesterol efflux is mainly mediated by specific transporters, ABCA1 and ABCG1, in association with extracellular cholesterol acceptors, including apolipoproteins (APO) APOA1 and APOE, or lipoprotein particles (e.g., nascent high density lipoprotein [HDL] or HDL2) ( Figure 3 ) <REF-93> . ABCG1 is rather localized within the cell and seems to move sterols between intracellular compartments <REF-88> . ABCA1 is more dedicated to extrude cholesterol derivatives outside the cell <REF-88> . Cholesterol regulates critical cellular functions, including plasma membrane formation and fluidity, allowing the clustering of receptors into lipid rafts for efficient signaling <REF-92> . These latter functions are implicated in signaling pathway regulation. Localization of signaling complexes within the lipid rafts is critical for certain receptors.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_44",
            "content": "Figure 3.",
            "ntype": "label",
            "meta": {
                "id": "f3",
                "caption": "Cholesterol metabolism controls plasmacytoid dendritic cell (PDC) innate functions. Activation of the LXR pathway by \u201cphysiological\u201d oxidized cholesterol derivatives (oxysterols) or synthetic LXR agonists induces the decrease of PDC intracellular cholesterol content by stimulating cholesterol efflux through ABCA1 cholesterol transporter, inhibiting cholesterol entry by decreasing LDL or VLDL receptor (LDLR and VLDLR, respectively) expression and inhibiting de novo cholesterol biosynthesis (also known as the mevalonate pathway). Cholesterol efflux via ABCA1 requires cholesterol acceptors, such as APOA1, and immature HDL (HDL2/3) to generate mature HDL that transport cholesterol towards the liver. Activation of this LXR pathway inhibits TLR7-induced NF-\u03baB activation and phosphorylation of STAT5 and Akt in response to IL-3 stimulation (green font and green arrows). Inhibition of cholesterol biosynthesis by statins (violet font and arrows) inhibits TLR7/9-induced IRF7 translocation in the nucleus, as well as phosphorylation of p38 kinase, and consequently the production of type I IFN. For more details and abbreviations, please refer to the main text.",
                "uri": "https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure3.gif",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_45",
            "content": "<fig xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" fig-type=\"figure\" id=\"f3\" position=\"float\"> <caption> <title>Cholesterol metabolism controls plasmacytoid dendritic cell (PDC) innate functions.</title> <p>Activation of the LXR pathway by &#8220;physiological&#8221; oxidized cholesterol derivatives (oxysterols) or synthetic LXR agonists induces the decrease of PDC intracellular cholesterol content by stimulating cholesterol efflux through ABCA1 cholesterol transporter, inhibiting cholesterol entry by decreasing LDL or VLDL receptor (LDLR and VLDLR, respectively) expression and inhibiting <italic>de novo</italic> cholesterol biosynthesis (also known as the mevalonate pathway). Cholesterol efflux <italic>via</italic> ABCA1 requires cholesterol acceptors, such as APOA1, and immature HDL (HDL2/3) to generate mature HDL that transport cholesterol towards the liver. Activation of this LXR pathway inhibits TLR7-induced NF-&#954;B activation and phosphorylation of STAT5 and Akt in response to IL-3 stimulation (green font and green arrows). Inhibition of cholesterol biosynthesis by statins (violet font and arrows) inhibits TLR7/9-induced IRF7 translocation in the nucleus, as well as phosphorylation of p38 kinase, and consequently the production of type I IFN. For more details and abbreviations, please refer to the main text.</p> </caption> <graphic xlink:href=\"https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure3.gif\"/> </fig>",
            "ntype": "fig",
            "meta": {
                "id": "f3",
                "caption": "Cholesterol metabolism controls plasmacytoid dendritic cell (PDC) innate functions. Activation of the LXR pathway by \u201cphysiological\u201d oxidized cholesterol derivatives (oxysterols) or synthetic LXR agonists induces the decrease of PDC intracellular cholesterol content by stimulating cholesterol efflux through ABCA1 cholesterol transporter, inhibiting cholesterol entry by decreasing LDL or VLDL receptor (LDLR and VLDLR, respectively) expression and inhibiting de novo cholesterol biosynthesis (also known as the mevalonate pathway). Cholesterol efflux via ABCA1 requires cholesterol acceptors, such as APOA1, and immature HDL (HDL2/3) to generate mature HDL that transport cholesterol towards the liver. Activation of this LXR pathway inhibits TLR7-induced NF-\u03baB activation and phosphorylation of STAT5 and Akt in response to IL-3 stimulation (green font and green arrows). Inhibition of cholesterol biosynthesis by statins (violet font and arrows) inhibits TLR7/9-induced IRF7 translocation in the nucleus, as well as phosphorylation of p38 kinase, and consequently the production of type I IFN. For more details and abbreviations, please refer to the main text.",
                "uri": "https://f1000researchdata.s3.amazonaws.com/manuscripts/12232/1dab5bb1-fcb8-4982-a75d-2803b4f107f0_figure3.gif",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_46",
            "content": "Cholesterol homeostasis is regulated at least by LXR. These nuclear receptors are expressed as two isoforms, including the ubiquitous LXR\u03b2 isoform and LXR\u03b1, which exhibits an expression restricted to cells with high cholesterol turnover (e.g., macrophages) <REF-86> , <REF-90> , <REF-94> . The LXR pathway is activated by intermediates from the cholesterol biosynthesis (e.g., desmosterol), endogenous oxidized cholesterol derivatives (called oxysterols, such as 22(R)-hydroxycholesterol [22RHC]), and synthetic agonists (e.g., T0901317 or GW3965) <REF-86> . LXR activation upregulates the expression of several genes involved in cholesterol homeostasis ( i.e. , LXR target genes), including: ABCA1 , ABCG1 <REF-87> , and APOE (related to cholesterol efflux) <REF-88> , <REF-95> , as well as the \u2018inducible degrader of the low-density lipoprotein receptor\u2019 (IDOL), preventing cholesterol uptake through LDLR/VLDLR degradation <REF-96> . Overall, these mechanisms triggered by LXR activation participate in the decrease of intracellular cholesterol content. Again, the LXR pathway has been studied extensively in the regulation of macrophage functions, including cholesterol homeostasis and inflammatory responses, as well as apoptotic cell uptake (a process called efferocytosis) <REF-90> . However, the role of cholesterol and LXR begins only to be deciphered in PDC innate functions.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_47",
            "content": "Inhibition of the mevalonate pathway ( i.e ., de novo cholesterol biosynthesis) by statins (simvastatin and pitavastatin) blocks TLR7- and TLR9-induced type I IFN production by human PDC ( Figure 3 ) <REF-97> . This has been demonstrated with blood-derived PDC obtained from healthy donors, as well as from patients with SLE <REF-97> . Statin treatment also inhibits TNF secretion by human PDC in response to either TLR7 (loxoribine) or TLR9 (CpGA) ligands <REF-97> . These data have been confirmed in vivo using ssRNA Sendai virus <REF-97> . Inhibition of de novo cholesterol synthesis by statins in PDC interferes with the p38 MAPK pathway, Akt and nuclear translocation of IRF7 ( Figure 3 ) <REF-97> . Finally, the inhibitory effect of statins has been tested in vivo and on mouse PDC, since treatment of C57BL/6 mouse with statins before triggering type I IFN production by ssRNA poly(U) injection decreases circulating IFN-\u03b1 <REF-97> . Thus, the inhibition of cholesterol synthesis in PDC is associated with an anti-inflammatory response. This confirms the global anti-inflammatory effects of statins <REF-98> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_48",
            "content": "Recently, we reported that the LXR\u03b2 isoform is expressed in human PDC <REF-6> , as well as in mouse PDC (unpublished study, Ceroi A, Bonnefoy F, Angelot-Delettre F and Saas P), and that this LXR pathway is fully functional <REF-6> . Using freshly blood-isolated human PDC and a PDC cell line CAL-1, a functional LXR pathway has been demonstrated, as attested by increased LXR target gene expression in response to three different LXR agonists (two synthetic agonists and an oxysterol, 22RHC that represents a more physiological LXR ligand). The activation of the LXR pathway in PDC reduces the pro-inflammatory cytokine secretion (IL-6 and TNF-\u03b1) induced by TLR7 triggering <REF-6> . Moreover, these data obtained in human PDC from healthy donors <REF-6> and in leukemic PDC <REF-99> demonstrate that the LXR pathway interferes with TLR7-induced NF-\u03baB activation at different levels, including a transcriptional repression of p65 NF-\u03baB subunit and a reduced phosphorylation of this NF-\u03baB subunit ( Figure 3 ) <REF-6> , <REF-99> . Pretreatment of leukemic PDC with synthetic LXR agonists also reduces Akt and STAT5 phosphorylation in response to IL-3 ( Figure 3 ) <REF-99> . LXR stimulation in the PDC cell line CAL-1 increases cholesterol efflux via the upregulation of cholesterol transporters, such as ABCA1 ( Figure 3 ) <REF-99> . Although the cholesterol efflux was only tested using this CAL-1 PDC cell line <REF-99> , upregulation of cholesterol transporters at mRNA and protein levels was also observed in human blood-derived PDC treated with LXR agonists <REF-6> . Stimulation of cholesterol efflux by the addition of a cholesterol acceptor, APOA1, amplifies the effects of LXR activation in leukemic PDC, including inhibition of the IL-3 signaling pathway (Akt and STAT5 phosphorylation) and cell survival ( Figure 3 ) <REF-99> . This confirms the previous data using statins <REF-97> , and suggests that modifying cholesterol homeostasis in PDC can be useful to limit their detrimental role in pathological situations. Alteration of PDC survival after modification of intracellular cholesterol content using either statins <REF-97> or LXR agonists <REF-99> is only detected at highest concentrations (100 \u00b5M). In addition, LXR activation in human PDC also increases microparticle internalization via the phosphatidylserine receptor (PtdSerR), BAI-1 <REF-6> . This contrasts with data obtained in macrophages in which LXR stimulation induces another PtdSerR, called Mer-TK (Mer tyrosine kinase) <REF-100> . Nevertheless, this suggests that stimulation of PDC via the LXR pathway may improve their capacity to eliminate circulating pro-inflammatory microparticles. Triggering LXR pathway using LXR agonists before exposure to pro-inflammatory endothelial-derived microparticles prevents NF-\u03baB activation and pro-inflammatory cytokine production by human PDC <REF-6> . This sustains an anti-inflammatory role of LXR agonists.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_49",
            "content": "A discrepancy exists concerning type I IFN production after inhibition of cholesterol biosynthesis (using statins <REF-97> ) and the massive decrease of intracellular cholesterol content (using LXR agonists <REF-6> , <REF-99> ). Inhibition of type I IFN has been reported after statin treatment <REF-97> , but not after cholesterol deprivation <REF-6> . This may be due to a compensatory mechanism, since massively decreasing the pool size of synthesized cholesterol alone induces spontaneous type I IFN production associated with an antiviral immunity in bone marrow-derived macrophages <REF-101> . This response occurs via the cGAS/STING/TBK1/IRF3 pathway <REF-101> . Thus, LXR agonists could inhibit TLR7/9-mediated type I IFN by interfering with this signaling pathway together with massively decreasing the intracellular cholesterol pool size. This could explain why IFN-\u03b1 production is unaffected after LXR agonist treatment of PDC. Another difference between the effect of statins and LXR agonists lies in the inhibition of IRF7 (but not of NF-\u03baB phosphorylation by statins) <REF-97> , whereas the activation of the LXR pathway in PDC blocks NF-\u03baB activation via several mechanisms <REF-6> , <REF-99> (see above). Overall, the manipulation of cholesterol metabolism in PDC can be proposed to limit their pro-inflammatory functions.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_50",
            "content": "4. Conclusions",
            "ntype": "title",
            "meta": {
                "section": "4",
                "sec-type": "conclusions",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_51",
            "content": "Here, we summarize data currently available showing that several metabolic pathways are triggered in PDC by different stimuli, including pro-inflammatory signals (e.g., TLR7/9 ligands or endothelial-derived microparticles), as well as anti-inflammatory signals (e.g., platelet-derived microparticles). These pathways comprise: the mTOR signaling pathway, glycolysis, FAO coupled to OXPHOS, fatty acid synthesis and cholesterol metabolism. All of these pathways are connected together, and they are globally necessary for efficient type I IFN production by PDC in response to TLR7/9-mediated activation. Few data are available, but it seems that induction of pro-inflammatory cytokines (e.g., TNF, IL-6 and IL-8) and costimulatory molecules ( i.e ., CD80 or CD86) also need most of these metabolic pathways. On the contrary, alteration of cholesterol metabolism associated with decreased intracellular cholesterol content either after inhibition of de novo cholesterol synthesis or LXR activation inhibits the pro-inflammatory functions of PDC. These data suggest that pharmacological manipulation of the host metabolism may be useful to reprogram altered PDC immune functions.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_52",
            "content": "Since cellular metabolism is highly dependent on the microenvironment (oxygen availability and nutrients), changes in the local tissue microenvironment may modulate PDC innate immune functions. This modulation of metabolism may result from exogenous metabolites that diffuse passively or through transporters into the PDC. Among these metabolites, one may find ligands of lipid-activated nuclear receptors, such as LXR or PPAR <REF-3> , <REF-90> .",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_53",
            "content": "Microenvironment and metabolic pathways may be modulated or controlled by microbiota. A recent study analyzed germ-free mice mono-colonized with each of the 53 human-resident bacterial species and the consequences of each bacterium on different immune cell subsets <REF-102> . Among these 53 bacteria, some bacteria were identified as modifying PDC frequencies in the colon and the small intestine <REF-102> . Among the genes for which their expression was correlated with PDC frequencies, the authors identified IFN-inducible signature transcripts, but also transcripts involved in lipid and protein metabolic pathways. Moreover, the Hif1a transcript coding for the metabolism regulator HIF-1\u03b1 was also associated with PDC frequencies <REF-102> . This suggests a connection between PDC frequencies in the gastro-intestinal tract and metabolic pathways and nutrients/metabolites provided by microbiota.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_54",
            "content": "We discussed above the connection of metabolism with epigenetic regulation. While few data are available concerning epigenetic regulation of PDC innate immune functions, it has been shown that the inhibitor of histone deacetylase, valproic acid, alters human PDC functions, including the production of pro-inflammatory cytokines (IFN-\u03b1 TNF and IL-6) in response to TLR9 ligand, CpGA <REF-103> . Thus, it remains to be determined how metabolism may regulate epigenetic modification of DNA and histones in PDC.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_55",
            "content": "Lastly, acute perturbations in intracellular lipid content, via for instance LXR activation, may also influence cell proliferation and survival by inducing significant ER stress <REF-88> . This cellular organelle is responsible for protein folding. The result of this ER stress is an accumulation of unfolded proteins. This pathway leads also to the expression of the transcription factor X-box binding protein 1 (XBP1), which induces lipid synthesis. XBP1 has been shown to regulate cDC infiltrating ovarian tumors; accumulation of lipids in the tumor-infiltrating cDC following ER stress and XBP1 activation reduces their ability to present antigens, and thus impairs anti-tumor T-cell responses <REF-104> . Whether this may occur in infiltrating PDC remains to be analyzed. Nevertheless, PDC have been shown to express XBP1 <REF-105> . This factor can be targeted with bortezomib, which maintains ER homeostasis <REF-105> . This can be an additional way related to metabolism to block pro-inflammatory PDC functions. In conclusion, a better understanding of PDC immunometabolism may help to limit the detrimental effect of these cells and increase their beneficial role in the future.",
            "ntype": "p",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_56",
            "content": "<REF-1> O'Neill LA Pearce EJ : Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016 ; 213 ( 1 ): 15 \u2013 23 . 26694970 10.1084/jem.20151570 4710204",
            "ntype": "ref",
            "meta": {
                "id": "ref-1",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_57",
            "content": "<REF-2> O'Neill LA Kishton RJ Rathmell J : A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016 ; 16 ( 9 ): 553 \u2013 565 . 27396447 10.1038/nri.2016.70 5001910",
            "ntype": "ref",
            "meta": {
                "id": "ref-2",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_58",
            "content": "<REF-3> Pearce EJ Everts B : Dendritic cell metabolism. Nat Rev Immunol. 2015 ; 15 ( 1 ): 18 \u2013 29 . 25534620 10.1038/nri3771 4495583",
            "ntype": "ref",
            "meta": {
                "id": "ref-3",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_59",
            "content": "<REF-4> Bajwa G DeBerardinis RJ Shao B : Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses. J Immunol. 2016 ; 196 ( 5 ): 2004 \u2013 2009 . 26826244 10.4049/jimmunol.1501557 4761472",
            "ntype": "ref",
            "meta": {
                "id": "ref-4",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_60",
            "content": "<REF-5> Wu D Sanin DE Everts B : Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function. Immunity. 2016 ; 44 ( 6 ): 1325 \u2013 1336 . 27332732 10.1016/j.immuni.2016.06.006",
            "ntype": "ref",
            "meta": {
                "id": "ref-5",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_61",
            "content": "<REF-6> Ceroi A Delettre FA Marotel C : The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. Haematologica. 2016 ; 101 ( 3 ): e72 \u2013 76 . 26635040 10.3324/haematol.2015.135459 4815731",
            "ntype": "ref",
            "meta": {
                "id": "ref-6",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_62",
            "content": "<REF-7> Swiecki M Colonna M : The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015 ; 15 ( 8 ): 471 \u2013 485 . 26160613 10.1038/nri3865 4808588",
            "ntype": "ref",
            "meta": {
                "id": "ref-7",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_63",
            "content": "<REF-8> Weichhart T Hengstschl\u00e4ger M Linke M : Regulation of innate immune cell function by mTOR. Nat Rev Immunol. 2015 ; 15 ( 10 ): 599 \u2013 614 . 26403194 10.1038/nri3901",
            "ntype": "ref",
            "meta": {
                "id": "ref-8",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_64",
            "content": "<REF-9> Sharma MD Hou DY Liu Y : Indoleamine 2,3-dioxygenase controls conversion of Foxp3 + Tregs to TH17-like cells in tumor-draining lymph nodes. Blood. 2009 ; 113 ( 24 ): 6102 \u2013 6111 . 19366986 10.1182/blood-2008-12-195354 2699232",
            "ntype": "ref",
            "meta": {
                "id": "ref-9",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_65",
            "content": "<REF-10> Pearce EL Pearce EJ : Metabolic pathways in immune cell activation and quiescence. Immunity. 2013 ; 38 ( 4 ): 633 \u2013 643 . 23601682 10.1016/j.immuni.2013.04.005 3654249",
            "ntype": "ref",
            "meta": {
                "id": "ref-10",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_66",
            "content": "<REF-11> Audano M Ferrari A Fiorino E : Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function. Curr Genomics. 2014 ; 15 ( 6 ): 436 \u2013 456 . 25646072 10.2174/138920291506150106151119 4311388",
            "ntype": "ref",
            "meta": {
                "id": "ref-11",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_67",
            "content": "<REF-12> Li W Sivakumar R Titov AA : Metabolic Factors that Contribute to Lupus Pathogenesis. Crit Rev Immunol. 2016 ; 36 ( 1 ): 75 \u2013 98 . 27480903 10.1615/CritRevImmunol.2016017164 5278665",
            "ntype": "ref",
            "meta": {
                "id": "ref-12",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_68",
            "content": "<REF-13> Guilliams M Ginhoux F Jakubzick C : Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014 ; 14 ( 8 ): 571 \u2013 578 . 25033907 10.1038/nri3712 4638219",
            "ntype": "ref",
            "meta": {
                "id": "ref-13",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_69",
            "content": "<REF-14> Cella M Jarrossay D Facchetti F : Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999 ; 5 ( 8 ): 919 \u2013 923 . 10426316 10.1038/11360",
            "ntype": "ref",
            "meta": {
                "id": "ref-14",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_70",
            "content": "<REF-15> Siegal FP Kadowaki N Shodell M : The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999 ; 284 ( 5421 ): 1835 \u2013 1837 . 10364556 10.1126/science.284.5421.1835",
            "ntype": "ref",
            "meta": {
                "id": "ref-15",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_71",
            "content": "<REF-16> Asselin-Paturel C Boonstra A Dalod M : Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol. 2001 ; 2 ( 12 ): 1144 \u2013 1150 . 11713464 10.1038/ni736",
            "ntype": "ref",
            "meta": {
                "id": "ref-16",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_72",
            "content": "<REF-19> Martin P Del Hoyo GM Anjuere F : Characterization of a new subpopulation of mouse CD8\u03b1 + B220 + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood. 2002 ; 100 ( 2 ): 383 \u2013 390 . 12091326 10.1182/blood.V100.2.383",
            "ntype": "ref",
            "meta": {
                "id": "ref-19",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_73",
            "content": "<REF-20> Robbins SH Walzer T Demb\u00e9l\u00e9 D : Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008 ; 9 ( 1 ): R17 . 18218067 10.1186/gb-2008-9-1-r17 2395256",
            "ntype": "ref",
            "meta": {
                "id": "ref-20",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_74",
            "content": "<REF-21> Liu K Victora GD Schwickert TA : In vivo analysis of dendritic cell development and homeostasis. Science. 2009 ; 324 ( 5925 ): 392 \u2013 397 . 19286519 10.1126/science.1170540 2803315",
            "ntype": "ref",
            "meta": {
                "id": "ref-21",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_75",
            "content": "<REF-22> Li HS Gelbard A Martinez GJ : Cell-intrinsic role for IFN-\u03b1-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood. 2011 ; 118 ( 14 ): 3879 \u2013 3889 . 21828128 10.1182/blood-2011-04-349761 3193265",
            "ntype": "ref",
            "meta": {
                "id": "ref-22",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_76",
            "content": "<REF-23> Sisirak V Vey N Vanbervliet B : CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood. 2011 ; 118 ( 19 ): 5130 \u2013 5140 . 21937703 10.1182/blood-2010-07-295626 3217401",
            "ntype": "ref",
            "meta": {
                "id": "ref-23",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_77",
            "content": "<REF-24> de Heer HJ Hammad H Soulli\u00e9 T : Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med. 2004 ; 200 ( 1 ): 89 \u2013 98 . 15238608 10.1084/jem.20040035 2213319",
            "ntype": "ref",
            "meta": {
                "id": "ref-24",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_78",
            "content": "<REF-25> Tokita D Sumpter TL Raimondi G : Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol. 2008 ; 49 ( 6 ): 1008 \u2013 1018 . 18926588 10.1016/j.jhep.2008.07.028 2631180",
            "ntype": "ref",
            "meta": {
                "id": "ref-25",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_79",
            "content": "<REF-26> Matta BM Castellaneta A Thomson AW : Tolerogenic plasmacytoid DC. Eur J Immunol. 2010 ; 40 ( 10 ): 2667 \u2013 2676 . 20821731 10.1002/eji.201040839 3974856",
            "ntype": "ref",
            "meta": {
                "id": "ref-26",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_80",
            "content": "<REF-27> Okada T Lian ZX Naiki M : Murine thymic plasmacytoid dendritic cells. Eur J Immunol. 2003 ; 33 ( 4 ): 1012 \u2013 1019 . 12672067 10.1002/eji.200323616",
            "ntype": "ref",
            "meta": {
                "id": "ref-27",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_81",
            "content": "<REF-29> Hadeiba H Lahl K Edalati A : Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity. 2012 ; 36 ( 3 ): 438 \u2013 450 . 22444632 10.1016/j.immuni.2012.01.017 3315699",
            "ntype": "ref",
            "meta": {
                "id": "ref-29",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_82",
            "content": "<REF-30> Vermi W Riboldi E Wittamer V : Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med. 2005 ; 201 ( 4 ): 509 \u2013 515 . 15728234 10.1084/jem.20041310 2213064",
            "ntype": "ref",
            "meta": {
                "id": "ref-30",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_83",
            "content": "<REF-31> Gilliet M Cao W Liu YJ : Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008 ; 8 ( 8 ): 594 \u2013 606 . 18641647 10.1038/nri2358",
            "ntype": "ref",
            "meta": {
                "id": "ref-31",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_84",
            "content": "<REF-32> Reizis B Bunin A Ghosh HS : Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011 ; 29 : 163 \u2013 183 . 21219184 10.1146/annurev-immunol-031210-101345 4160806",
            "ntype": "ref",
            "meta": {
                "id": "ref-32",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_85",
            "content": "<REF-33> Cervantes-Barragan L Lewis KL Firner S : Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A. 2012 ; 109 ( 8 ): 3012 \u2013 3017 . 22315415 10.1073/pnas.1117359109 3286988",
            "ntype": "ref",
            "meta": {
                "id": "ref-33",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_86",
            "content": "<REF-35> Takagi H Fukaya T Eizumi K : Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo . Immunity. 2011 ; 35 ( 6 ): 958 \u2013 971 . 22177923 10.1016/j.immuni.2011.10.014",
            "ntype": "ref",
            "meta": {
                "id": "ref-35",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_87",
            "content": "<REF-36> Pelka K Latz E : IRF5, IRF8, and IRF7 in human pDCs - the good, the bad, and the insignificant? Eur J Immunol. 2013 ; 43 ( 7 ): 1693 \u2013 1697 . 23828296 10.1002/eji.201343739",
            "ntype": "ref",
            "meta": {
                "id": "ref-36",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_88",
            "content": "<REF-37> Kadowaki N Ho S Antonenko S : Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001 ; 194 ( 6 ): 863 \u2013 869 . 11561001 10.1084/jem.194.6.863 2195968",
            "ntype": "ref",
            "meta": {
                "id": "ref-37",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_89",
            "content": "<REF-38> Diebold SS Kaisho T Hemmi H : Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004 ; 303 ( 5663 ): 1529 \u2013 1531 . 14976261 10.1126/science.1093616",
            "ntype": "ref",
            "meta": {
                "id": "ref-38",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_90",
            "content": "<REF-39> Moynagh PN : TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005 ; 26 ( 9 ): 469 \u2013 476 . 16006187 10.1016/j.it.2005.06.009",
            "ntype": "ref",
            "meta": {
                "id": "ref-39",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_91",
            "content": "<REF-40> Barrat FJ Meeker T Gregorio J : Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005 ; 202 ( 8 ): 1131 \u2013 1139 . 16230478 10.1084/jem.20050914 2213213",
            "ntype": "ref",
            "meta": {
                "id": "ref-40",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_92",
            "content": "<REF-41> Lande R Gregorio J Facchinetti V : Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007 ; 449 ( 7162 ): 564 \u2013 569 . 17873860 10.1038/nature06116",
            "ntype": "ref",
            "meta": {
                "id": "ref-41",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_93",
            "content": "<REF-42> Ganguly D Chamilos G Lande R : Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009 ; 206 ( 9 ): 1983 \u2013 1994 . 19703986 10.1084/jem.20090480 2737167",
            "ntype": "ref",
            "meta": {
                "id": "ref-42",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_94",
            "content": "<REF-43> Honda K Yanai H Negishi H : IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005 ; 434 ( 7034 ): 772 \u2013 777 . 15800576 10.1038/nature03464",
            "ntype": "ref",
            "meta": {
                "id": "ref-43",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_95",
            "content": "<REF-44> Guiducci C Ghirelli C Marloie-Provost MA : PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J Exp Med. 2008 ; 205 ( 2 ): 315 \u2013 322 . 18227218 10.1084/jem.20070763 2271003",
            "ntype": "ref",
            "meta": {
                "id": "ref-44",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_96",
            "content": "<REF-45> Bauer M Redecke V Ellwart JW : Bacterial CpG-DNA triggers activation and maturation of human CD11c - , CD123 + dendritic cells. J Immunol. 2001 ; 166 ( 8 ): 5000 \u2013 5007 . 11290780 10.4049/jimmunol.166.8.5000",
            "ntype": "ref",
            "meta": {
                "id": "ref-45",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_97",
            "content": "<REF-46> Angelot F Seill\u00e8s E Biichl\u00e9 S : Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica. 2009 ; 94 ( 11 ): 1502 \u2013 1512 . 19648164 10.3324/haematol.2009.010934 2770960",
            "ntype": "ref",
            "meta": {
                "id": "ref-46",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_98",
            "content": "<REF-47> Piqueras B Connolly J Freitas H : Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood. 2006 ; 107 ( 7 ): 2613 \u2013 2618 . 16317096 10.1182/blood-2005-07-2965 1895384",
            "ntype": "ref",
            "meta": {
                "id": "ref-47",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_99",
            "content": "<REF-48> Kerkmann M Rothenfusser S Hornung V : Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol. 2003 ; 170 ( 9 ): 4465 \u2013 4474 . 12707322 10.4049/jimmunol.170.9.4465",
            "ntype": "ref",
            "meta": {
                "id": "ref-48",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_100",
            "content": "<REF-49> Tian J Avalos AM Mao SY : Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007 ; 8 ( 5 ): 487 \u2013 496 . 17417641 10.1038/ni1457",
            "ntype": "ref",
            "meta": {
                "id": "ref-49",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_101",
            "content": "<REF-50> Dumitriu IE Baruah P Bianchi ME : Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol. 2005 ; 35 ( 7 ): 2184 \u2013 2190 . 15915542 10.1002/eji.200526066",
            "ntype": "ref",
            "meta": {
                "id": "ref-50",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_102",
            "content": "<REF-51> Rovere-Querini P Capobianco A Scaffidi P : HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004 ; 5 ( 8 ): 825 \u2013 830 . 15272298 10.1038/sj.embor.7400205 1299116",
            "ntype": "ref",
            "meta": {
                "id": "ref-51",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_103",
            "content": "<REF-52> Garcia-Romo GS Caielli S Vega B : Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011 ; 3 ( 73 ): 73ra20 . 21389264 10.1126/scitranslmed.3001201 3143837",
            "ntype": "ref",
            "meta": {
                "id": "ref-52",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_104",
            "content": "<REF-53> Lande R Ganguly D Facchinetti V : Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med. 2011 ; 3 ( 73 ): 73ra19 . 21389263 10.1126/scitranslmed.3001180 3399524",
            "ntype": "ref",
            "meta": {
                "id": "ref-53",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_105",
            "content": "<REF-54> Duffau P Seneschal J Nicco C : Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med. 2010 ; 2 ( 47 ): 47ra63 . 20811042 10.1126/scitranslmed.3001001",
            "ntype": "ref",
            "meta": {
                "id": "ref-54",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_106",
            "content": "<REF-55> Broz P Monack DM : Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol. 2013 ; 13 ( 8 ): 551 \u2013 565 . 23846113 10.1038/nri3479",
            "ntype": "ref",
            "meta": {
                "id": "ref-55",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_107",
            "content": "<REF-56> Bonnefoy F Perruche S Couturier M : Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol. 2011 ; 186 ( 10 ): 5696 \u2013 5705 . 21460208 10.4049/jimmunol.1001523",
            "ntype": "ref",
            "meta": {
                "id": "ref-56",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_108",
            "content": "<REF-57> Munn DH Sharma MD Hou D : Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest. 2004 ; 114 ( 2 ): 280 \u2013 290 . 15254595 10.1172/JCI21583 449750",
            "ntype": "ref",
            "meta": {
                "id": "ref-57",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_109",
            "content": "<REF-58> Sharma MD Baban B Chandler P : Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest. 2007 ; 117 ( 9 ): 2570 \u2013 2582 . 17710230 10.1172/JCI31911 1940240",
            "ntype": "ref",
            "meta": {
                "id": "ref-58",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_110",
            "content": "<REF-59> Mellor AL Baban B Chandler PR : Cutting edge: CpG oligonucleotides induce splenic CD19 + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol. 2005 ; 175 ( 9 ): 5601 \u2013 5605 . 16237046 10.4049/jimmunol.175.9.5601",
            "ntype": "ref",
            "meta": {
                "id": "ref-59",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_111",
            "content": "<REF-60> Pallotta MT Orabona C Volpi C : Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011 ; 12 ( 9 ): 870 \u2013 878 . 21804557 10.1038/ni.2077",
            "ntype": "ref",
            "meta": {
                "id": "ref-60",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_112",
            "content": "<REF-61> Cao W Rosen DB Ito T : Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006 ; 203 ( 6 ): 1399 \u2013 1405 . 16735691 10.1084/jem.20052454 2118323",
            "ntype": "ref",
            "meta": {
                "id": "ref-61",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_113",
            "content": "<REF-62> Dzionek A Sohma Y Nagafune J : BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001 ; 194 ( 12 ): 1823 \u2013 1834 . 11748283 10.1084/jem.194.12.1823 2193584",
            "ntype": "ref",
            "meta": {
                "id": "ref-62",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_114",
            "content": "<REF-63> Saas P Perruche S : Functions of TGF-\u03b2-exposed plasmacytoid dendritic cells. Crit Rev Immunol. 2012 ; 32 ( 6 ): 529 \u2013 553 . 23428227 10.1615/CritRevImmunol.2013005868",
            "ntype": "ref",
            "meta": {
                "id": "ref-63",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_115",
            "content": "<REF-64> Grouard G Rissoan MC Filgueira L : The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997 ; 185 ( 6 ): 1101 \u2013 1111 . 9091583 10.1084/jem.185.6.1101 2196227",
            "ntype": "ref",
            "meta": {
                "id": "ref-64",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_116",
            "content": "<REF-65> Ghirelli C Zollinger R Soumelis V : Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells. Blood. 2010 ; 115 ( 24 ): 5037 \u2013 5040 . 20382843 10.1182/blood-2010-01-266932",
            "ntype": "ref",
            "meta": {
                "id": "ref-65",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_117",
            "content": "<REF-66> Chistiakov DA Orekhov AN Sobenin IA : Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation. Front Physiol. 2014 ; 5 : 279 . 25120492 10.3389/fphys.2014.00279 4110479",
            "ntype": "ref",
            "meta": {
                "id": "ref-66",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_118",
            "content": "<REF-67> Fritsch SD Weichhart T : Effects of Interferons and Viruses on Metabolism. Front Immunol. 2016 ; 7 : 630 . 28066439 10.3389/fimmu.2016.00630 5174094",
            "ntype": "ref",
            "meta": {
                "id": "ref-67",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_119",
            "content": "<REF-68> Banchereau J Pascual V : Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006 ; 25 ( 3 ): 383 \u2013 392 . 16979570 10.1016/j.immuni.2006.08.010",
            "ntype": "ref",
            "meta": {
                "id": "ref-68",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_120",
            "content": "<REF-69> Diana J Simoni Y Furio L : Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med. 2013 ; 19 ( 1 ): 65 \u2013 73 . 23242473 10.1038/nm.3042",
            "ntype": "ref",
            "meta": {
                "id": "ref-69",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_121",
            "content": "<REF-70> van Bon L Affandi AJ Broen J : Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014 ; 370 ( 5 ): 433 \u2013 443 . 24350901 10.1056/NEJMoa1114576 4040466",
            "ntype": "ref",
            "meta": {
                "id": "ref-70",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_122",
            "content": "<REF-71> Nestle FO Conrad C Tun-Kyi A : Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005 ; 202 ( 1 ): 135 \u2013 143 . 15998792 10.1084/jem.20050500 2212894",
            "ntype": "ref",
            "meta": {
                "id": "ref-71",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_123",
            "content": "<REF-72> Millet A Martin KR Bonnefoy F : Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest. 2015 ; 125 ( 11 ): 4107 \u2013 4121 . 26436651 10.1172/JCI78182 4639994",
            "ntype": "ref",
            "meta": {
                "id": "ref-72",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_124",
            "content": "<REF-73> Bossard C Malard F Arbez J : Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia. 2012 ; 26 ( 7 ): 1471 \u2013 1474 . 22333879 10.1038/leu.2012.41",
            "ntype": "ref",
            "meta": {
                "id": "ref-73",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_125",
            "content": "<REF-74> Malard F Bossard C Brissot E : Increased plasmacytoid dendritic cells and ROR\u03b3t-expressing immune effectors in cutaneous acute graft-versus-host disease. J Leukoc Biol. 2013 ; 94 ( 6 ): 1337 \u2013 1343 . 23990625 10.1189/jlb.0513295",
            "ntype": "ref",
            "meta": {
                "id": "ref-74",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_126",
            "content": "<REF-75> D\u00f6ring Y Zernecke A : Plasmacytoid dendritic cells in atherosclerosis. Front Physiol. 2012 ; 3 : 230 . 22754539 10.3389/fphys.2012.00230 3385355",
            "ntype": "ref",
            "meta": {
                "id": "ref-75",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_127",
            "content": "<REF-76> Soumelis V Scott I Gheyas F : Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood. 2001 ; 98 ( 4 ): 906 \u2013 912 . 11493432 10.1182/blood.V98.4.906",
            "ntype": "ref",
            "meta": {
                "id": "ref-76",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_128",
            "content": "<REF-77> Szabo G Dolganiuc A : The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity. Crit Rev Immunol. 2008 ; 28 ( 1 ): 61 \u2013 94 . 18298384 10.1615/CritRevImmunol.v28.i1.40",
            "ntype": "ref",
            "meta": {
                "id": "ref-77",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_129",
            "content": "<REF-78> Costa-Mattioli M Sonenberg N : RAPping production of type I interferon in pDCs through mTOR. Nat Immunol. 2008 ; 9 ( 10 ): 1097 \u2013 1099 . 18800159 10.1038/ni1008-1097",
            "ntype": "ref",
            "meta": {
                "id": "ref-78",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_130",
            "content": "<REF-79> Cao W Manicassamy S Tang H : Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol. 2008 ; 9 ( 10 ): 1157 \u2013 1164 . 18758466 10.1038/ni.1645 3732485",
            "ntype": "ref",
            "meta": {
                "id": "ref-79",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_131",
            "content": "<REF-80> Corcoran SE O'Neill LA : HIF1\u03b1 and metabolic reprogramming in inflammation. J Clin Invest. 2016 ; 126 ( 10 ): 3699 \u2013 3707 . 27571407 10.1172/JCI84431 5096812",
            "ntype": "ref",
            "meta": {
                "id": "ref-80",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_132",
            "content": "<REF-81> Van Krinks CH Matyszak MK Gaston JS : Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid. Rheumatology (Oxford). 2004 ; 43 ( 4 ): 453 \u2013 460 . 14762226 10.1093/rheumatology/keh115",
            "ntype": "ref",
            "meta": {
                "id": "ref-81",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_133",
            "content": "<REF-83> Cavanagh LL Boyce A Smith L : Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther. 2005 ; 7 ( 2 ): R230 \u2013 240 . 15743469 10.1186/ar1467 1065313",
            "ntype": "ref",
            "meta": {
                "id": "ref-83",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_134",
            "content": "<REF-84> Arimura K Takagi H Uto T : Crucial role of plasmacytoid dendritic cells in the development of acute colitis through the regulation of intestinal inflammation. Mucosal Immunol. 2017 ; In press. 27848952 10.1038/mi.2016.96",
            "ntype": "ref",
            "meta": {
                "id": "ref-84",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_135",
            "content": "<REF-85> Lund JM Alexopoulou L Sato A : Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004 ; 101 ( 15 ): 5598 \u2013 5603 . 15034168 10.1073/pnas.0400937101 397437",
            "ntype": "ref",
            "meta": {
                "id": "ref-85",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_136",
            "content": "<REF-86> Hong C Tontonoz P : Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov. 2014 ; 13 ( 6 ): 433 \u2013 444 . 24833295 10.1038/nrd4280",
            "ntype": "ref",
            "meta": {
                "id": "ref-86",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_137",
            "content": "<REF-87> W\u00f3jcicka G Jamroz-Wisniewska A Horoszewicz K : Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw (Online). 2007 ; 61 : 736 \u2013 759 . 18063918",
            "ntype": "ref",
            "meta": {
                "id": "ref-87",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_138",
            "content": "<REF-88> Kidani Y Bensinger SJ : Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev. 2012 ; 249 ( 1 ): 72 \u2013 83 . 22889216 10.1111/j.1600-065X.2012.01153.x 4007066",
            "ntype": "ref",
            "meta": {
                "id": "ref-88",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_139",
            "content": "<REF-89> Rakhshandehroo M Knoch B Muller M : Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010 ; 2010 ; pii: 612089. 20936127 10.1155/2010/612089 2948931",
            "ntype": "ref",
            "meta": {
                "id": "ref-89",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_140",
            "content": "<REF-90> Kiss M Czimmerer Z Nagy L : The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. J Allergy Clin Immunol. 2013 ; 132 ( 2 ): 264 \u2013 286 . 23905916 10.1016/j.jaci.2013.05.044",
            "ntype": "ref",
            "meta": {
                "id": "ref-90",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_141",
            "content": "<REF-91> Horton JD Goldstein JL Brown MS : SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002 ; 109 ( 9 ): 1125 \u2013 1131 . 11994399 10.1172/JCI15593 150968",
            "ntype": "ref",
            "meta": {
                "id": "ref-91",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_142",
            "content": "<REF-92> Ikonen E : Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008 ; 9 ( 2 ): 125 \u2013 138 . 18216769 10.1038/nrm2336",
            "ntype": "ref",
            "meta": {
                "id": "ref-92",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_143",
            "content": "<REF-93> Oram JF Vaughan AM : ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006 ; 99 ( 10 ): 1031 \u2013 1043 . 17095732 10.1161/01.RES.0000250171.54048.5c",
            "ntype": "ref",
            "meta": {
                "id": "ref-93",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_144",
            "content": "<REF-94> Im SS Osborne TF : Liver x receptors in atherosclerosis and inflammation. Circ Res. 2011 ; 108 ( 8 ): 996 \u2013 1001 . 21493922 10.1161/CIRCRESAHA.110.226878 3082200",
            "ntype": "ref",
            "meta": {
                "id": "ref-94",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_145",
            "content": "<REF-95> Dove DE Linton MF Fazio S : ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects. Am J Physiol Cell Physiol. 2005 ; 288 ( 3 ): C586 \u2013 592 . 15509658 10.1152/ajpcell.00210.2004",
            "ntype": "ref",
            "meta": {
                "id": "ref-95",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_146",
            "content": "<REF-96> Hong C Duit S Jalonen P : The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J Biol Chem. 2010 ; 285 ( 26 ): 19720 \u2013 19726 . 20427281 10.1074/jbc.M110.123729 2888382",
            "ntype": "ref",
            "meta": {
                "id": "ref-96",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_147",
            "content": "<REF-97> Amuro H Ito T Miyamoto R : Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Arthritis Rheum. 2010 ; 62 ( 7 ): 2073 \u2013 2085 . 20506142 10.1002/art.27478",
            "ntype": "ref",
            "meta": {
                "id": "ref-97",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_148",
            "content": "<REF-98> Bu DX Griffin G Lichtman AH : Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol. 2011 ; 22 ( 3 ): 165 \u2013 170 . 21412153 10.1097/MOL.0b013e3283453e41",
            "ntype": "ref",
            "meta": {
                "id": "ref-98",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_149",
            "content": "<REF-99> Ceroi A Masson D Roggy A : LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. Blood. 2016 ; 128 ( 23 ): 2694 \u2013 2707 . 27702801 10.1182/blood-2016-06-724807 5271175",
            "ntype": "ref",
            "meta": {
                "id": "ref-99",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_150",
            "content": "<REF-100> A-Gonzalez N Bensinger SJ Hong C : Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity. 2009 ; 31 ( 2 ): 245 \u2013 258 . 19646905 10.1016/j.immuni.2009.06.018 2791787",
            "ntype": "ref",
            "meta": {
                "id": "ref-100",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_151",
            "content": "<REF-101> York AG Williams KJ Argus JP : Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling. Cell. 2015 ; 163 ( 7 ): 1716 \u2013 1729 . 26686653 10.1016/j.cell.2015.11.045 4783382",
            "ntype": "ref",
            "meta": {
                "id": "ref-101",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_152",
            "content": "<REF-102> Geva-Zatorsky N Sefik E Kua L : Mining the Human Gut Microbiota for Immunomodulatory Organisms. Cell. 2017 ; 168 ( 5 ): 928 \u2013 943.e911 . 28215708 10.1016/j.cell.2017.01.022",
            "ntype": "ref",
            "meta": {
                "id": "ref-102",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_153",
            "content": "<REF-103> Arbez J Lamarthee B Gaugler B : Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function. Immunobiology. 2014 ; 219 ( 8 ): 637 \u2013 643 . 24742998 10.1016/j.imbio.2014.03.013",
            "ntype": "ref",
            "meta": {
                "id": "ref-103",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_154",
            "content": "<REF-104> Cubillos-Ruiz JR Bettigole SE Glimcher LH : Molecular Pathways: Immunosuppressive Roles of IRE1\u03b1-XBP1 Signaling in Dendritic Cells of the Tumor Microenvironment. Clin Cancer Res. 2016 ; 22 ( 9 ): 2121 \u2013 2126 . 26979393 10.1158/1078-0432.CCR-15-1570 4854763",
            "ntype": "ref",
            "meta": {
                "id": "ref-104",
                "created_by": "F1000XMLParser"
            }
        },
        {
            "ix": "6-456_v1_155",
            "content": "<REF-105> Hirai M Kadowaki N Kitawaki T : Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Blood. 2011 ; 117 ( 2 ): 500 \u2013 509 . 20956804 10.1182/blood-2010-05-284737",
            "ntype": "ref",
            "meta": {
                "id": "ref-105",
                "created_by": "F1000XMLParser"
            }
        }
    ],
    "span_nodes": [
        {
            "ix": "6-456_v1_0@0",
            "content": "Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_0",
            "start": 0,
            "end": 141,
            "label": {}
        },
        {
            "ix": "6-456_v1_1@0",
            "content": "Abstract",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_1",
            "start": 0,
            "end": 7,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@0",
            "content": "There are more and more data concerning the role of cellular metabolism in innate immune cells, such as macrophages or conventional dendritic cells.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 0,
            "end": 147,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@1",
            "content": "However, few data are available currently concerning plasmacytoid dendritic cells (PDC), another type of innate immune cells.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 149,
            "end": 273,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@2",
            "content": "These cells are the main type I interferon (IFN) producing cells, but they also secrete other pro-inflammatory cytokines (e.g., tumor necrosis factor or interleukin [IL]-6) or immunomodulatory factors (e.g., IL-10 or transforming growth factor-\u03b2).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 275,
            "end": 521,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@3",
            "content": "Through these functions, PDC participate in antimicrobial responses or maintenance of immune tolerance, and have been implicated in the pathophysiology of several autoimmune diseases.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 523,
            "end": 705,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@4",
            "content": "Recent data support the idea that the glycolytic pathway (or glycolysis), as well as lipid metabolism (including both cholesterol and fatty acid metabolism) may impact some innate immune functions of PDC or may be involved in these functions after Toll-like receptor (TLR) 7/9 triggering.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 707,
            "end": 994,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@5",
            "content": "Some differences may be related to the origin of PDC (human versus mouse PDC or blood-sorted versus FLT3 ligand stimulated-bone marrow-sorted PDC).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 996,
            "end": 1142,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@6",
            "content": "The kinetics of glycolysis may differ between human and murine PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 1144,
            "end": 1210,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@7",
            "content": "In mouse PDC, metabolism changes promoted by TLR7/9 activation may depend on an autocrine/paracrine loop, implicating type I IFN and its receptor IFNAR, explaining a delayed glycolysis.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 1212,
            "end": 1396,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@8",
            "content": "Moreover, PDC functions can be modulated by the metabolism of cholesterol and fatty acids.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 1398,
            "end": 1487,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@9",
            "content": "This may occur via the production of lipid ligands that activate nuclear receptors (e.g., liver X receptor [LXR]) in PDC or through limiting intracellular cholesterol pool size (by statins or LXR agonists) in these cells.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 1489,
            "end": 1709,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@10",
            "content": "Finally, lipid-activated nuclear receptors ( i.e ., LXR or peroxisome proliferator activated receptor) may also directly interact with pro-inflammatory transcription factors, such as NF-\u03baB.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 1711,
            "end": 1899,
            "label": {}
        },
        {
            "ix": "6-456_v1_2@11",
            "content": "Here, we discuss how glycolysis and lipid metabolism may modulate PDC functions and how this may be harnessed in pathological situations where PDC play a detrimental role.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_2",
            "start": 1901,
            "end": 2071,
            "label": {}
        },
        {
            "ix": "6-456_v1_3@0",
            "content": "1. Introduction",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_3",
            "start": 0,
            "end": 14,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@0",
            "content": "More and more data are available concerning the role of cellular metabolism in innate immune cells, such as macrophages or conventional dendritic cells (cDC) <REF-1> \u2013 <REF-3> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 0,
            "end": 176,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@1",
            "content": "However, few data are available currently concerning plasmacytoid dendritic cells (PDC).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 178,
            "end": 265,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@2",
            "content": "PDC belong to the family of dendritic cells (DC) and possess specific features that distinguish them from cDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 267,
            "end": 376,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@3",
            "content": "PDC represent the main type I interferon (IFN) secreting cells and play a critical role in antimicrobial immune responses.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 378,
            "end": 499,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@4",
            "content": "The involvement of PDC through IFN-\u03b1 secretion has also been reported in several autoimmune diseases (see section 2.4).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 501,
            "end": 619,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@5",
            "content": "Furthermore, PDC release other pro-inflammatory cytokines, as well as immunoregulatory factors.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 621,
            "end": 715,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@6",
            "content": "In these ways, they may exert pro-inflammatory functions or, on the contrary, participate in tolerance mechanisms.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 717,
            "end": 830,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@7",
            "content": "In this Review article, based on recent publications <REF-4> \u2013 <REF-6> , we will discuss how the innate immune functions of PDC may be modulated by or dependent on the glycolytic pathway (also known as glycolysis) and lipid metabolism, including the metabolism of cholesterol and fatty acids.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 832,
            "end": 1123,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@8",
            "content": "Before that, we will describe the innate functions of PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 1125,
            "end": 1182,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@9",
            "content": "PDC also have the capacity to present antigens to T cells and to polarize CD4 + helper T cell responses, as well as those interacting with B cells <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 1184,
            "end": 1339,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@10",
            "content": "These functions will not be discussed in this article, since no sufficient data are available concerning the impact of metabolism on the capacity of PDC to interact with the adaptive immune system.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 1341,
            "end": 1537,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@11",
            "content": "Although the \u201cimmunometabolism\u201d (as defined in Ref# <REF-2> ) includes six metabolic pathways (glycolysis, the tricarboxylic acid [TCA] cycle, the pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis and amino acid metabolism) that influence immune cell effector functions <REF-2> , this article will focus on glycolysis and lipid metabolism (extended to the cholesterol metabolism).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 1539,
            "end": 1938,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@12",
            "content": "Concerning amino acid metabolism, PDC innate functions have been shown to be modulated by mammalian target of rapamycin (mTOR) signaling.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 1940,
            "end": 2076,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@13",
            "content": "This central metabolic regulator, mTOR can sense amino acid sufficiency in lysosomes, and promotes mRNA translation and lipid synthesis to support cell growth and proliferation <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 2078,
            "end": 2263,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@14",
            "content": "Furthermore, mTOR, through its association with regulatory-associated protein of mTOR (RAPTOR), constitutes the mTOR complex 1 (mTORC1), which is connected with other metabolic pathways (see section 3.1).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 2265,
            "end": 2468,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@15",
            "content": "This will be discussed briefly, since the role of mTOR in innate immune cell functions has been reviewed recently <REF-3> , <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 2470,
            "end": 2602,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@16",
            "content": "Finally, concerning amino acid metabolism, PDC are able to sense amino acid deficiency through their expression of GCN2 (general control nonderepressible 2) serine/threonine kinase.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 2604,
            "end": 2784,
            "label": {}
        },
        {
            "ix": "6-456_v1_4@17",
            "content": "Indeed, the suppression of interleukin (IL)-6 production in PDC by indoleamine 2,3-dioxygenase (IDO) involves GCN2 kinase <REF-9> (see section 2.3).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_4",
            "start": 2786,
            "end": 2933,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@0",
            "content": "What are the main roles of the immunometabolism in immune cells?",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 0,
            "end": 63,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@1",
            "content": "First of all, this is a way to provide energy.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 65,
            "end": 110,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@2",
            "content": "Cells need energy to execute cellular functions, such as survival, proliferation or cytokine secretion.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 112,
            "end": 214,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@3",
            "content": "This energy is provided as adenosine triphosphate (ATP) by several pathways.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 216,
            "end": 291,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@4",
            "content": "The first is glycolysis, which involves the conversion of glucose to pyruvate in the cytosol.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 293,
            "end": 385,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@5",
            "content": "The second pathway is the TCA cycle (also called the Krebs cycle), which donates electrons to the electron transport chain located in the mitochondria to fuel oxidative phosphorylation or respiration (OXPHOS).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 387,
            "end": 595,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@6",
            "content": "This OXPHOS process generates ATP in the mitochondria.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 597,
            "end": 650,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@7",
            "content": "Other substrates, such as fatty acids via \u03b2-oxidation (also called fatty acid oxidation [FAO]), can replenish the TCA cycle to fuel OXPHOS <REF-10> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 652,
            "end": 800,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@8",
            "content": "In addition to substrates used for energy production and de novo biosynthesis, mitochondrial metabolic pathways (such as the TCA, FAO, or OXPHOS) provide substrates for epigenetic modifications of DNA and histones <REF-11> , <REF-12> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 802,
            "end": 1036,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@9",
            "content": "This is the case, for instance, of acetyl-CoA for histone acetylation, which is associated with active transcription <REF-11> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 1038,
            "end": 1164,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@10",
            "content": "This connects mitochondrial metabolism to epigenetic regulation <REF-12> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 1166,
            "end": 1239,
            "label": {}
        },
        {
            "ix": "6-456_v1_5@11",
            "content": "This specific aspect will be briefly discussed in the Conclusions of this article.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_5",
            "start": 1241,
            "end": 1322,
            "label": {}
        },
        {
            "ix": "6-456_v1_6@0",
            "content": "2. The innate immune functions of plasmacytoid dendritic cells",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_6",
            "start": 0,
            "end": 61,
            "label": {}
        },
        {
            "ix": "6-456_v1_7@0",
            "content": "PDC belong to the DC family and possess specific features that distinguish them from cDC <REF-13> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_7",
            "start": 0,
            "end": 98,
            "label": {}
        },
        {
            "ix": "6-456_v1_7@1",
            "content": "These features include: the capacity to rapidly and massively produce type I IFN ( i.e ., IFN-\u03b1/\u03b2), the expression of a particular set of pathogen-recognition receptors (PRR), leading to the recognition of specific pathogen-associated molecular pattern (PAMP) and damage-associated molecular pattern (DAMP) molecules, as well as a preferential localization in lymphoid organs <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_7",
            "start": 100,
            "end": 484,
            "label": {}
        },
        {
            "ix": "6-456_v1_8@0",
            "content": "PDC were firstly identified in human as the major IFN-\u03b1 producing cells, and thus initially called IPC (IFN-\u03b1 producing cells) <REF-14> , <REF-15> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_8",
            "start": 0,
            "end": 147,
            "label": {}
        },
        {
            "ix": "6-456_v1_8@1",
            "content": "After this characterization in human, its murine PDC counterpart was then isolated <REF-16> \u2013 <REF-19> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_8",
            "start": 149,
            "end": 252,
            "label": {}
        },
        {
            "ix": "6-456_v1_8@2",
            "content": "Human PDC are usually identified as CD4 + , CD303 + (previously known as BDCA-2), and CD123 high , whereas mouse PDC are CD11c int , B220 + , SIGLEC-H + , and CD317 + <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_8",
            "start": 254,
            "end": 429,
            "label": {}
        },
        {
            "ix": "6-456_v1_8@3",
            "content": "Despite the difference in phenotypes of human and mouse PDC, PDC from both species exhibit a conserved genetic signature with some common genes (e.g., tlr7 ) <REF-20> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_8",
            "start": 431,
            "end": 598,
            "label": {}
        },
        {
            "ix": "6-456_v1_8@4",
            "content": "Moreover, PDC exhibit specific transcription factors, such as the transcription factor E2-2 (also known as TCF4) or SPIB <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_8",
            "start": 600,
            "end": 729,
            "label": {}
        },
        {
            "ix": "6-456_v1_8@5",
            "content": "A differentiation/ontogeny process distinct from those of cDC has been reported <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_8",
            "start": 731,
            "end": 819,
            "label": {}
        },
        {
            "ix": "6-456_v1_9@0",
            "content": "2.1. PDC ontogeny and localization",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_9",
            "start": 0,
            "end": 33,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@0",
            "content": "Development of PDC from hematopoietic stem cells occurs in the bone marrow.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 0,
            "end": 74,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@1",
            "content": "As mentioned above, PDC-defining transcription factors have been identified, such as E2-2 (TCF4) or SPIB <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 76,
            "end": 189,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@2",
            "content": "After differentiation in the bone marrow, PDC are released into the bloodstream for homing to different lymphoid tissues <REF-21> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 191,
            "end": 321,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@3",
            "content": "Thus, PDC isolated from blood of healthy donors or patients consist in PDC migrating to these tissues <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 323,
            "end": 433,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@4",
            "content": "In steady state, PDC reside mainly in T cell-rich areas in lymph nodes and secondary lymphoid organs <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 435,
            "end": 544,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@5",
            "content": "Localizations of PDC in other lymphoid organs, such as Peyer\u2019s patches of the gut <REF-22> , and tonsils <REF-23> , have been reported.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 546,
            "end": 680,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@6",
            "content": "PDC residing in non-lymphoid tissue \u2013 such as the airways <REF-24> and the liver <REF-25> \u2013 exert a critical role in steady state by regulating mucosal immunity and maintaining tolerance to inhaled or ingested antigens <REF-26> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 682,
            "end": 910,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@7",
            "content": "Finally, PDC are also present in the thymus during homeostatic conditions, where they play a role in central tolerance <REF-27> \u2013 <REF-29> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 912,
            "end": 1051,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@8",
            "content": "In contrast, during infections or autoimmune diseases, PDC migrate to inflamed lymph nodes <REF-14> or inflamed epithelia <REF-14> , <REF-23> , <REF-30> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 1053,
            "end": 1206,
            "label": {}
        },
        {
            "ix": "6-456_v1_10@9",
            "content": "The microenvironment in which PDC are present may influence oxygen and nutrient availability, which impacts on metabolic pathways (see section 3).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_10",
            "start": 1208,
            "end": 1353,
            "label": {}
        },
        {
            "ix": "6-456_v1_11@0",
            "content": "2.2. Type I IFN and pro-inflammatory cytokines secreted by PDC",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_11",
            "start": 0,
            "end": 61,
            "label": {}
        },
        {
            "ix": "6-456_v1_12@0",
            "content": "PDC constitute a DC subset, specialized in antimicrobial immune responses.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_12",
            "start": 0,
            "end": 73,
            "label": {}
        },
        {
            "ix": "6-456_v1_12@1",
            "content": "This occurs mainly through a rapid type I IFN (IFN-\u03b1/\u03b2) production <REF-7> , <REF-31> , <REF-32> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_12",
            "start": 75,
            "end": 172,
            "label": {}
        },
        {
            "ix": "6-456_v1_12@2",
            "content": "Selective depletion of PDC by genetic approaches supports the critical role of PDC for early IFN-\u03b1 production after microbial infections <REF-33> \u2013 <REF-35> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_12",
            "start": 174,
            "end": 331,
            "label": {}
        },
        {
            "ix": "6-456_v1_12@3",
            "content": "The type I IFN response is triggered by Toll-like receptor (TLR) signaling after PAMP recognition.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_12",
            "start": 333,
            "end": 430,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@0",
            "content": "Compared to cDC, PDC express a limited number of PRR.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 0,
            "end": 52,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@1",
            "content": "TLR 7/9 are expressed by both human and mouse PDC <REF-7> , <REF-36> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 54,
            "end": 123,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@2",
            "content": "These two endoplasmic TLRs allow PDC to recognize cytosine-phosphate guanosine (CpG)-rich unmethylated DNA from bacteria and DNA viruses, <REF-7> , <REF-31> , <REF-37> , as well as viral single-stranded RNA (ssRNA), <REF-31> , <REF-38> , <REF-39> , respectively.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 125,
            "end": 386,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@3",
            "content": "In addition, PDC are able to recognize via TLR7/9 mammalian nucleic acids <REF-40> , in particular when these nucleic acids are complexed or associated with antimicrobial peptides (e.g., LL37) <REF-41> , <REF-42> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 388,
            "end": 601,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@4",
            "content": "Once PDC have sensed pathogens or DAMP through endoplasmic TLR, signaling is mediated via MyD88 (myeloid differentiation factor 88), a docking protein for IRAK1\u20444 (IL-1R-associated kinase 1/4), and the ubiquitin ligase TRAF6 (tumor necrosis factor [TNF] receptor-associated factor 6).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 603,
            "end": 886,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@5",
            "content": "IFN-regulatory factor 7 (IRF7) is then phosphorylated and translocates into the nucleus to induce type I IFN gene and IFN-inducible gene transcription ( Figure 1 ) <REF-43> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 888,
            "end": 1061,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@6",
            "content": "This is true for human PDC <REF-36> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 1063,
            "end": 1099,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@7",
            "content": "Concerning mouse PDC, other intermediates may participate in type I IFN mRNA transcription in the TLR-dependent IRF7 signaling pathway.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 1101,
            "end": 1235,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@8",
            "content": "This involves a complex, associating TRAF3, IRAK1, osteopontin, PI3K (phosphatidylinositol 3-kinase) and IKK\u03b1 (I\u03baB kinase-\u03b1) <REF-36> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 1237,
            "end": 1371,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@9",
            "content": "A critical role of PI3K has also been reported for type I IFN production by human PDC <REF-44> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 1373,
            "end": 1468,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@10",
            "content": "In addition, in TLR7- or TLR9-activated human PDC, TRAF6 can also recruit TAK1 (transforming growth factor [TGF]-\u03b2-activating kinase; also known as MAP3K7 for mitogen-activated protein kinase kinase kinase 7) to trigger the synthesis of pro-inflammatory cytokines via NF-\u03baB activation <REF-36> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 1470,
            "end": 1764,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@11",
            "content": "In mouse PDC, TAK-1/MAP3K7 activates the mitogen-activated protein kinase (MAPK) pathway that upregulates costimulatory molecule expression (e.g., CD40, CD80 or CD86) <REF-36> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 1766,
            "end": 1942,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@12",
            "content": "Both human and mouse PDC have been shown to secrete TNF-\u03b1 <REF-4> \u2013 <REF-6> , <REF-45> , <REF-46> , IL-6 <REF-4> \u2013 <REF-6> , <REF-45> , <REF-46> , IL-8 <REF-45> \u2013 <REF-47> or granulocyte macrophage colony-stimulating factor (GM-CSF) <REF-45> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 1944,
            "end": 2186,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@13",
            "content": "This TLR-induced cytokine synthesis is regulated in PDC by the translocation of NF-\u03baB, p38 MAPK and c-Jun N-terminal kinase (JNK) into the nucleus.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 2188,
            "end": 2334,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@14",
            "content": "In human PDC, the association of NF-\u03baB p65 and p50 subunits with IRF5 appears to be the master inducer of IL-6 mRNA transcription <REF-36> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 2336,
            "end": 2475,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@15",
            "content": "Depending on the TLR9 ligand used, the cytokine response can be different.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 2477,
            "end": 2550,
            "label": {}
        },
        {
            "ix": "6-456_v1_13@16",
            "content": "For instance, type A CpG-containing oligonucleotide (CpG-ODN) (CpGA) induces mainly type I IFN production, whereas type B CpG-ODN (CpGB) induces pro-inflammatory cytokine secretion and upregulation of co-stimulatory molecules <REF-48> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_13",
            "start": 2552,
            "end": 2787,
            "label": {}
        },
        {
            "ix": "6-456_v1_14@0",
            "content": "Figure 1.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_14",
            "start": 0,
            "end": 8,
            "label": {}
        },
        {
            "ix": "6-456_v1_16@0",
            "content": "In addition to virus or pathogen-expressing TLR7/TLR9 ligands or synthetic ligands, PDC can be activated to release cytokines by other stimuli, including DAMP.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_16",
            "start": 0,
            "end": 158,
            "label": {}
        },
        {
            "ix": "6-456_v1_16@1",
            "content": "PDC express RAGE (receptor for advanced glycation end products), a PRR that recognizes high-mobility group box-1 (HMGB1) <REF-49> , <REF-50> , a nuclear DNA-binding protein released from necrotic cells <REF-51> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_16",
            "start": 160,
            "end": 371,
            "label": {}
        },
        {
            "ix": "6-456_v1_16@2",
            "content": "PDC can also be activated by neutrophil extracellular traps (NET), released by dying or activated neutrophils.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_16",
            "start": 373,
            "end": 482,
            "label": {}
        },
        {
            "ix": "6-456_v1_16@3",
            "content": "These NET contain DNA fibers, histones, as well as a large amount of LL37 and HMGB1 <REF-52> , <REF-53> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_16",
            "start": 484,
            "end": 588,
            "label": {}
        },
        {
            "ix": "6-456_v1_16@4",
            "content": "Human PDC can also be activated by CD154 from activated platelets <REF-54> or endothelial-derived microvesicles <REF-6> , <REF-46> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_16",
            "start": 590,
            "end": 721,
            "label": {}
        },
        {
            "ix": "6-456_v1_16@5",
            "content": "Other PRR are present in the cytoplasm of PDC and dedicated to RNA virus recognition.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_16",
            "start": 723,
            "end": 807,
            "label": {}
        },
        {
            "ix": "6-456_v1_16@6",
            "content": "This is the case of retinoic acid-inducible gene (RIG)-I-like receptors, DHX9 or DHX36 <REF-55> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_16",
            "start": 809,
            "end": 905,
            "label": {}
        },
        {
            "ix": "6-456_v1_17@0",
            "content": "2.3. Regulatory or immunosuppressive factors expressed by PDC",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_17",
            "start": 0,
            "end": 60,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@0",
            "content": "In addition to type I IFN and pro-inflammatory cytokine production, PDC have regulatory and immunosuppressive functions <REF-26> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 0,
            "end": 129,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@1",
            "content": "This has been demonstrated by in vivo PDC depletion studies <REF-24> , <REF-56> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 131,
            "end": 211,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@2",
            "content": "For instance, PDC exert immunoregulatory functions in the lung, preventing deleterious asthmatic reactions <REF-24> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 213,
            "end": 329,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@3",
            "content": "Moreover, PDC may express immunosuppressive factors that confer tolerogenic properties <REF-26> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 331,
            "end": 427,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@4",
            "content": "One major factor is the enzyme IDO <REF-26> , <REF-57> , <REF-58> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 429,
            "end": 495,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@5",
            "content": "This enzyme is involved in the catabolism of the essential amino acid, tryptophan, and the synthesis of kynurenines.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 497,
            "end": 612,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@6",
            "content": "Tryptophan is required for T cell proliferation and kynurenines have immunosuppressive properties.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 614,
            "end": 711,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@7",
            "content": "Engagement of several receptors, including CD80/CD86, or TLR9 <REF-59> , participates in active IDO induction.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 713,
            "end": 822,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@8",
            "content": "Amino acid withdrawal resulting from IDO enzymatic activity, stimulates the GCN2 kinase in PDC and then prevents IL-6 secretion by PDC <REF-9> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 824,
            "end": 967,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@9",
            "content": "Moreover, IDO exerts a regulatory function independently of its catabolic activity by participating in TGF-\u03b2-signaling pathway <REF-60> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 969,
            "end": 1105,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@10",
            "content": "Receptors expressed by PDC, such as immunoglobulin-like transcript 7 <REF-61> or CD303 <REF-62> may also inhibit TLR7/9-mediated type I IFN production.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 1107,
            "end": 1257,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@11",
            "content": "In addition, PDC can produce, under certain circumstances, high levels of immunosuppressive cytokines, such as IL-10 <REF-19> , <REF-25> or TGF-\u03b2 <REF-56> , <REF-63> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 1259,
            "end": 1425,
            "label": {}
        },
        {
            "ix": "6-456_v1_18@12",
            "content": "In addition, PDC participate in the maintenance of immune tolerance via the induction and/or expansion of regulatory T cells (please refer to Refs# <REF-7> , <REF-63> ; this is out of the scope of this review).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_18",
            "start": 1427,
            "end": 1636,
            "label": {}
        },
        {
            "ix": "6-456_v1_19@0",
            "content": "When one evokes cellular metabolism, cell survival has to be discussed.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_19",
            "start": 0,
            "end": 70,
            "label": {}
        },
        {
            "ix": "6-456_v1_19@1",
            "content": "IL-3 has been identified as a critical factor for the development and survival of PDC <REF-64> , <REF-65> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_19",
            "start": 72,
            "end": 178,
            "label": {}
        },
        {
            "ix": "6-456_v1_19@2",
            "content": "This cytokine interacts with the IL-3 receptor associating two chains, the common chain CD131 and the IL-3R\u03b1 chain (CD123) that is highly expressed by PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_19",
            "start": 180,
            "end": 334,
            "label": {}
        },
        {
            "ix": "6-456_v1_19@3",
            "content": "Signaling through this receptor involves Janus kinase 2 (JAK2), Src kinases, transcription factors STAT3/STAT5 (signal transducer and activator of transcription 3/5) and Akt ( Figure 1 ) <REF-66> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_19",
            "start": 336,
            "end": 532,
            "label": {}
        },
        {
            "ix": "6-456_v1_19@4",
            "content": "Another cytokine that shares the common chain CD131 and influences PDC survival with nearly the same signaling pathway is GM-CSF ( Figure 1 ) <REF-65> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_19",
            "start": 534,
            "end": 685,
            "label": {}
        },
        {
            "ix": "6-456_v1_19@5",
            "content": "Finally, PDC express IFNAR, the membrane receptor for type I IFN (IFN-\u03b1 or IFN-\u03b2) that consists of two subunits, IFNAR1 and IFNAR2.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_19",
            "start": 687,
            "end": 817,
            "label": {}
        },
        {
            "ix": "6-456_v1_19@6",
            "content": "Engagement of this receptor by its ligand activates JAK1 (associated with IFNAR1) and tyrosine kinase 2 (associated with IFNAR2) that phosphorylate and activate STAT1 and STAT2, respectively ( Figure 1 ) <REF-66> , <REF-67> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_19",
            "start": 819,
            "end": 1043,
            "label": {}
        },
        {
            "ix": "6-456_v1_20@0",
            "content": "2.4. Implications of PDC in diseases",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_20",
            "start": 0,
            "end": 35,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@0",
            "content": "Before discussing the role of immunometabolism, the role of PDC in beneficial and detrimental immune responses will be briefly detailed.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 0,
            "end": 135,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@1",
            "content": "As type I IFN producing cells, PDC play a major beneficial role in antimicrobial immune responses <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 137,
            "end": 243,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@2",
            "content": "However, uncontrolled IFN-\u03b1 production in acute viral infection may be detrimental to the host.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 245,
            "end": 339,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@3",
            "content": "Moreover, high levels of type I IFN released by PDC may be detrimental in chronic inflammatory or autoimmune diseases <REF-7> , <REF-54> , <REF-68> \u2013 <REF-71> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 341,
            "end": 500,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@4",
            "content": "This is the case of systemic lupus erythematosus (SLE) <REF-52> \u2013 <REF-54> , type 1 diabetes <REF-69> , and psoriasis <REF-41> , <REF-71> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 502,
            "end": 640,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@5",
            "content": "Furthermore, PDC may participate in inflammatory autoimmune disorders ( i.e ., systemic sclerosis <REF-70> or autoimmune vasculitis <REF-72> ) via the secretion of other pro-inflammatory cytokines than type I IFN <REF-72> or chimiokines <REF-70> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 642,
            "end": 888,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@6",
            "content": "Since PDC infiltrate inflamed tissues, they may release pro-inflammatory factors participating in the amplification of diseases.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 890,
            "end": 1017,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@7",
            "content": "Therefore, PDC have been reported to infiltrate acute graft- versus -host disease lesions, including gastro-intestinal <REF-73> and cutaneous <REF-74> lesions.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 1019,
            "end": 1177,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@8",
            "content": "PDC emerge as cells present in atherosclerotic plaques and may play a role in atherosclerosis <REF-66> , <REF-75> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 1179,
            "end": 1293,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@9",
            "content": "Atherosclerotic plaques are enriched in lipids.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 1295,
            "end": 1341,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@10",
            "content": "This may modify the lipid metabolism of infiltrated PDC by the uptake of lipid-enriched lipoproteins or oxidized lipoproteins, and subsequently PDC functions (see section 3.3.3).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 1343,
            "end": 1520,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@11",
            "content": "Finally, insufficient or exhausted production of IFN-\u03b1 during chronic viral infections (e.g., chronic hepatitis C virus or HIV) has also been reported <REF-76> , <REF-77> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 1522,
            "end": 1693,
            "label": {}
        },
        {
            "ix": "6-456_v1_21@12",
            "content": "Thus, the metabolism of PDC may be pharmacologically modified in order to restore type I IFN production.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_21",
            "start": 1695,
            "end": 1798,
            "label": {}
        },
        {
            "ix": "6-456_v1_22@0",
            "content": "3. The influence of the metabolism on innate immune functions of plasmacytoid dendritic cells",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_22",
            "start": 0,
            "end": 92,
            "label": {}
        },
        {
            "ix": "6-456_v1_23@0",
            "content": "3.1. PDC innate immune functions and mTOR signaling",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_23",
            "start": 0,
            "end": 50,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@0",
            "content": "The kinase mTOR is a key regulator of different biological processes, including metabolism <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 0,
            "end": 99,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@1",
            "content": "This is a serine/threonine protein kinase that senses and integrates signals (such as nutrients and oxygen) originating from the extracellular milieu, as well as intracellular signals <REF-78> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 101,
            "end": 294,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@2",
            "content": "In fact, mTOR is the catalytic subunit of two different complexes, mTORC1 and mTORC2.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 296,
            "end": 380,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@3",
            "content": "As mentioned briefly in the Introduction, mTORC1 is connected with several metabolic pathways.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 382,
            "end": 475,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@4",
            "content": "Indeed, mTORC1 promotes glycolysis through hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) <REF-8> , as well as cholesterol and fatty acid synthesis using TCA cycle intermediates through a pathway involving sterol regulatory element-binding proteins (SREBP) and the nuclear receptor, peroxisome proliferator-activated receptor (PPAR) \u03b3 <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 477,
            "end": 810,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@5",
            "content": "Cholesterol and fatty acids are used as \u201cbuilding blocks\u201d <REF-8> for complete maturation of endoplasmic reticulum (ER) and Golgi apparatus.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 812,
            "end": 951,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@6",
            "content": "Both organelles can promote the transport of pro-inflammatory cytokines within the cell that precedes their secretion <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 953,
            "end": 1079,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@7",
            "content": "In addition, mTORC1 can have a negative effect on mitochondrial OXPHOS by inducing the expression of type I IFN and production of nitric oxide, which subsequently promotes aerobic glycolysis <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 1081,
            "end": 1280,
            "label": {}
        },
        {
            "ix": "6-456_v1_24@8",
            "content": "This has been well described in macrophages <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_24",
            "start": 1282,
            "end": 1334,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@0",
            "content": "Concerning PDC innate immune functions, mTOR plays an important role in type I IFN production <REF-79> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 0,
            "end": 103,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@1",
            "content": "The TLR9 ligand, CpGA, stimulates the rapid phosphorylation of mTOR and its downstream targets, the p70 ribosomal S6 kinase 1 and the eukaryotic translation initiation factor 4E-binding protein (4E-BP) <REF-79> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 105,
            "end": 316,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@2",
            "content": "Thus, mTOR is involved in the TLR9-induced type I IFN signaling pathway ( Figure 2 ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 318,
            "end": 402,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@3",
            "content": "Using the mTORC1 inhibitor rapamycin, the same authors demonstrated that TLR7/9-mediated production of type I IFN is inhibited in both human and mouse PDC <REF-79> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 404,
            "end": 568,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@4",
            "content": "These data have been confirmed in vivo using live attenuated viral yellow fever vaccine <REF-79> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 570,
            "end": 667,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@5",
            "content": "The virus responsible for yellow fever is an ssRNA virus and TLR7 recognizes ssRNA <REF-38> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 669,
            "end": 761,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@6",
            "content": "Rapamycin may act at two levels: i ) by inactivating via the inhibition of 4E-BP phosphorylation the nuclear translocation of IRF7 required for type I IFN gene transcription; and ii ) by blocking the formation of the TLR9-MyD88 complex via the p70 ribosomal S6 kinase 1 <REF-78> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 763,
            "end": 1042,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@7",
            "content": "In addition to type I IFN production, the inhibition of mTORC1 reduces TLR7/9-induced TNF and IL-6 production by human and mouse PDC <REF-79> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 1044,
            "end": 1186,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@8",
            "content": "Overall, mTOR signaling is involved in the TLR9-induced type I IFN signaling pathway and blocking mTORC1 inhibits TLR7/9-stimulated secretion of pro-inflammatory cytokines ( i.e., type I IFN, TNF and IL-6) by PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 1188,
            "end": 1400,
            "label": {}
        },
        {
            "ix": "6-456_v1_25@9",
            "content": "Thus, the use of mTOR inhibitors may block the detrimental pro-inflammatory functions of PDC in inflammatory disorders, but may also prevent the beneficial antimicrobial response of PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_25",
            "start": 1402,
            "end": 1587,
            "label": {}
        },
        {
            "ix": "6-456_v1_26@0",
            "content": "Figure 2.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_26",
            "start": 0,
            "end": 8,
            "label": {}
        },
        {
            "ix": "6-456_v1_28@0",
            "content": "Lastly, mTORC1 stimulates glycolysis in innate immune cells, at least via HIF-1\u03b1 induction, but also through the increased expression of the glucose transporter 1 (GLUT1) at the cell surface ( Figure 2 ) <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_28",
            "start": 0,
            "end": 212,
            "label": {}
        },
        {
            "ix": "6-456_v1_28@1",
            "content": "GLUT1 enhances glucose uptake from the extracellular milieu <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_28",
            "start": 214,
            "end": 282,
            "label": {}
        },
        {
            "ix": "6-456_v1_28@2",
            "content": "Thus, the implication of mTOR signaling pathway in the response of PDC to TLR9 ligand <REF-79> suggests that glycolysis may be triggered in the cells.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_28",
            "start": 284,
            "end": 433,
            "label": {}
        },
        {
            "ix": "6-456_v1_28@3",
            "content": "This will be discussed in the next section.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_28",
            "start": 435,
            "end": 477,
            "label": {}
        },
        {
            "ix": "6-456_v1_29@0",
            "content": "3.2. PDC innate immune functions and glycolysis",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_29",
            "start": 0,
            "end": 46,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@0",
            "content": "The glycolytic pathway (also known as glycolysis) involves the uptake of extracellular glucose ( i.e ., present in the microenvironment) and its conversion in the cytosol to generate pyruvate <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 0,
            "end": 200,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@1",
            "content": "Most pyruvate is then excreted from the cells as lactate after a process called aerobic glycolysis.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 202,
            "end": 300,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@2",
            "content": "This is a relatively inefficient pathway for the generation of energy ( i.e ., cellular ATP) compared to the TCA cycle coupled to OXPHOS <REF-80> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 302,
            "end": 448,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@3",
            "content": "The preferential use of glycolysis versus the TCA cycle and OXPHOS depends on oxygen availability <REF-2> , <REF-80> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 450,
            "end": 567,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@4",
            "content": "Glycolysis is favored during hypoxia, a situation encountered, for instance, in joints during rheumatoid arthritis or in the inflamed colon during Crohn\u2019s disease <REF-80> - PDC can be present in both inflamed tissues ( i.e ., the synovial fluid <REF-81> \u2013 <REF-83> and the colon <REF-73> , <REF-84> ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 569,
            "end": 870,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@5",
            "content": "This energy provided by glycolysis may represent the resources necessary for cytokine secretion, since PDC does not proliferate in the same way as adaptive cells ( i.e ., T cells).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 872,
            "end": 1051,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@6",
            "content": "However, PDC become highly secretory upon activation <REF-7> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 1053,
            "end": 1114,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@7",
            "content": "Finally, growth factors triggering PI3K and MAPK in their signaling pathway promote, in theory, the cellular use of glycolysis <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 1116,
            "end": 1251,
            "label": {}
        },
        {
            "ix": "6-456_v1_30@8",
            "content": "This may be the case when PDC are stimulated by TLR7/9 ligands (see previous section).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_30",
            "start": 1253,
            "end": 1338,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@0",
            "content": "The exposure of human PDC to two different ssRNA viruses, influenza virus (Flu) and Rhinovirus (RV) \u2013 triggering the TLR7 pathway via ssRNA recognition <REF-38> \u2013 activates HIF-1\u03b1 <REF-4> , a major regulator of metabolism ( Figure 2A ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 0,
            "end": 235,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@1",
            "content": "Indeed, HIF-1\u03b1 is critical for glycolysis to generate ATP, since it induces the expression of different glycolytic enzymes, such as hexokinase and phosphofructokinase <REF-80> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 237,
            "end": 413,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@2",
            "content": "In addition to HIF-1\u03b1 activation, the TLR7 agonist gardiquimod, as well as Flu and RV, induces early glycolysis (within minutes) in human PDC, as attested by elevated extracellular acidification rate (ECAR; a reflection of lactate secretion in extracellular milieu, an indicator of glycolysis in real time) and elevated rates of lactate production <REF-4> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 415,
            "end": 771,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@3",
            "content": "Moreover, the inhibition of glycolysis by 2-deoxyglucose (2-DG; a glycolytic inhibitor) impairs ssRNA virus- or TLR7 ligand-induced type I IFN by PDC, as well as the upregulation of HLA-DR, CD80 and CD86 at PDC cell surface <REF-4> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 773,
            "end": 1005,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@4",
            "content": "Furthermore, 2-DG inhibits the increase of IFNA , CD80 and CD86 mRNA induced by exposure to Flu <REF-4> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 1007,
            "end": 1111,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@5",
            "content": "This suggests that glycolysis induced by the TLR7 pathway regulates these genes at the transcriptional level.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 1113,
            "end": 1221,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@6",
            "content": "The involvement of the TLR7 pathway in glycolysis was supported by the use of chloroquine, known to disrupt endosomal acidification required for TLR7 signaling <REF-85> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 1223,
            "end": 1392,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@7",
            "content": "Chloroquine treatment inhibits the lactate production by PDC in response to Flu or gardiquimod <REF-4> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 1394,
            "end": 1497,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@8",
            "content": "Overall, ssRNA viruses enhance glycolysis in human PDC via the TLR7 pathway ( Figure 2A ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 1499,
            "end": 1588,
            "label": {}
        },
        {
            "ix": "6-456_v1_31@9",
            "content": "This finding was confirmed in vivo , since viral infection using live attenuated influenza vaccine increases glycolysis in ex vivo isolated human PDC and correlates with IFN-\u03b1 production by these cells <REF-4> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_31",
            "start": 1590,
            "end": 1800,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@0",
            "content": "These data contrast with a recent report showing that mouse PDC activation in response to the TLR9 ligand, CpGA, is not accompanied by a rapid change in ECAR ( i.e ., during the first 150 minutes).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 0,
            "end": 196,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@1",
            "content": "This contrasts with data obtained in the same experiments using cDC \u2013 as a control of PDC \u2013 stimulated by either lipopolysaccharide, Poly(I:C) or CpGA <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 198,
            "end": 357,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@2",
            "content": "However, glycolysis is detected late (24 hours) in TLR9-stimulated mouse PDC <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 359,
            "end": 444,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@3",
            "content": "Moreover, the authors also studied the role of the TLR7 pathway in mouse PDC, but not extensively.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 446,
            "end": 543,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@4",
            "content": "Again, they found a delayed activation of glycolysis after stimulation of mouse PDC with the TLR7 agonist imiquimod <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 545,
            "end": 669,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@5",
            "content": "Thus, whether the origin of PDC (human <REF-4> versus mouse <REF-5> ) or their source (sorted from peripheral blood mononuclear cells <REF-4> versus sorted from FLT3-stimulated ligand-bone marrow cultures <REF-5> ) may explain this discrepancy remains to be determined.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 671,
            "end": 939,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@6",
            "content": "Another difference between these two studies lies in the direct effect of IFN-\u03b1 on PDC metabolism.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 941,
            "end": 1038,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@7",
            "content": "Treatment of human PDC with IFN-\u03b1 is not sufficient to induce PDC lactate efflux ( i.e ., glycolysis) and IFN-\u03b1/\u03b2 receptor (IFNAR) blockade does not affect PDC lactate efflux induced by Flu infection <REF-4> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 1040,
            "end": 1248,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@8",
            "content": "This suggests that type I IFN does not regulate in an autocrine/paracrine manner Flu-induced early glycolysis in human PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 1250,
            "end": 1372,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@9",
            "content": "In contrast, this autocrine/paracrine loop involving type I IFN and its receptor may play a significant role in TLR-induced glycolysis in mouse PDC ( Figure 2B ) <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 1374,
            "end": 1544,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@10",
            "content": "Nevertheless, all these data support that glycolysis plays a role as a source of energy in the production of type I IFN, pro-inflammatory cytokines (IL-6 and TNF) and costimulatory molecule upregulation by PDC in response to TLR7/9 activation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 1546,
            "end": 1788,
            "label": {}
        },
        {
            "ix": "6-456_v1_32@11",
            "content": "The modulation of this metabolic pathway may limit uncontrolled pro-inflammatory cytokines by PDC in pathological situations or may restore type I IFN production in chronic infectious diseases.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_32",
            "start": 1790,
            "end": 1982,
            "label": {}
        },
        {
            "ix": "6-456_v1_33@0",
            "content": "3.3. PDC innate immune functions and lipid metabolism",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_33",
            "start": 0,
            "end": 52,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@0",
            "content": "In this section, we will discuss fatty acid metabolism, including fatty acid oxidation (FAO; also known as mitochondrial \u03b2-oxidation) and fatty acid synthesis, as well as cholesterol metabolism.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 0,
            "end": 193,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@1",
            "content": "Lipid metabolism is regulated by many key enzymes.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 195,
            "end": 244,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@2",
            "content": "Some of these enzymes involved in de novo lipid synthesis are controlled by lipid-activated nuclear receptors, such as liver X receptor (LXR) or PPAR.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 246,
            "end": 395,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@3",
            "content": "The genes coding for these enzymes are thus called LXR or PPAR target genes, respectively.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 397,
            "end": 486,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@4",
            "content": "Among these LXR or PPAR target genes, one may cite FASN coding for fatty acid synthase <REF-86> \u2013 <REF-88> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 488,
            "end": 595,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@5",
            "content": "These LXR or PPAR target genes code not only for enzymes involved in lipid metabolism, but also for transcription factors and transporters, and regulate also to glucose or amino acid metabolism.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 597,
            "end": 790,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@6",
            "content": "This is the case of the transcription factors, SREBP, or of glucose or cholesterol transporters involved in nutrient entry (e.g., the GLUT1 glucose transporter) or efflux, such as ATP binding cassette (ABC) transporters A1 and G1 (ABCA1 and ABCG1, respectively) involved in cholesterol efflux <REF-2> , <REF-86> , <REF-87> , <REF-89> , <REF-90> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 792,
            "end": 1137,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@7",
            "content": "PPAR and LXR are both mainly found associated with retinoid X receptor (RXR) to form a heterodimer.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 1139,
            "end": 1237,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@8",
            "content": "Considered as permissive heterodimer receptors, they can be activated by the ligands of each partner (e.g., PPAR or RXR ligands; LXR or RXR ligands) <REF-88> , <REF-90> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 1239,
            "end": 1408,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@9",
            "content": "While the involvement of these nuclear receptors in innate immune responses is well described for macrophages and cDC <REF-90> , few data are available for PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 1410,
            "end": 1569,
            "label": {}
        },
        {
            "ix": "6-456_v1_34@10",
            "content": "Here, we will discuss how lipid metabolism modulates PDC innate immune functions and how PDC activation by TLR ligands or other stimuli modifies lipid metabolism.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_34",
            "start": 1571,
            "end": 1732,
            "label": {}
        },
        {
            "ix": "6-456_v1_35@0",
            "content": "3.3.1.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_35",
            "start": 0,
            "end": 5,
            "label": {}
        },
        {
            "ix": "6-456_v1_35@1",
            "content": "Fatty acid oxidation .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_35",
            "start": 7,
            "end": 28,
            "label": {}
        },
        {
            "ix": "6-456_v1_35@2",
            "content": "The FAO pathway allows the conversion of fatty acids into numerous products in the mitochondria.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_35",
            "start": 30,
            "end": 125,
            "label": {}
        },
        {
            "ix": "6-456_v1_35@3",
            "content": "These products, such as acetyl-CoA, NADH (nicotinamide adenine dinucleotide dehydrogenase) and FADH <REF-2> (the fully reduced form of flavin adenine dinucleotide [FAD]), can be used in the TCA cycle and the electron transport chain to generate energy <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_35",
            "start": 127,
            "end": 387,
            "label": {}
        },
        {
            "ix": "6-456_v1_35@4",
            "content": "As discussed before, normoxia supports the TCA cycle and OXPHOS, while hypoxia via HIF-1\u03b1 activation followed by the induction of glycolytic enzymes leads to glycolysis <REF-2> , <REF-80> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_35",
            "start": 389,
            "end": 577,
            "label": {}
        },
        {
            "ix": "6-456_v1_35@5",
            "content": "The TCA cycle coupled to OXPHOS is the major metabolic pathway used by most quiescent or non-proliferating cells <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_35",
            "start": 579,
            "end": 700,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@0",
            "content": "A recent well-received manuscript reports that FAO and mitochondrial OXPHOS play a critical role in murine PDC activation by the TLR9 pathway ( Figure 2B ) <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 0,
            "end": 164,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@1",
            "content": "This is particularly well demonstrated for type I IFN production by these cells <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 166,
            "end": 254,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@2",
            "content": "Mouse PDC stimulated by the TLR9 ligand, CpGA, exhibit an increase of basal oxygen consumption rate (OCR) and spare respiratory capacity (SRC) <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 256,
            "end": 407,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@3",
            "content": "Both increased basal OCR and SRC are indicators of FAO.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 409,
            "end": 463,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@4",
            "content": "To directly demonstrate that CpGA increases FAO, the authors used etomoxir, an irreversible inhibitor of carnitine palmitoyl transferase I <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 465,
            "end": 612,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@5",
            "content": "This enzyme is responsible for the entry of activated fatty acids ( i.e ., medium-chain and long-chain fatty acids conjugated with carnitine) into mitochondria for FAO <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 614,
            "end": 790,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@6",
            "content": "Etomoxir inhibits both the increase of basal OCR and SRC induced by TLR9 ligand stimulation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 792,
            "end": 883,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@7",
            "content": "Moreover, etomoxir limits the production of IFN-\u03b1 and pro-inflammatory cytokines (TNF-\u03b1 and IL-6) by PDC in response to CpGA stimulation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 885,
            "end": 1021,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@8",
            "content": "This inhibition of TLR9 activation by etomoxir also prevents the upregulation of CD86 expression at PDC cell surface <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 1023,
            "end": 1148,
            "label": {}
        },
        {
            "ix": "6-456_v1_36@9",
            "content": "Overall, TLR9-induced mouse PDC activation is accompanied by an increased FAO, and stimulation of this metabolic pathway is required for pro-inflammatory cytokine secretion and PDC maturation ( i.e ., CD86 upregulation).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_36",
            "start": 1150,
            "end": 1369,
            "label": {}
        },
        {
            "ix": "6-456_v1_37@0",
            "content": "An increase of basal OCR and SRC attesting for FAO has also been observed after the activation of mouse PDC by the TLR7 agonist imiquimod.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_37",
            "start": 0,
            "end": 137,
            "label": {}
        },
        {
            "ix": "6-456_v1_37@1",
            "content": "Treatment of mouse PDC by etomoxir inhibits imiquimod-induced IFN-\u03b1 production <REF-5> , suggesting that FAO is also required for type I IFN production in response to TLR7 ligand.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_37",
            "start": 139,
            "end": 317,
            "label": {}
        },
        {
            "ix": "6-456_v1_37@2",
            "content": "Implication of FAO in vivo was assessed using etomoxir and mice infected with the ssRNA lymphocytic choriomeningitis virus (LCMV).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_37",
            "start": 319,
            "end": 448,
            "label": {}
        },
        {
            "ix": "6-456_v1_37@3",
            "content": "Etomoxir-treated and LCMV-infected mice exhibit reduced circulating IFN-\u03b1 3 days after infection and significantly more LCMV are detected in the liver and spleen of etomoxir-treated versus untreated infected mice <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_37",
            "start": 450,
            "end": 671,
            "label": {}
        },
        {
            "ix": "6-456_v1_37@4",
            "content": "This demonstrates the in vivo relevance of these data.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_37",
            "start": 673,
            "end": 726,
            "label": {}
        },
        {
            "ix": "6-456_v1_38@0",
            "content": "Changes in basal OCR are not detected at early time points after murine PDC activation by CpGA, but this requires new gene transcription.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_38",
            "start": 0,
            "end": 136,
            "label": {}
        },
        {
            "ix": "6-456_v1_38@1",
            "content": "This may suggest that IFN-\u03b1 production and IFNAR signaling induced by CpGA stimulation may be responsible for these changes in PDC metabolism.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_38",
            "start": 138,
            "end": 279,
            "label": {}
        },
        {
            "ix": "6-456_v1_38@2",
            "content": "Indeed, treatment with IFN-\u03b1 alone is sufficient to induce increased FAO in mouse PDC <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_38",
            "start": 281,
            "end": 375,
            "label": {}
        },
        {
            "ix": "6-456_v1_38@3",
            "content": "Thus, increased FAO induced by CpGA stimulation in mouse PDC are therefore the results of an autocrine or paracrine loop involving the type I IFN signaling pathway.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_38",
            "start": 377,
            "end": 540,
            "label": {}
        },
        {
            "ix": "6-456_v1_39@0",
            "content": "One goal of the FAO pathway is to generate energy, by the production of a high number of ATP molecules <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_39",
            "start": 0,
            "end": 111,
            "label": {}
        },
        {
            "ix": "6-456_v1_39@1",
            "content": "This occurs in fact by fueling OXPHOS <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_39",
            "start": 113,
            "end": 159,
            "label": {}
        },
        {
            "ix": "6-456_v1_39@2",
            "content": "To definitively demonstrate the implication of energy provided by FAO coupled to OXPHOS in type I IFN-induced mouse PDC activation, ATP was quantified in response to IFN-\u03b1 and different inhibitors were used <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_39",
            "start": 161,
            "end": 376,
            "label": {}
        },
        {
            "ix": "6-456_v1_39@3",
            "content": "Metabolic reprogramming of mouse PDC induced by IFN-\u03b1 leads to enhanced ATP availability <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_39",
            "start": 378,
            "end": 475,
            "label": {}
        },
        {
            "ix": "6-456_v1_39@4",
            "content": "The quantity of ATP in response to CpGA activation is significantly reduced by the inhibition of either FAO (using etomoxir), pyruvate import into mitochondria required for the TCA cycle (using UK5099) or fatty acid synthesis (using tall oil fatty acid [TOFA]) <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_39",
            "start": 477,
            "end": 746,
            "label": {}
        },
        {
            "ix": "6-456_v1_39@5",
            "content": "This confirms that type I IFN stimulation of mouse PDC generates significant amounts of ATP via the FAO pathway.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_39",
            "start": 748,
            "end": 859,
            "label": {}
        },
        {
            "ix": "6-456_v1_39@6",
            "content": "This pathway fuels OXPHOS in this setting and is itself fueled by fatty acid synthesis, as demonstrated by the use of the inhibitor TOFA ( Figure 2B ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_39",
            "start": 861,
            "end": 1011,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@0",
            "content": "The pathways responsible for the changes in metabolism induced by type I IFN in mouse PDC were studied by an unbiased RNA-seq based approach <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 0,
            "end": 149,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@1",
            "content": "This analysis shows that OXPHOS is the major network induced by type I IFN, and FAO is connected to this network.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 151,
            "end": 263,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@2",
            "content": "Furthermore and surprisingly, this analysis reveals also a PPAR\u03b1 gene signature <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 265,
            "end": 353,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@3",
            "content": "While PPAR\u03b3 is expressed in macrophages and cDC <REF-90> , the PPAR\u03b1 isoform is mainly and highly expressed in metabolic active tissues, such as the liver or brown adipose tissues <REF-88> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 355,
            "end": 544,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@4",
            "content": "After having confirmed that the PPAR\u03b1 isoform is expressed by bone marrow-derived and splenic mouse PDC, a PPAR\u03b1 antagonist, GW6471 was used <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 546,
            "end": 695,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@5",
            "content": "GW6471 blocks both IFN-\u03b1 production and the increase of basal OCR in response to CpGA activation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 697,
            "end": 793,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@6",
            "content": "Furthermore, increased basal OCR and SRC in mouse PDC are observed after incubation with a PPAR\u03b1 agonist gemfibrozil, as well as with the combined PPAR\u03b1 and PPAR\u03b3 agonist, muraglitazar <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 795,
            "end": 988,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@7",
            "content": "Overall, this indicates that PPAR\u03b1 is involved in FAO and OXPHOS induced by CpGA activation ( Figure 2B ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 990,
            "end": 1095,
            "label": {}
        },
        {
            "ix": "6-456_v1_40@8",
            "content": "This PPAR\u03b1 pathway in PDC functions will be discussed later in this review together with the other lipid-activated nuclear receptor, LXR (see the following two sections).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_40",
            "start": 1097,
            "end": 1266,
            "label": {}
        },
        {
            "ix": "6-456_v1_41@0",
            "content": "3.3.2.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_41",
            "start": 0,
            "end": 5,
            "label": {}
        },
        {
            "ix": "6-456_v1_41@1",
            "content": "Fatty acid synthesis .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_41",
            "start": 7,
            "end": 28,
            "label": {}
        },
        {
            "ix": "6-456_v1_41@2",
            "content": "The fatty acid synthesis pathway allows cells to generate lipids that are necessary for cellular growth and proliferation <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_41",
            "start": 30,
            "end": 160,
            "label": {}
        },
        {
            "ix": "6-456_v1_41@3",
            "content": "Fatty acid synthesis is performed in the cytosol, and it uses citrate from the TCA cycle and exported from the mitochondria into the cytosol to generate fatty acids ( Figure 2B ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_41",
            "start": 162,
            "end": 340,
            "label": {}
        },
        {
            "ix": "6-456_v1_41@4",
            "content": "As mentioned above, de novo fatty acid synthesis is dependent on key enzymes, such as FASN, that are controlled by either the mTOR signaling pathway <REF-8> , LXR <REF-86> , <REF-87> or SREBP-1c <REF-2> , <REF-91> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_41",
            "start": 342,
            "end": 556,
            "label": {}
        },
        {
            "ix": "6-456_v1_41@5",
            "content": "Fatty acids generated by this synthesis can be used to fuel mitochondrial FAO <REF-2> , to activate PPAR nuclear receptors <REF-89> , or can be condensed with glycolysis-derived glycerol to produce triacylglycerol and phospholipids <REF-2> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_41",
            "start": 558,
            "end": 798,
            "label": {}
        },
        {
            "ix": "6-456_v1_41@6",
            "content": "These latter two are key components of many cellular structures, such as the cell membrane, ER or Golgi apparatus <REF-2> , <REF-8> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_41",
            "start": 800,
            "end": 932,
            "label": {}
        },
        {
            "ix": "6-456_v1_42@0",
            "content": "The inhibition of the fatty acid synthesis using two different inhibitors (TOFA, an inhibitor of acetyl-CoA carboxylase; C75, an inhibitor of FASN) <REF-2> prevents the increase of IFN-\u03b1, TNF-\u03b1, and IL-6 production by mouse PDC in response to CpGA stimulation <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_42",
            "start": 0,
            "end": 268,
            "label": {}
        },
        {
            "ix": "6-456_v1_42@1",
            "content": "As previously demonstrated for FAO and OXPHOS, fatty acid synthesis induced by the TLR9 pathway implicates a type I IFN/IFNAR loop <REF-5> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_42",
            "start": 270,
            "end": 409,
            "label": {}
        },
        {
            "ix": "6-456_v1_42@2",
            "content": "Moreover, using the TOFA inhibitor before measuring both the quantity of ATP in response to CpGA activation and the expression of PPAR\u03b1 target genes, Acadl and Pltp in CpGA-activated mouse PDC <REF-5> allowed the authors to conclude that fatty acid synthesis induced in mouse PDC rather fuels FAO and OXPHOS than provides lipid ligands for PPAR\u03b1 activation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_42",
            "start": 411,
            "end": 767,
            "label": {}
        },
        {
            "ix": "6-456_v1_42@3",
            "content": "It is well described that the natural ligands of PPAR\u03b1 include different fatty acids, as well as numerous fatty acid derivatives and compounds with structural resemblance to fatty acids, such as acyl-CoAs, or oxidized fatty acids <REF-89> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_42",
            "start": 769,
            "end": 1008,
            "label": {}
        },
        {
            "ix": "6-456_v1_42@4",
            "content": "Here in PDC, fatty acids synthetized in response to the TLR9 signaling pathway do not seem to directly stimulate PPAR\u03b1 by providing PPAR\u03b1 ligands.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_42",
            "start": 1010,
            "end": 1155,
            "label": {}
        },
        {
            "ix": "6-456_v1_42@5",
            "content": "One may hypothesize that, as reported for lipid-activated nuclear receptors <REF-86> , <REF-88> , activation of PPAR\u03b1 by TLR9 ligand may interfere with transcription factors <REF-3> , <REF-88> that are critical for pro-inflammatory cytokine secretion by PDC (see section below).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_42",
            "start": 1157,
            "end": 1434,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@0",
            "content": "3.3.3.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 0,
            "end": 5,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@1",
            "content": "Cholesterol metabolism .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 7,
            "end": 30,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@2",
            "content": "Cholesterol is one of the major constituents of lipid rafts together with glycosphingolipids <REF-92> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 32,
            "end": 134,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@3",
            "content": "Cellular cholesterol content results from cholesterol uptake and biosynthesis through the mevalonate pathway, while its elimination from cells is mediated by cholesterol efflux.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 136,
            "end": 312,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@4",
            "content": "Cholesterol uptake involves plasma lipoproteins (mainly low density lipoprotein [LDL] and very low density lipoprotein [VLDL]) after interactions with their specific receptors, LDLR and VLDLR, respectively.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 314,
            "end": 519,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@5",
            "content": "Cholesterol efflux is mainly mediated by specific transporters, ABCA1 and ABCG1, in association with extracellular cholesterol acceptors, including apolipoproteins (APO) APOA1 and APOE, or lipoprotein particles (e.g., nascent high density lipoprotein [HDL] or HDL2) ( Figure 3 ) <REF-93> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 521,
            "end": 809,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@6",
            "content": "ABCG1 is rather localized within the cell and seems to move sterols between intracellular compartments <REF-88> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 811,
            "end": 923,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@7",
            "content": "ABCA1 is more dedicated to extrude cholesterol derivatives outside the cell <REF-88> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 925,
            "end": 1010,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@8",
            "content": "Cholesterol regulates critical cellular functions, including plasma membrane formation and fluidity, allowing the clustering of receptors into lipid rafts for efficient signaling <REF-92> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 1012,
            "end": 1200,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@9",
            "content": "These latter functions are implicated in signaling pathway regulation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 1202,
            "end": 1271,
            "label": {}
        },
        {
            "ix": "6-456_v1_43@10",
            "content": "Localization of signaling complexes within the lipid rafts is critical for certain receptors.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_43",
            "start": 1273,
            "end": 1365,
            "label": {}
        },
        {
            "ix": "6-456_v1_44@0",
            "content": "Figure 3.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_44",
            "start": 0,
            "end": 8,
            "label": {}
        },
        {
            "ix": "6-456_v1_46@0",
            "content": "Cholesterol homeostasis is regulated at least by LXR.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_46",
            "start": 0,
            "end": 52,
            "label": {}
        },
        {
            "ix": "6-456_v1_46@1",
            "content": "These nuclear receptors are expressed as two isoforms, including the ubiquitous LXR\u03b2 isoform and LXR\u03b1, which exhibits an expression restricted to cells with high cholesterol turnover (e.g., macrophages) <REF-86> , <REF-90> , <REF-94> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_46",
            "start": 54,
            "end": 288,
            "label": {}
        },
        {
            "ix": "6-456_v1_46@2",
            "content": "The LXR pathway is activated by intermediates from the cholesterol biosynthesis (e.g., desmosterol), endogenous oxidized cholesterol derivatives (called oxysterols, such as 22(R)-hydroxycholesterol [22RHC]), and synthetic agonists (e.g., T0901317 or GW3965) <REF-86> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_46",
            "start": 290,
            "end": 557,
            "label": {}
        },
        {
            "ix": "6-456_v1_46@3",
            "content": "LXR activation upregulates the expression of several genes involved in cholesterol homeostasis ( i.e. , LXR target genes), including: ABCA1 , ABCG1 <REF-87> , and APOE (related to cholesterol efflux) <REF-88> , <REF-95> , as well as the \u2018inducible degrader of the low-density lipoprotein receptor\u2019 (IDOL), preventing cholesterol uptake through LDLR/VLDLR degradation <REF-96> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_46",
            "start": 559,
            "end": 935,
            "label": {}
        },
        {
            "ix": "6-456_v1_46@4",
            "content": "Overall, these mechanisms triggered by LXR activation participate in the decrease of intracellular cholesterol content.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_46",
            "start": 937,
            "end": 1055,
            "label": {}
        },
        {
            "ix": "6-456_v1_46@5",
            "content": "Again, the LXR pathway has been studied extensively in the regulation of macrophage functions, including cholesterol homeostasis and inflammatory responses, as well as apoptotic cell uptake (a process called efferocytosis) <REF-90> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_46",
            "start": 1057,
            "end": 1289,
            "label": {}
        },
        {
            "ix": "6-456_v1_46@6",
            "content": "However, the role of cholesterol and LXR begins only to be deciphered in PDC innate functions.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_46",
            "start": 1291,
            "end": 1384,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@0",
            "content": "Inhibition of the mevalonate pathway ( i.e ., de novo cholesterol biosynthesis) by statins (simvastatin and pitavastatin) blocks TLR7- and TLR9-induced type I IFN production by human PDC ( Figure 3 ) <REF-97> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 0,
            "end": 209,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@1",
            "content": "This has been demonstrated with blood-derived PDC obtained from healthy donors, as well as from patients with SLE <REF-97> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 211,
            "end": 334,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@2",
            "content": "Statin treatment also inhibits TNF secretion by human PDC in response to either TLR7 (loxoribine) or TLR9 (CpGA) ligands <REF-97> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 336,
            "end": 466,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@3",
            "content": "These data have been confirmed in vivo using ssRNA Sendai virus <REF-97> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 468,
            "end": 541,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@4",
            "content": "Inhibition of de novo cholesterol synthesis by statins in PDC interferes with the p38 MAPK pathway, Akt and nuclear translocation of IRF7 ( Figure 3 ) <REF-97> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 543,
            "end": 703,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@5",
            "content": "Finally, the inhibitory effect of statins has been tested in vivo and on mouse PDC, since treatment of C57BL/6 mouse with statins before triggering type I IFN production by ssRNA poly(U) injection decreases circulating IFN-\u03b1 <REF-97> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 705,
            "end": 939,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@6",
            "content": "Thus, the inhibition of cholesterol synthesis in PDC is associated with an anti-inflammatory response.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 941,
            "end": 1042,
            "label": {}
        },
        {
            "ix": "6-456_v1_47@7",
            "content": "This confirms the global anti-inflammatory effects of statins <REF-98> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_47",
            "start": 1044,
            "end": 1115,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@0",
            "content": "Recently, we reported that the LXR\u03b2 isoform is expressed in human PDC <REF-6> , as well as in mouse PDC (unpublished study, Ceroi A, Bonnefoy F, Angelot-Delettre F and Saas P), and that this LXR pathway is fully functional <REF-6> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 0,
            "end": 231,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@1",
            "content": "Using freshly blood-isolated human PDC and a PDC cell line CAL-1, a functional LXR pathway has been demonstrated, as attested by increased LXR target gene expression in response to three different LXR agonists (two synthetic agonists and an oxysterol, 22RHC that represents a more physiological LXR ligand).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 233,
            "end": 539,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@2",
            "content": "The activation of the LXR pathway in PDC reduces the pro-inflammatory cytokine secretion (IL-6 and TNF-\u03b1) induced by TLR7 triggering <REF-6> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 541,
            "end": 682,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@3",
            "content": "Moreover, these data obtained in human PDC from healthy donors <REF-6> and in leukemic PDC <REF-99> demonstrate that the LXR pathway interferes with TLR7-induced NF-\u03baB activation at different levels, including a transcriptional repression of p65 NF-\u03baB subunit and a reduced phosphorylation of this NF-\u03baB subunit ( Figure 3 ) <REF-6> , <REF-99> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 684,
            "end": 1028,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@4",
            "content": "Pretreatment of leukemic PDC with synthetic LXR agonists also reduces Akt and STAT5 phosphorylation in response to IL-3 ( Figure 3 ) <REF-99> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 1030,
            "end": 1172,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@5",
            "content": "LXR stimulation in the PDC cell line CAL-1 increases cholesterol efflux via the upregulation of cholesterol transporters, such as ABCA1 ( Figure 3 ) <REF-99> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 1174,
            "end": 1332,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@6",
            "content": "Although the cholesterol efflux was only tested using this CAL-1 PDC cell line <REF-99> , upregulation of cholesterol transporters at mRNA and protein levels was also observed in human blood-derived PDC treated with LXR agonists <REF-6> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 1334,
            "end": 1571,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@7",
            "content": "Stimulation of cholesterol efflux by the addition of a cholesterol acceptor, APOA1, amplifies the effects of LXR activation in leukemic PDC, including inhibition of the IL-3 signaling pathway (Akt and STAT5 phosphorylation) and cell survival ( Figure 3 ) <REF-99> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 1573,
            "end": 1837,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@8",
            "content": "This confirms the previous data using statins <REF-97> , and suggests that modifying cholesterol homeostasis in PDC can be useful to limit their detrimental role in pathological situations.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 1839,
            "end": 2027,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@9",
            "content": "Alteration of PDC survival after modification of intracellular cholesterol content using either statins <REF-97> or LXR agonists <REF-99> is only detected at highest concentrations (100 \u00b5M).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 2029,
            "end": 2218,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@10",
            "content": "In addition, LXR activation in human PDC also increases microparticle internalization via the phosphatidylserine receptor (PtdSerR), BAI-1 <REF-6> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 2220,
            "end": 2367,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@11",
            "content": "This contrasts with data obtained in macrophages in which LXR stimulation induces another PtdSerR, called Mer-TK (Mer tyrosine kinase) <REF-100> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 2369,
            "end": 2514,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@12",
            "content": "Nevertheless, this suggests that stimulation of PDC via the LXR pathway may improve their capacity to eliminate circulating pro-inflammatory microparticles.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 2516,
            "end": 2671,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@13",
            "content": "Triggering LXR pathway using LXR agonists before exposure to pro-inflammatory endothelial-derived microparticles prevents NF-\u03baB activation and pro-inflammatory cytokine production by human PDC <REF-6> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 2673,
            "end": 2874,
            "label": {}
        },
        {
            "ix": "6-456_v1_48@14",
            "content": "This sustains an anti-inflammatory role of LXR agonists.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_48",
            "start": 2876,
            "end": 2931,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@0",
            "content": "A discrepancy exists concerning type I IFN production after inhibition of cholesterol biosynthesis (using statins <REF-97> ) and the massive decrease of intracellular cholesterol content (using LXR agonists <REF-6> , <REF-99> ).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 0,
            "end": 227,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@1",
            "content": "Inhibition of type I IFN has been reported after statin treatment <REF-97> , but not after cholesterol deprivation <REF-6> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 229,
            "end": 352,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@2",
            "content": "This may be due to a compensatory mechanism, since massively decreasing the pool size of synthesized cholesterol alone induces spontaneous type I IFN production associated with an antiviral immunity in bone marrow-derived macrophages <REF-101> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 354,
            "end": 598,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@3",
            "content": "This response occurs via the cGAS/STING/TBK1/IRF3 pathway <REF-101> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 600,
            "end": 668,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@4",
            "content": "Thus, LXR agonists could inhibit TLR7/9-mediated type I IFN by interfering with this signaling pathway together with massively decreasing the intracellular cholesterol pool size.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 670,
            "end": 847,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@5",
            "content": "This could explain why IFN-\u03b1 production is unaffected after LXR agonist treatment of PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 849,
            "end": 937,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@6",
            "content": "Another difference between the effect of statins and LXR agonists lies in the inhibition of IRF7 (but not of NF-\u03baB phosphorylation by statins) <REF-97> , whereas the activation of the LXR pathway in PDC blocks NF-\u03baB activation via several mechanisms <REF-6> , <REF-99> (see above).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 939,
            "end": 1219,
            "label": {}
        },
        {
            "ix": "6-456_v1_49@7",
            "content": "Overall, the manipulation of cholesterol metabolism in PDC can be proposed to limit their pro-inflammatory functions.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_49",
            "start": 1221,
            "end": 1337,
            "label": {}
        },
        {
            "ix": "6-456_v1_50@0",
            "content": "4. Conclusions",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_50",
            "start": 0,
            "end": 13,
            "label": {}
        },
        {
            "ix": "6-456_v1_51@0",
            "content": "Here, we summarize data currently available showing that several metabolic pathways are triggered in PDC by different stimuli, including pro-inflammatory signals (e.g., TLR7/9 ligands or endothelial-derived microparticles), as well as anti-inflammatory signals (e.g., platelet-derived microparticles).",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_51",
            "start": 0,
            "end": 300,
            "label": {}
        },
        {
            "ix": "6-456_v1_51@1",
            "content": "These pathways comprise: the mTOR signaling pathway, glycolysis, FAO coupled to OXPHOS, fatty acid synthesis and cholesterol metabolism.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_51",
            "start": 302,
            "end": 437,
            "label": {}
        },
        {
            "ix": "6-456_v1_51@2",
            "content": "All of these pathways are connected together, and they are globally necessary for efficient type I IFN production by PDC in response to TLR7/9-mediated activation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_51",
            "start": 439,
            "end": 601,
            "label": {}
        },
        {
            "ix": "6-456_v1_51@3",
            "content": "Few data are available, but it seems that induction of pro-inflammatory cytokines (e.g., TNF, IL-6 and IL-8) and costimulatory molecules ( i.e ., CD80 or CD86) also need most of these metabolic pathways.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_51",
            "start": 603,
            "end": 805,
            "label": {}
        },
        {
            "ix": "6-456_v1_51@4",
            "content": "On the contrary, alteration of cholesterol metabolism associated with decreased intracellular cholesterol content either after inhibition of de novo cholesterol synthesis or LXR activation inhibits the pro-inflammatory functions of PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_51",
            "start": 807,
            "end": 1042,
            "label": {}
        },
        {
            "ix": "6-456_v1_51@5",
            "content": "These data suggest that pharmacological manipulation of the host metabolism may be useful to reprogram altered PDC immune functions.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_51",
            "start": 1044,
            "end": 1175,
            "label": {}
        },
        {
            "ix": "6-456_v1_52@0",
            "content": "Since cellular metabolism is highly dependent on the microenvironment (oxygen availability and nutrients), changes in the local tissue microenvironment may modulate PDC innate immune functions.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_52",
            "start": 0,
            "end": 192,
            "label": {}
        },
        {
            "ix": "6-456_v1_52@1",
            "content": "This modulation of metabolism may result from exogenous metabolites that diffuse passively or through transporters into the PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_52",
            "start": 194,
            "end": 321,
            "label": {}
        },
        {
            "ix": "6-456_v1_52@2",
            "content": "Among these metabolites, one may find ligands of lipid-activated nuclear receptors, such as LXR or PPAR <REF-3> , <REF-90> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_52",
            "start": 323,
            "end": 446,
            "label": {}
        },
        {
            "ix": "6-456_v1_53@0",
            "content": "Microenvironment and metabolic pathways may be modulated or controlled by microbiota.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_53",
            "start": 0,
            "end": 84,
            "label": {}
        },
        {
            "ix": "6-456_v1_53@1",
            "content": "A recent study analyzed germ-free mice mono-colonized with each of the 53 human-resident bacterial species and the consequences of each bacterium on different immune cell subsets <REF-102> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_53",
            "start": 86,
            "end": 275,
            "label": {}
        },
        {
            "ix": "6-456_v1_53@2",
            "content": "Among these 53 bacteria, some bacteria were identified as modifying PDC frequencies in the colon and the small intestine <REF-102> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_53",
            "start": 277,
            "end": 408,
            "label": {}
        },
        {
            "ix": "6-456_v1_53@3",
            "content": "Among the genes for which their expression was correlated with PDC frequencies, the authors identified IFN-inducible signature transcripts, but also transcripts involved in lipid and protein metabolic pathways.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_53",
            "start": 410,
            "end": 619,
            "label": {}
        },
        {
            "ix": "6-456_v1_53@4",
            "content": "Moreover, the Hif1a transcript coding for the metabolism regulator HIF-1\u03b1 was also associated with PDC frequencies <REF-102> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_53",
            "start": 621,
            "end": 746,
            "label": {}
        },
        {
            "ix": "6-456_v1_53@5",
            "content": "This suggests a connection between PDC frequencies in the gastro-intestinal tract and metabolic pathways and nutrients/metabolites provided by microbiota.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_53",
            "start": 748,
            "end": 901,
            "label": {}
        },
        {
            "ix": "6-456_v1_54@0",
            "content": "We discussed above the connection of metabolism with epigenetic regulation.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_54",
            "start": 0,
            "end": 74,
            "label": {}
        },
        {
            "ix": "6-456_v1_54@1",
            "content": "While few data are available concerning epigenetic regulation of PDC innate immune functions, it has been shown that the inhibitor of histone deacetylase, valproic acid, alters human PDC functions, including the production of pro-inflammatory cytokines (IFN-\u03b1 TNF and IL-6) in response to TLR9 ligand, CpGA <REF-103> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_54",
            "start": 76,
            "end": 393,
            "label": {}
        },
        {
            "ix": "6-456_v1_54@2",
            "content": "Thus, it remains to be determined how metabolism may regulate epigenetic modification of DNA and histones in PDC.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_54",
            "start": 395,
            "end": 507,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@0",
            "content": "Lastly, acute perturbations in intracellular lipid content, via for instance LXR activation, may also influence cell proliferation and survival by inducing significant ER stress <REF-88> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 0,
            "end": 187,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@1",
            "content": "This cellular organelle is responsible for protein folding.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 189,
            "end": 247,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@2",
            "content": "The result of this ER stress is an accumulation of unfolded proteins.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 249,
            "end": 317,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@3",
            "content": "This pathway leads also to the expression of the transcription factor X-box binding protein 1 (XBP1), which induces lipid synthesis.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 319,
            "end": 450,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@4",
            "content": "XBP1 has been shown to regulate cDC infiltrating ovarian tumors; accumulation of lipids in the tumor-infiltrating cDC following ER stress and XBP1 activation reduces their ability to present antigens, and thus impairs anti-tumor T-cell responses <REF-104> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 452,
            "end": 708,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@5",
            "content": "Whether this may occur in infiltrating PDC remains to be analyzed.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 710,
            "end": 775,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@6",
            "content": "Nevertheless, PDC have been shown to express XBP1 <REF-105> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 777,
            "end": 837,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@7",
            "content": "This factor can be targeted with bortezomib, which maintains ER homeostasis <REF-105> .",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 839,
            "end": 925,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@8",
            "content": "This can be an additional way related to metabolism to block pro-inflammatory PDC functions.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 927,
            "end": 1018,
            "label": {}
        },
        {
            "ix": "6-456_v1_55@9",
            "content": "In conclusion, a better understanding of PDC immunometabolism may help to limit the detrimental effect of these cells and increase their beneficial role in the future.",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_55",
            "start": 1020,
            "end": 1186,
            "label": {}
        },
        {
            "ix": "6-456_v1_56@0",
            "content": "<REF-1> O'Neill LA Pearce EJ : Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016 ; 213 ( 1 ): 15 \u2013 23 . 26694970 10.1084/jem.20151570 4710204",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_56",
            "start": 0,
            "end": 171,
            "label": {}
        },
        {
            "ix": "6-456_v1_57@0",
            "content": "<REF-2> O'Neill LA Kishton RJ Rathmell J : A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016 ; 16 ( 9 ): 553 \u2013 565 . 27396447 10.1038/nri.2016.70 5001910",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_57",
            "start": 0,
            "end": 171,
            "label": {}
        },
        {
            "ix": "6-456_v1_58@0",
            "content": "<REF-3> Pearce EJ Everts B : Dendritic cell metabolism. Nat Rev Immunol. 2015 ; 15 ( 1 ): 18 \u2013 29 . 25534620 10.1038/nri3771 4495583",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_58",
            "start": 0,
            "end": 131,
            "label": {}
        },
        {
            "ix": "6-456_v1_59@0",
            "content": "<REF-4> Bajwa G DeBerardinis RJ Shao B : Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses. J Immunol. 2016 ; 196 ( 5 ): 2004 \u2013 2009 . 26826244 10.4049/jimmunol.1501557 4761472",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_59",
            "start": 0,
            "end": 224,
            "label": {}
        },
        {
            "ix": "6-456_v1_60@0",
            "content": "<REF-5> Wu D Sanin DE Everts B : Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function. Immunity. 2016 ; 44 ( 6 ): 1325 \u2013 1336 . 27332732 10.1016/j.immuni.2016.06.006",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_60",
            "start": 0,
            "end": 202,
            "label": {}
        },
        {
            "ix": "6-456_v1_61@0",
            "content": "<REF-6> Ceroi A Delettre FA Marotel C : The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. Haematologica. 2016 ; 101 ( 3 ): e72 \u2013 76 . 26635040 10.3324/haematol.2015.135459 4815731",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_61",
            "start": 0,
            "end": 268,
            "label": {}
        },
        {
            "ix": "6-456_v1_62@0",
            "content": "<REF-7> Swiecki M Colonna M : The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015 ; 15 ( 8 ): 471 \u2013 485 . 26160613 10.1038/nri3865 4808588",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_62",
            "start": 0,
            "end": 165,
            "label": {}
        },
        {
            "ix": "6-456_v1_63@0",
            "content": "<REF-8> Weichhart T Hengstschl\u00e4ger M Linke M : Regulation of innate immune cell function by mTOR. Nat Rev Immunol. 2015 ; 15 ( 10 ): 599 \u2013 614 . 26403194 10.1038/nri3901",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_63",
            "start": 0,
            "end": 168,
            "label": {}
        },
        {
            "ix": "6-456_v1_64@0",
            "content": "<REF-9> Sharma MD Hou DY Liu Y : Indoleamine 2,3-dioxygenase controls conversion of Foxp3 + Tregs to TH17-like cells in tumor-draining lymph nodes. Blood. 2009 ; 113 ( 24 ): 6102 \u2013 6111 . 19366986 10.1182/blood-2008-12-195354 2699232",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_64",
            "start": 0,
            "end": 232,
            "label": {}
        },
        {
            "ix": "6-456_v1_65@0",
            "content": "<REF-10> Pearce EL Pearce EJ : Metabolic pathways in immune cell activation and quiescence. Immunity. 2013 ; 38 ( 4 ): 633 \u2013 643 . 23601682 10.1016/j.immuni.2013.04.005 3654249",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_65",
            "start": 0,
            "end": 175,
            "label": {}
        },
        {
            "ix": "6-456_v1_66@0",
            "content": "<REF-11> Audano M Ferrari A Fiorino E : Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function. Curr Genomics. 2014 ; 15 ( 6 ): 436 \u2013 456 . 25646072 10.2174/138920291506150106151119 4311388",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_66",
            "start": 0,
            "end": 220,
            "label": {}
        },
        {
            "ix": "6-456_v1_67@0",
            "content": "<REF-12> Li W Sivakumar R Titov AA : Metabolic Factors that Contribute to Lupus Pathogenesis. Crit Rev Immunol. 2016 ; 36 ( 1 ): 75 \u2013 98 . 27480903 10.1615/CritRevImmunol.2016017164 5278665",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_67",
            "start": 0,
            "end": 188,
            "label": {}
        },
        {
            "ix": "6-456_v1_68@0",
            "content": "<REF-13> Guilliams M Ginhoux F Jakubzick C : Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014 ; 14 ( 8 ): 571 \u2013 578 . 25033907 10.1038/nri3712 4638219",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_68",
            "start": 0,
            "end": 208,
            "label": {}
        },
        {
            "ix": "6-456_v1_69@0",
            "content": "<REF-14> Cella M Jarrossay D Facchetti F : Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999 ; 5 ( 8 ): 919 \u2013 923 . 10426316 10.1038/11360",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_69",
            "start": 0,
            "end": 204,
            "label": {}
        },
        {
            "ix": "6-456_v1_70@0",
            "content": "<REF-15> Siegal FP Kadowaki N Shodell M : The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999 ; 284 ( 5421 ): 1835 \u2013 1837 . 10364556 10.1126/science.284.5421.1835",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_70",
            "start": 0,
            "end": 201,
            "label": {}
        },
        {
            "ix": "6-456_v1_71@0",
            "content": "<REF-16> Asselin-Paturel C Boonstra A Dalod M : Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol. 2001 ; 2 ( 12 ): 1144 \u2013 1150 . 11713464 10.1038/ni736",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_71",
            "start": 0,
            "end": 194,
            "label": {}
        },
        {
            "ix": "6-456_v1_72@0",
            "content": "<REF-19> Martin P Del Hoyo GM Anjuere F : Characterization of a new subpopulation of mouse CD8\u03b1 + B220 + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood. 2002 ; 100 ( 2 ): 383 \u2013 390 . 12091326 10.1182/blood.V100.2.383",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_72",
            "start": 0,
            "end": 268,
            "label": {}
        },
        {
            "ix": "6-456_v1_73@0",
            "content": "<REF-20> Robbins SH Walzer T Demb\u00e9l\u00e9 D : Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008 ; 9 ( 1 ): R17 . 18218067 10.1186/gb-2008-9-1-r17 2395256",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_73",
            "start": 0,
            "end": 249,
            "label": {}
        },
        {
            "ix": "6-456_v1_74@0",
            "content": "<REF-21> Liu K Victora GD Schwickert TA : In vivo analysis of dendritic cell development and homeostasis. Science. 2009 ; 324 ( 5925 ): 392 \u2013 397 . 19286519 10.1126/science.1170540 2803315",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_74",
            "start": 0,
            "end": 187,
            "label": {}
        },
        {
            "ix": "6-456_v1_75@0",
            "content": "<REF-22> Li HS Gelbard A Martinez GJ : Cell-intrinsic role for IFN-\u03b1-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood. 2011 ; 118 ( 14 ): 3879 \u2013 3889 . 21828128 10.1182/blood-2011-04-349761 3193265",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_75",
            "start": 0,
            "end": 272,
            "label": {}
        },
        {
            "ix": "6-456_v1_76@0",
            "content": "<REF-23> Sisirak V Vey N Vanbervliet B : CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood. 2011 ; 118 ( 19 ): 5130 \u2013 5140 . 21937703 10.1182/blood-2010-07-295626 3217401",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_76",
            "start": 0,
            "end": 246,
            "label": {}
        },
        {
            "ix": "6-456_v1_77@0",
            "content": "<REF-24> de Heer HJ Hammad H Soulli\u00e9 T : Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med. 2004 ; 200 ( 1 ): 89 \u2013 98 . 15238608 10.1084/jem.20040035 2213319",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_77",
            "start": 0,
            "end": 231,
            "label": {}
        },
        {
            "ix": "6-456_v1_78@0",
            "content": "<REF-25> Tokita D Sumpter TL Raimondi G : Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol. 2008 ; 49 ( 6 ): 1008 \u2013 1018 . 18926588 10.1016/j.jhep.2008.07.028 2631180",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_78",
            "start": 0,
            "end": 257,
            "label": {}
        },
        {
            "ix": "6-456_v1_79@0",
            "content": "<REF-26> Matta BM Castellaneta A Thomson AW : Tolerogenic plasmacytoid DC. Eur J Immunol. 2010 ; 40 ( 10 ): 2667 \u2013 2676 . 20821731 10.1002/eji.201040839 3974856",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_79",
            "start": 0,
            "end": 159,
            "label": {}
        },
        {
            "ix": "6-456_v1_80@0",
            "content": "<REF-27> Okada T Lian ZX Naiki M : Murine thymic plasmacytoid dendritic cells. Eur J Immunol. 2003 ; 33 ( 4 ): 1012 \u2013 1019 . 12672067 10.1002/eji.200323616",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_80",
            "start": 0,
            "end": 154,
            "label": {}
        },
        {
            "ix": "6-456_v1_81@0",
            "content": "<REF-29> Hadeiba H Lahl K Edalati A : Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity. 2012 ; 36 ( 3 ): 438 \u2013 450 . 22444632 10.1016/j.immuni.2012.01.017 3315699",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_81",
            "start": 0,
            "end": 224,
            "label": {}
        },
        {
            "ix": "6-456_v1_82@0",
            "content": "<REF-30> Vermi W Riboldi E Wittamer V : Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med. 2005 ; 201 ( 4 ): 509 \u2013 515 . 15728234 10.1084/jem.20041310 2213064",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_82",
            "start": 0,
            "end": 242,
            "label": {}
        },
        {
            "ix": "6-456_v1_83@0",
            "content": "<REF-31> Gilliet M Cao W Liu YJ : Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008 ; 8 ( 8 ): 594 \u2013 606 . 18641647 10.1038/nri2358",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_83",
            "start": 0,
            "end": 198,
            "label": {}
        },
        {
            "ix": "6-456_v1_84@0",
            "content": "<REF-32> Reizis B Bunin A Ghosh HS : Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011 ; 29 : 163 \u2013 183 . 21219184 10.1146/annurev-immunol-031210-101345 4160806",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_84",
            "start": 0,
            "end": 198,
            "label": {}
        },
        {
            "ix": "6-456_v1_85@0",
            "content": "<REF-33> Cervantes-Barragan L Lewis KL Firner S : Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A. 2012 ; 109 ( 8 ): 3012 \u2013 3017 . 22315415 10.1073/pnas.1117359109 3286988",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_85",
            "start": 0,
            "end": 228,
            "label": {}
        },
        {
            "ix": "6-456_v1_86@0",
            "content": "<REF-35> Takagi H Fukaya T Eizumi K : Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo . Immunity. 2011 ; 35 ( 6 ): 958 \u2013 971 . 22177923 10.1016/j.immuni.2011.10.014",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_86",
            "start": 0,
            "end": 219,
            "label": {}
        },
        {
            "ix": "6-456_v1_87@0",
            "content": "<REF-36> Pelka K Latz E : IRF5, IRF8, and IRF7 in human pDCs - the good, the bad, and the insignificant? Eur J Immunol. 2013 ; 43 ( 7 ): 1693 \u2013 1697 . 23828296 10.1002/eji.201343739",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_87",
            "start": 0,
            "end": 180,
            "label": {}
        },
        {
            "ix": "6-456_v1_88@0",
            "content": "<REF-37> Kadowaki N Ho S Antonenko S : Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001 ; 194 ( 6 ): 863 \u2013 869 . 11561001 10.1084/jem.194.6.863 2195968",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_88",
            "start": 0,
            "end": 243,
            "label": {}
        },
        {
            "ix": "6-456_v1_89@0",
            "content": "<REF-38> Diebold SS Kaisho T Hemmi H : Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004 ; 303 ( 5663 ): 1529 \u2013 1531 . 14976261 10.1126/science.1093616",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_89",
            "start": 0,
            "end": 203,
            "label": {}
        },
        {
            "ix": "6-456_v1_90@0",
            "content": "<REF-39> Moynagh PN : TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005 ; 26 ( 9 ): 469 \u2013 476 . 16006187 10.1016/j.it.2005.06.009",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_90",
            "start": 0,
            "end": 189,
            "label": {}
        },
        {
            "ix": "6-456_v1_91@0",
            "content": "<REF-40> Barrat FJ Meeker T Gregorio J : Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005 ; 202 ( 8 ): 1131 \u2013 1139 . 16230478 10.1084/jem.20050914 2213213",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_91",
            "start": 0,
            "end": 254,
            "label": {}
        },
        {
            "ix": "6-456_v1_92@0",
            "content": "<REF-41> Lande R Gregorio J Facchinetti V : Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007 ; 449 ( 7162 ): 564 \u2013 569 . 17873860 10.1038/nature06116",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_92",
            "start": 0,
            "end": 192,
            "label": {}
        },
        {
            "ix": "6-456_v1_93@0",
            "content": "<REF-42> Ganguly D Chamilos G Lande R : Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009 ; 206 ( 9 ): 1983 \u2013 1994 . 19703986 10.1084/jem.20090480 2737167",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_93",
            "start": 0,
            "end": 214,
            "label": {}
        },
        {
            "ix": "6-456_v1_94@0",
            "content": "<REF-43> Honda K Yanai H Negishi H : IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005 ; 434 ( 7034 ): 772 \u2013 777 . 15800576 10.1038/nature03464",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_94",
            "start": 0,
            "end": 184,
            "label": {}
        },
        {
            "ix": "6-456_v1_95@0",
            "content": "<REF-44> Guiducci C Ghirelli C Marloie-Provost MA : PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J Exp Med. 2008 ; 205 ( 2 ): 315 \u2013 322 . 18227218 10.1084/jem.20070763 2271003",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_95",
            "start": 0,
            "end": 283,
            "label": {}
        },
        {
            "ix": "6-456_v1_96@0",
            "content": "<REF-45> Bauer M Redecke V Ellwart JW : Bacterial CpG-DNA triggers activation and maturation of human CD11c - , CD123 + dendritic cells. J Immunol. 2001 ; 166 ( 8 ): 5000 \u2013 5007 . 11290780 10.4049/jimmunol.166.8.5000",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_96",
            "start": 0,
            "end": 215,
            "label": {}
        },
        {
            "ix": "6-456_v1_97@0",
            "content": "<REF-46> Angelot F Seill\u00e8s E Biichl\u00e9 S : Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica. 2009 ; 94 ( 11 ): 1502 \u2013 1512 . 19648164 10.3324/haematol.2009.010934 2770960",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_97",
            "start": 0,
            "end": 268,
            "label": {}
        },
        {
            "ix": "6-456_v1_98@0",
            "content": "<REF-47> Piqueras B Connolly J Freitas H : Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood. 2006 ; 107 ( 7 ): 2613 \u2013 2618 . 16317096 10.1182/blood-2005-07-2965 1895384",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_98",
            "start": 0,
            "end": 254,
            "label": {}
        },
        {
            "ix": "6-456_v1_99@0",
            "content": "<REF-48> Kerkmann M Rothenfusser S Hornung V : Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol. 2003 ; 170 ( 9 ): 4465 \u2013 4474 . 12707322 10.4049/jimmunol.170.9.4465",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_99",
            "start": 0,
            "end": 278,
            "label": {}
        },
        {
            "ix": "6-456_v1_100@0",
            "content": "<REF-49> Tian J Avalos AM Mao SY : Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007 ; 8 ( 5 ): 487 \u2013 496 . 17417641 10.1038/ni1457",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_100",
            "start": 0,
            "end": 206,
            "label": {}
        },
        {
            "ix": "6-456_v1_101@0",
            "content": "<REF-50> Dumitriu IE Baruah P Bianchi ME : Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol. 2005 ; 35 ( 7 ): 2184 \u2013 2190 . 15915542 10.1002/eji.200526066",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_101",
            "start": 0,
            "end": 206,
            "label": {}
        },
        {
            "ix": "6-456_v1_102@0",
            "content": "<REF-51> Rovere-Querini P Capobianco A Scaffidi P : HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004 ; 5 ( 8 ): 825 \u2013 830 . 15272298 10.1038/sj.embor.7400205 1299116",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_102",
            "start": 0,
            "end": 197,
            "label": {}
        },
        {
            "ix": "6-456_v1_103@0",
            "content": "<REF-52> Garcia-Romo GS Caielli S Vega B : Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011 ; 3 ( 73 ): 73ra20 . 21389264 10.1126/scitranslmed.3001201 3143837",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_103",
            "start": 0,
            "end": 236,
            "label": {}
        },
        {
            "ix": "6-456_v1_104@0",
            "content": "<REF-53> Lande R Ganguly D Facchinetti V : Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med. 2011 ; 3 ( 73 ): 73ra19 . 21389263 10.1126/scitranslmed.3001180 3399524",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_104",
            "start": 0,
            "end": 252,
            "label": {}
        },
        {
            "ix": "6-456_v1_105@0",
            "content": "<REF-54> Duffau P Seneschal J Nicco C : Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med. 2010 ; 2 ( 47 ): 47ra63 . 20811042 10.1126/scitranslmed.3001001",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_105",
            "start": 0,
            "end": 237,
            "label": {}
        },
        {
            "ix": "6-456_v1_106@0",
            "content": "<REF-55> Broz P Monack DM : Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol. 2013 ; 13 ( 8 ): 551 \u2013 565 . 23846113 10.1038/nri3479",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_106",
            "start": 0,
            "end": 184,
            "label": {}
        },
        {
            "ix": "6-456_v1_107@0",
            "content": "<REF-56> Bonnefoy F Perruche S Couturier M : Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol. 2011 ; 186 ( 10 ): 5696 \u2013 5705 . 21460208 10.4049/jimmunol.1001523",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_107",
            "start": 0,
            "end": 218,
            "label": {}
        },
        {
            "ix": "6-456_v1_108@0",
            "content": "<REF-57> Munn DH Sharma MD Hou D : Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest. 2004 ; 114 ( 2 ): 280 \u2013 290 . 15254595 10.1172/JCI21583 449750",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_108",
            "start": 0,
            "end": 216,
            "label": {}
        },
        {
            "ix": "6-456_v1_109@0",
            "content": "<REF-58> Sharma MD Baban B Chandler P : Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest. 2007 ; 117 ( 9 ): 2570 \u2013 2582 . 17710230 10.1172/JCI31911 1940240",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_109",
            "start": 0,
            "end": 250,
            "label": {}
        },
        {
            "ix": "6-456_v1_110@0",
            "content": "<REF-59> Mellor AL Baban B Chandler PR : Cutting edge: CpG oligonucleotides induce splenic CD19 + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol. 2005 ; 175 ( 9 ): 5601 \u2013 5605 . 16237046 10.4049/jimmunol.175.9.5601",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_110",
            "start": 0,
            "end": 302,
            "label": {}
        },
        {
            "ix": "6-456_v1_111@0",
            "content": "<REF-60> Pallotta MT Orabona C Volpi C : Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011 ; 12 ( 9 ): 870 \u2013 878 . 21804557 10.1038/ni.2077",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_111",
            "start": 0,
            "end": 200,
            "label": {}
        },
        {
            "ix": "6-456_v1_112@0",
            "content": "<REF-61> Cao W Rosen DB Ito T : Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006 ; 203 ( 6 ): 1399 \u2013 1405 . 16735691 10.1084/jem.20052454 2118323",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_112",
            "start": 0,
            "end": 240,
            "label": {}
        },
        {
            "ix": "6-456_v1_113@0",
            "content": "<REF-62> Dzionek A Sohma Y Nagafune J : BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001 ; 194 ( 12 ): 1823 \u2013 1834 . 11748283 10.1084/jem.194.12.1823 2193584",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_113",
            "start": 0,
            "end": 286,
            "label": {}
        },
        {
            "ix": "6-456_v1_114@0",
            "content": "<REF-63> Saas P Perruche S : Functions of TGF-\u03b2-exposed plasmacytoid dendritic cells. Crit Rev Immunol. 2012 ; 32 ( 6 ): 529 \u2013 553 . 23428227 10.1615/CritRevImmunol.2013005868",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_114",
            "start": 0,
            "end": 174,
            "label": {}
        },
        {
            "ix": "6-456_v1_115@0",
            "content": "<REF-64> Grouard G Rissoan MC Filgueira L : The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997 ; 185 ( 6 ): 1101 \u2013 1111 . 9091583 10.1084/jem.185.6.1101 2196227",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_115",
            "start": 0,
            "end": 229,
            "label": {}
        },
        {
            "ix": "6-456_v1_116@0",
            "content": "<REF-65> Ghirelli C Zollinger R Soumelis V : Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells. Blood. 2010 ; 115 ( 24 ): 5037 \u2013 5040 . 20382843 10.1182/blood-2010-01-266932",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_116",
            "start": 0,
            "end": 254,
            "label": {}
        },
        {
            "ix": "6-456_v1_117@0",
            "content": "<REF-66> Chistiakov DA Orekhov AN Sobenin IA : Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation. Front Physiol. 2014 ; 5 : 279 . 25120492 10.3389/fphys.2014.00279 4110479",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_117",
            "start": 0,
            "end": 215,
            "label": {}
        },
        {
            "ix": "6-456_v1_118@0",
            "content": "<REF-67> Fritsch SD Weichhart T : Effects of Interferons and Viruses on Metabolism. Front Immunol. 2016 ; 7 : 630 . 28066439 10.3389/fimmu.2016.00630 5174094",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_118",
            "start": 0,
            "end": 156,
            "label": {}
        },
        {
            "ix": "6-456_v1_119@0",
            "content": "<REF-68> Banchereau J Pascual V : Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006 ; 25 ( 3 ): 383 \u2013 392 . 16979570 10.1016/j.immuni.2006.08.010",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_119",
            "start": 0,
            "end": 190,
            "label": {}
        },
        {
            "ix": "6-456_v1_120@0",
            "content": "<REF-69> Diana J Simoni Y Furio L : Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med. 2013 ; 19 ( 1 ): 65 \u2013 73 . 23242473 10.1038/nm.3042",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_120",
            "start": 0,
            "end": 201,
            "label": {}
        },
        {
            "ix": "6-456_v1_121@0",
            "content": "<REF-70> van Bon L Affandi AJ Broen J : Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014 ; 370 ( 5 ): 433 \u2013 443 . 24350901 10.1056/NEJMoa1114576 4040466",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_121",
            "start": 0,
            "end": 192,
            "label": {}
        },
        {
            "ix": "6-456_v1_122@0",
            "content": "<REF-71> Nestle FO Conrad C Tun-Kyi A : Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005 ; 202 ( 1 ): 135 \u2013 143 . 15998792 10.1084/jem.20050500 2212894",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_122",
            "start": 0,
            "end": 205,
            "label": {}
        },
        {
            "ix": "6-456_v1_123@0",
            "content": "<REF-72> Millet A Martin KR Bonnefoy F : Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest. 2015 ; 125 ( 11 ): 4107 \u2013 4121 . 26436651 10.1172/JCI78182 4639994",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_123",
            "start": 0,
            "end": 205,
            "label": {}
        },
        {
            "ix": "6-456_v1_124@0",
            "content": "<REF-73> Bossard C Malard F Arbez J : Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia. 2012 ; 26 ( 7 ): 1471 \u2013 1474 . 22333879 10.1038/leu.2012.41",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_124",
            "start": 0,
            "end": 226,
            "label": {}
        },
        {
            "ix": "6-456_v1_125@0",
            "content": "<REF-74> Malard F Bossard C Brissot E : Increased plasmacytoid dendritic cells and ROR\u03b3t-expressing immune effectors in cutaneous acute graft-versus-host disease. J Leukoc Biol. 2013 ; 94 ( 6 ): 1337 \u2013 1343 . 23990625 10.1189/jlb.0513295",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_125",
            "start": 0,
            "end": 236,
            "label": {}
        },
        {
            "ix": "6-456_v1_126@0",
            "content": "<REF-75> D\u00f6ring Y Zernecke A : Plasmacytoid dendritic cells in atherosclerosis. Front Physiol. 2012 ; 3 : 230 . 22754539 10.3389/fphys.2012.00230 3385355",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_126",
            "start": 0,
            "end": 152,
            "label": {}
        },
        {
            "ix": "6-456_v1_127@0",
            "content": "<REF-76> Soumelis V Scott I Gheyas F : Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood. 2001 ; 98 ( 4 ): 906 \u2013 912 . 11493432 10.1182/blood.V98.4.906",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_127",
            "start": 0,
            "end": 204,
            "label": {}
        },
        {
            "ix": "6-456_v1_128@0",
            "content": "<REF-77> Szabo G Dolganiuc A : The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity. Crit Rev Immunol. 2008 ; 28 ( 1 ): 61 \u2013 94 . 18298384 10.1615/CritRevImmunol.v28.i1.40",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_128",
            "start": 0,
            "end": 197,
            "label": {}
        },
        {
            "ix": "6-456_v1_129@0",
            "content": "<REF-78> Costa-Mattioli M Sonenberg N : RAPping production of type I interferon in pDCs through mTOR. Nat Immunol. 2008 ; 9 ( 10 ): 1097 \u2013 1099 . 18800159 10.1038/ni1008-1097",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_129",
            "start": 0,
            "end": 173,
            "label": {}
        },
        {
            "ix": "6-456_v1_130@0",
            "content": "<REF-79> Cao W Manicassamy S Tang H : Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol. 2008 ; 9 ( 10 ): 1157 \u2013 1164 . 18758466 10.1038/ni.1645 3732485",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_130",
            "start": 0,
            "end": 265,
            "label": {}
        },
        {
            "ix": "6-456_v1_131@0",
            "content": "<REF-80> Corcoran SE O'Neill LA : HIF1\u03b1 and metabolic reprogramming in inflammation. J Clin Invest. 2016 ; 126 ( 10 ): 3699 \u2013 3707 . 27571407 10.1172/JCI84431 5096812",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_131",
            "start": 0,
            "end": 165,
            "label": {}
        },
        {
            "ix": "6-456_v1_132@0",
            "content": "<REF-81> Van Krinks CH Matyszak MK Gaston JS : Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid. Rheumatology (Oxford). 2004 ; 43 ( 4 ): 453 \u2013 460 . 14762226 10.1093/rheumatology/keh115",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_132",
            "start": 0,
            "end": 225,
            "label": {}
        },
        {
            "ix": "6-456_v1_133@0",
            "content": "<REF-83> Cavanagh LL Boyce A Smith L : Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther. 2005 ; 7 ( 2 ): R230 \u2013 240 . 15743469 10.1186/ar1467 1065313",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_133",
            "start": 0,
            "end": 187,
            "label": {}
        },
        {
            "ix": "6-456_v1_134@0",
            "content": "<REF-84> Arimura K Takagi H Uto T : Crucial role of plasmacytoid dendritic cells in the development of acute colitis through the regulation of intestinal inflammation. Mucosal Immunol. 2017 ; In press. 27848952 10.1038/mi.2016.96",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_134",
            "start": 0,
            "end": 228,
            "label": {}
        },
        {
            "ix": "6-456_v1_135@0",
            "content": "<REF-85> Lund JM Alexopoulou L Sato A : Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004 ; 101 ( 15 ): 5598 \u2013 5603 . 15034168 10.1073/pnas.0400937101 397437",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_135",
            "start": 0,
            "end": 205,
            "label": {}
        },
        {
            "ix": "6-456_v1_136@0",
            "content": "<REF-86> Hong C Tontonoz P : Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov. 2014 ; 13 ( 6 ): 433 \u2013 444 . 24833295 10.1038/nrd4280",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_136",
            "start": 0,
            "end": 175,
            "label": {}
        },
        {
            "ix": "6-456_v1_137@0",
            "content": "<REF-87> W\u00f3jcicka G Jamroz-Wisniewska A Horoszewicz K : Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw (Online). 2007 ; 61 : 736 \u2013 759 . 18063918",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_137",
            "start": 0,
            "end": 227,
            "label": {}
        },
        {
            "ix": "6-456_v1_138@0",
            "content": "<REF-88> Kidani Y Bensinger SJ : Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev. 2012 ; 249 ( 1 ): 72 \u2013 83 . 22889216 10.1111/j.1600-065X.2012.01153.x 4007066",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_138",
            "start": 0,
            "end": 236,
            "label": {}
        },
        {
            "ix": "6-456_v1_139@0",
            "content": "<REF-89> Rakhshandehroo M Knoch B Muller M : Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010 ; 2010 ; pii: 612089. 20936127 10.1155/2010/612089 2948931",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_139",
            "start": 0,
            "end": 180,
            "label": {}
        },
        {
            "ix": "6-456_v1_140@0",
            "content": "<REF-90> Kiss M Czimmerer Z Nagy L : The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. J Allergy Clin Immunol. 2013 ; 132 ( 2 ): 264 \u2013 286 . 23905916 10.1016/j.jaci.2013.05.044",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_140",
            "start": 0,
            "end": 252,
            "label": {}
        },
        {
            "ix": "6-456_v1_141@0",
            "content": "<REF-91> Horton JD Goldstein JL Brown MS : SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002 ; 109 ( 9 ): 1125 \u2013 1131 . 11994399 10.1172/JCI15593 150968",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_141",
            "start": 0,
            "end": 218,
            "label": {}
        },
        {
            "ix": "6-456_v1_142@0",
            "content": "<REF-92> Ikonen E : Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008 ; 9 ( 2 ): 125 \u2013 138 . 18216769 10.1038/nrm2336",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_142",
            "start": 0,
            "end": 153,
            "label": {}
        },
        {
            "ix": "6-456_v1_143@0",
            "content": "<REF-93> Oram JF Vaughan AM : ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006 ; 99 ( 10 ): 1031 \u2013 1043 . 17095732 10.1161/01.RES.0000250171.54048.5c",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_143",
            "start": 0,
            "end": 188,
            "label": {}
        },
        {
            "ix": "6-456_v1_144@0",
            "content": "<REF-94> Im SS Osborne TF : Liver x receptors in atherosclerosis and inflammation. Circ Res. 2011 ; 108 ( 8 ): 996 \u2013 1001 . 21493922 10.1161/CIRCRESAHA.110.226878 3082200",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_144",
            "start": 0,
            "end": 169,
            "label": {}
        },
        {
            "ix": "6-456_v1_145@0",
            "content": "<REF-95> Dove DE Linton MF Fazio S : ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects. Am J Physiol Cell Physiol. 2005 ; 288 ( 3 ): C586 \u2013 592 . 15509658 10.1152/ajpcell.00210.2004",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_145",
            "start": 0,
            "end": 227,
            "label": {}
        },
        {
            "ix": "6-456_v1_146@0",
            "content": "<REF-96> Hong C Duit S Jalonen P : The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J Biol Chem. 2010 ; 285 ( 26 ): 19720 \u2013 19726 . 20427281 10.1074/jbc.M110.123729 2888382",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_146",
            "start": 0,
            "end": 248,
            "label": {}
        },
        {
            "ix": "6-456_v1_147@0",
            "content": "<REF-97> Amuro H Ito T Miyamoto R : Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Arthritis Rheum. 2010 ; 62 ( 7 ): 2073 \u2013 2085 . 20506142 10.1002/art.27478",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_147",
            "start": 0,
            "end": 283,
            "label": {}
        },
        {
            "ix": "6-456_v1_148@0",
            "content": "<REF-98> Bu DX Griffin G Lichtman AH : Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol. 2011 ; 22 ( 3 ): 165 \u2013 170 . 21412153 10.1097/MOL.0b013e3283453e41",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_148",
            "start": 0,
            "end": 180,
            "label": {}
        },
        {
            "ix": "6-456_v1_149@0",
            "content": "<REF-99> Ceroi A Masson D Roggy A : LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. Blood. 2016 ; 128 ( 23 ): 2694 \u2013 2707 . 27702801 10.1182/blood-2016-06-724807 5271175",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_149",
            "start": 0,
            "end": 242,
            "label": {}
        },
        {
            "ix": "6-456_v1_150@0",
            "content": "<REF-100> A-Gonzalez N Bensinger SJ Hong C : Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity. 2009 ; 31 ( 2 ): 245 \u2013 258 . 19646905 10.1016/j.immuni.2009.06.018 2791787",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_150",
            "start": 0,
            "end": 241,
            "label": {}
        },
        {
            "ix": "6-456_v1_151@0",
            "content": "<REF-101> York AG Williams KJ Argus JP : Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling. Cell. 2015 ; 163 ( 7 ): 1716 \u2013 1729 . 26686653 10.1016/j.cell.2015.11.045 4783382",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_151",
            "start": 0,
            "end": 204,
            "label": {}
        },
        {
            "ix": "6-456_v1_152@0",
            "content": "<REF-102> Geva-Zatorsky N Sefik E Kua L : Mining the Human Gut Microbiota for Immunomodulatory Organisms. Cell. 2017 ; 168 ( 5 ): 928 \u2013 943.e911 . 28215708 10.1016/j.cell.2017.01.022",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_152",
            "start": 0,
            "end": 181,
            "label": {}
        },
        {
            "ix": "6-456_v1_153@0",
            "content": "<REF-103> Arbez J Lamarthee B Gaugler B : Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function. Immunobiology. 2014 ; 219 ( 8 ): 637 \u2013 643 . 24742998 10.1016/j.imbio.2014.03.013",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_153",
            "start": 0,
            "end": 227,
            "label": {}
        },
        {
            "ix": "6-456_v1_154@0",
            "content": "<REF-104> Cubillos-Ruiz JR Bettigole SE Glimcher LH : Molecular Pathways: Immunosuppressive Roles of IRE1\u03b1-XBP1 Signaling in Dendritic Cells of the Tumor Microenvironment. Clin Cancer Res. 2016 ; 22 ( 9 ): 2121 \u2013 2126 . 26979393 10.1158/1078-0432.CCR-15-1570 4854763",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_154",
            "start": 0,
            "end": 265,
            "label": {}
        },
        {
            "ix": "6-456_v1_155@0",
            "content": "<REF-105> Hirai M Kadowaki N Kitawaki T : Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Blood. 2011 ; 117 ( 2 ): 500 \u2013 509 . 20956804 10.1182/blood-2010-05-284737",
            "ntype": "s",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            },
            "src_ix": "6-456_v1_155",
            "start": 0,
            "end": 292,
            "label": {}
        }
    ],
    "edges": [
        {
            "src_ix": "6-456_v1_0",
            "tgt_ix": "6-456_v1_1",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_1",
            "tgt_ix": "6-456_v1_2",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_0",
            "tgt_ix": "6-456_v1_3",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_3",
            "tgt_ix": "6-456_v1_4",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_3",
            "tgt_ix": "6-456_v1_5",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_0",
            "tgt_ix": "6-456_v1_6",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_7",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_8",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_9",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_9",
            "tgt_ix": "6-456_v1_10",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_11",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_11",
            "tgt_ix": "6-456_v1_12",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_11",
            "tgt_ix": "6-456_v1_13",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_11",
            "tgt_ix": "6-456_v1_14",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_14",
            "tgt_ix": "6-456_v1_15",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_11",
            "tgt_ix": "6-456_v1_16",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_17",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_17",
            "tgt_ix": "6-456_v1_18",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_17",
            "tgt_ix": "6-456_v1_19",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_20",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_20",
            "tgt_ix": "6-456_v1_21",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_0",
            "tgt_ix": "6-456_v1_22",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_22",
            "tgt_ix": "6-456_v1_23",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_23",
            "tgt_ix": "6-456_v1_24",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_23",
            "tgt_ix": "6-456_v1_25",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_23",
            "tgt_ix": "6-456_v1_26",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_26",
            "tgt_ix": "6-456_v1_27",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_23",
            "tgt_ix": "6-456_v1_28",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_22",
            "tgt_ix": "6-456_v1_29",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_29",
            "tgt_ix": "6-456_v1_30",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_29",
            "tgt_ix": "6-456_v1_31",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_29",
            "tgt_ix": "6-456_v1_32",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_22",
            "tgt_ix": "6-456_v1_33",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_34",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_35",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_36",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_37",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_38",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_39",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_40",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_41",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_42",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_43",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_44",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_44",
            "tgt_ix": "6-456_v1_45",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_46",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_47",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_48",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_49",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_0",
            "tgt_ix": "6-456_v1_50",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_50",
            "tgt_ix": "6-456_v1_51",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_50",
            "tgt_ix": "6-456_v1_52",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_50",
            "tgt_ix": "6-456_v1_53",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_50",
            "tgt_ix": "6-456_v1_54",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_50",
            "tgt_ix": "6-456_v1_55",
            "etype": "parent",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_0",
            "tgt_ix": "6-456_v1_1",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_1",
            "tgt_ix": "6-456_v1_2",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_3",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_3",
            "tgt_ix": "6-456_v1_4",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_5",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_6",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_7",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_7",
            "tgt_ix": "6-456_v1_8",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_9",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_9",
            "tgt_ix": "6-456_v1_10",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_11",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_11",
            "tgt_ix": "6-456_v1_12",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_13",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_14",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_14",
            "tgt_ix": "6-456_v1_15",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_15",
            "tgt_ix": "6-456_v1_16",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_17",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_17",
            "tgt_ix": "6-456_v1_18",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_19",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_20",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_20",
            "tgt_ix": "6-456_v1_21",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_22",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_22",
            "tgt_ix": "6-456_v1_23",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_23",
            "tgt_ix": "6-456_v1_24",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_25",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_26",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_26",
            "tgt_ix": "6-456_v1_27",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_27",
            "tgt_ix": "6-456_v1_28",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_28",
            "tgt_ix": "6-456_v1_29",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_29",
            "tgt_ix": "6-456_v1_30",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_31",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_32",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_33",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_34",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_35",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_35",
            "tgt_ix": "6-456_v1_36",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_37",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_37",
            "tgt_ix": "6-456_v1_38",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_38",
            "tgt_ix": "6-456_v1_39",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_40",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_41",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_42",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_42",
            "tgt_ix": "6-456_v1_43",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_44",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_44",
            "tgt_ix": "6-456_v1_45",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_45",
            "tgt_ix": "6-456_v1_46",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_47",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_48",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_49",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_50",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_50",
            "tgt_ix": "6-456_v1_51",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_51",
            "tgt_ix": "6-456_v1_52",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_52",
            "tgt_ix": "6-456_v1_53",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_54",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_54",
            "tgt_ix": "6-456_v1_55",
            "etype": "next",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_56",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_57",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_58",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_59",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_60",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_61",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_62",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_63",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_64",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_65",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_66",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_67",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_7",
            "tgt_ix": "6-456_v1_68",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_69",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_70",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_71",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_72",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_73",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_74",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_75",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_76",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_77",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_78",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_79",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_80",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_81",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_82",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_83",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_84",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_85",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_86",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_87",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_88",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_89",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_90",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_91",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_92",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_93",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_94",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_95",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_96",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_97",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_98",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_99",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_100",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_101",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_102",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_103",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_104",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_105",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_106",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_107",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_108",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_109",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_110",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_111",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_112",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_113",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_114",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_115",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_116",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_117",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_118",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_119",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_120",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_121",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_122",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_123",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_124",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_125",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_126",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_127",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_128",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_129",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_130",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_131",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_132",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_133",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_134",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_135",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_136",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_137",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_138",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_139",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_140",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_141",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_142",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_143",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_144",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_145",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_146",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_147",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_148",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_149",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_150",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_151",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_152",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_54",
            "tgt_ix": "6-456_v1_153",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_154",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_155",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_15",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_27",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_45",
            "etype": "link",
            "meta": {
                "created_by": "F1000XMLParser"
            }
        },
        {
            "src_ix": "6-456_v1_0",
            "tgt_ix": "6-456_v1_0@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_1",
            "tgt_ix": "6-456_v1_1@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_2",
            "tgt_ix": "6-456_v1_2@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_3",
            "tgt_ix": "6-456_v1_3@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@12",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@13",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@14",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@15",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@16",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_4",
            "tgt_ix": "6-456_v1_4@17",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_5",
            "tgt_ix": "6-456_v1_5@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_6",
            "tgt_ix": "6-456_v1_6@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_7",
            "tgt_ix": "6-456_v1_7@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_7",
            "tgt_ix": "6-456_v1_7@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_8@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_8@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_8@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_8@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_8@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_8",
            "tgt_ix": "6-456_v1_8@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_9",
            "tgt_ix": "6-456_v1_9@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_10",
            "tgt_ix": "6-456_v1_10@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_11",
            "tgt_ix": "6-456_v1_11@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_12@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_12@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_12@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_12",
            "tgt_ix": "6-456_v1_12@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@12",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@13",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@14",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@15",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_13",
            "tgt_ix": "6-456_v1_13@16",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_14",
            "tgt_ix": "6-456_v1_14@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_16@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_16@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_16@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_16@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_16@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_16@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_16",
            "tgt_ix": "6-456_v1_16@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_17",
            "tgt_ix": "6-456_v1_17@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_18",
            "tgt_ix": "6-456_v1_18@12",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_19@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_19@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_19@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_19@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_19@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_19@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_19",
            "tgt_ix": "6-456_v1_19@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_20",
            "tgt_ix": "6-456_v1_20@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_21",
            "tgt_ix": "6-456_v1_21@12",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_22",
            "tgt_ix": "6-456_v1_22@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_23",
            "tgt_ix": "6-456_v1_23@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_24",
            "tgt_ix": "6-456_v1_24@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_25",
            "tgt_ix": "6-456_v1_25@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_26",
            "tgt_ix": "6-456_v1_26@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_28",
            "tgt_ix": "6-456_v1_28@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_28",
            "tgt_ix": "6-456_v1_28@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_28",
            "tgt_ix": "6-456_v1_28@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_28",
            "tgt_ix": "6-456_v1_28@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_29",
            "tgt_ix": "6-456_v1_29@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_30",
            "tgt_ix": "6-456_v1_30@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_31",
            "tgt_ix": "6-456_v1_31@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_32",
            "tgt_ix": "6-456_v1_32@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_33",
            "tgt_ix": "6-456_v1_33@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_34",
            "tgt_ix": "6-456_v1_34@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_35",
            "tgt_ix": "6-456_v1_35@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_35",
            "tgt_ix": "6-456_v1_35@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_35",
            "tgt_ix": "6-456_v1_35@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_35",
            "tgt_ix": "6-456_v1_35@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_35",
            "tgt_ix": "6-456_v1_35@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_35",
            "tgt_ix": "6-456_v1_35@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_36",
            "tgt_ix": "6-456_v1_36@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_37",
            "tgt_ix": "6-456_v1_37@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_37",
            "tgt_ix": "6-456_v1_37@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_37",
            "tgt_ix": "6-456_v1_37@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_37",
            "tgt_ix": "6-456_v1_37@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_37",
            "tgt_ix": "6-456_v1_37@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_38",
            "tgt_ix": "6-456_v1_38@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_38",
            "tgt_ix": "6-456_v1_38@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_38",
            "tgt_ix": "6-456_v1_38@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_38",
            "tgt_ix": "6-456_v1_38@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_39@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_39@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_39@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_39@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_39@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_39@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_39",
            "tgt_ix": "6-456_v1_39@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_40",
            "tgt_ix": "6-456_v1_40@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_41@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_41@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_41@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_41@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_41@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_41@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_41",
            "tgt_ix": "6-456_v1_41@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_42",
            "tgt_ix": "6-456_v1_42@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_42",
            "tgt_ix": "6-456_v1_42@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_42",
            "tgt_ix": "6-456_v1_42@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_42",
            "tgt_ix": "6-456_v1_42@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_42",
            "tgt_ix": "6-456_v1_42@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_42",
            "tgt_ix": "6-456_v1_42@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_43",
            "tgt_ix": "6-456_v1_43@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_44",
            "tgt_ix": "6-456_v1_44@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_46@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_46@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_46@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_46@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_46@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_46@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_46",
            "tgt_ix": "6-456_v1_46@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_47",
            "tgt_ix": "6-456_v1_47@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@10",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@11",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@12",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@13",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_48",
            "tgt_ix": "6-456_v1_48@14",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_49",
            "tgt_ix": "6-456_v1_49@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_50",
            "tgt_ix": "6-456_v1_50@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_51",
            "tgt_ix": "6-456_v1_51@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_51",
            "tgt_ix": "6-456_v1_51@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_51",
            "tgt_ix": "6-456_v1_51@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_51",
            "tgt_ix": "6-456_v1_51@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_51",
            "tgt_ix": "6-456_v1_51@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_51",
            "tgt_ix": "6-456_v1_51@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_52",
            "tgt_ix": "6-456_v1_52@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_52",
            "tgt_ix": "6-456_v1_52@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_52",
            "tgt_ix": "6-456_v1_52@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_53@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_53@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_53@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_53@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_53@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_53",
            "tgt_ix": "6-456_v1_53@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_54",
            "tgt_ix": "6-456_v1_54@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_54",
            "tgt_ix": "6-456_v1_54@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_54",
            "tgt_ix": "6-456_v1_54@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@1",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@2",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@3",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@4",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@5",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@6",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@7",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@8",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_55",
            "tgt_ix": "6-456_v1_55@9",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_56",
            "tgt_ix": "6-456_v1_56@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_57",
            "tgt_ix": "6-456_v1_57@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_58",
            "tgt_ix": "6-456_v1_58@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_59",
            "tgt_ix": "6-456_v1_59@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_60",
            "tgt_ix": "6-456_v1_60@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_61",
            "tgt_ix": "6-456_v1_61@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_62",
            "tgt_ix": "6-456_v1_62@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_63",
            "tgt_ix": "6-456_v1_63@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_64",
            "tgt_ix": "6-456_v1_64@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_65",
            "tgt_ix": "6-456_v1_65@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_66",
            "tgt_ix": "6-456_v1_66@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_67",
            "tgt_ix": "6-456_v1_67@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_68",
            "tgt_ix": "6-456_v1_68@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_69",
            "tgt_ix": "6-456_v1_69@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_70",
            "tgt_ix": "6-456_v1_70@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_71",
            "tgt_ix": "6-456_v1_71@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_72",
            "tgt_ix": "6-456_v1_72@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_73",
            "tgt_ix": "6-456_v1_73@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_74",
            "tgt_ix": "6-456_v1_74@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_75",
            "tgt_ix": "6-456_v1_75@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_76",
            "tgt_ix": "6-456_v1_76@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_77",
            "tgt_ix": "6-456_v1_77@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_78",
            "tgt_ix": "6-456_v1_78@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_79",
            "tgt_ix": "6-456_v1_79@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_80",
            "tgt_ix": "6-456_v1_80@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_81",
            "tgt_ix": "6-456_v1_81@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_82",
            "tgt_ix": "6-456_v1_82@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_83",
            "tgt_ix": "6-456_v1_83@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_84",
            "tgt_ix": "6-456_v1_84@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_85",
            "tgt_ix": "6-456_v1_85@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_86",
            "tgt_ix": "6-456_v1_86@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_87",
            "tgt_ix": "6-456_v1_87@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_88",
            "tgt_ix": "6-456_v1_88@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_89",
            "tgt_ix": "6-456_v1_89@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_90",
            "tgt_ix": "6-456_v1_90@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_91",
            "tgt_ix": "6-456_v1_91@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_92",
            "tgt_ix": "6-456_v1_92@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_93",
            "tgt_ix": "6-456_v1_93@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_94",
            "tgt_ix": "6-456_v1_94@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_95",
            "tgt_ix": "6-456_v1_95@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_96",
            "tgt_ix": "6-456_v1_96@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_97",
            "tgt_ix": "6-456_v1_97@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_98",
            "tgt_ix": "6-456_v1_98@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_99",
            "tgt_ix": "6-456_v1_99@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_100",
            "tgt_ix": "6-456_v1_100@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_101",
            "tgt_ix": "6-456_v1_101@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_102",
            "tgt_ix": "6-456_v1_102@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_103",
            "tgt_ix": "6-456_v1_103@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_104",
            "tgt_ix": "6-456_v1_104@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_105",
            "tgt_ix": "6-456_v1_105@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_106",
            "tgt_ix": "6-456_v1_106@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_107",
            "tgt_ix": "6-456_v1_107@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_108",
            "tgt_ix": "6-456_v1_108@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_109",
            "tgt_ix": "6-456_v1_109@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_110",
            "tgt_ix": "6-456_v1_110@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_111",
            "tgt_ix": "6-456_v1_111@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_112",
            "tgt_ix": "6-456_v1_112@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_113",
            "tgt_ix": "6-456_v1_113@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_114",
            "tgt_ix": "6-456_v1_114@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_115",
            "tgt_ix": "6-456_v1_115@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_116",
            "tgt_ix": "6-456_v1_116@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_117",
            "tgt_ix": "6-456_v1_117@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_118",
            "tgt_ix": "6-456_v1_118@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_119",
            "tgt_ix": "6-456_v1_119@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_120",
            "tgt_ix": "6-456_v1_120@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_121",
            "tgt_ix": "6-456_v1_121@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_122",
            "tgt_ix": "6-456_v1_122@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_123",
            "tgt_ix": "6-456_v1_123@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_124",
            "tgt_ix": "6-456_v1_124@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_125",
            "tgt_ix": "6-456_v1_125@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_126",
            "tgt_ix": "6-456_v1_126@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_127",
            "tgt_ix": "6-456_v1_127@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_128",
            "tgt_ix": "6-456_v1_128@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_129",
            "tgt_ix": "6-456_v1_129@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_130",
            "tgt_ix": "6-456_v1_130@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_131",
            "tgt_ix": "6-456_v1_131@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_132",
            "tgt_ix": "6-456_v1_132@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_133",
            "tgt_ix": "6-456_v1_133@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_134",
            "tgt_ix": "6-456_v1_134@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_135",
            "tgt_ix": "6-456_v1_135@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_136",
            "tgt_ix": "6-456_v1_136@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_137",
            "tgt_ix": "6-456_v1_137@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_138",
            "tgt_ix": "6-456_v1_138@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_139",
            "tgt_ix": "6-456_v1_139@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_140",
            "tgt_ix": "6-456_v1_140@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_141",
            "tgt_ix": "6-456_v1_141@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_142",
            "tgt_ix": "6-456_v1_142@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_143",
            "tgt_ix": "6-456_v1_143@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_144",
            "tgt_ix": "6-456_v1_144@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_145",
            "tgt_ix": "6-456_v1_145@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_146",
            "tgt_ix": "6-456_v1_146@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_147",
            "tgt_ix": "6-456_v1_147@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_148",
            "tgt_ix": "6-456_v1_148@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_149",
            "tgt_ix": "6-456_v1_149@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_150",
            "tgt_ix": "6-456_v1_150@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_151",
            "tgt_ix": "6-456_v1_151@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_152",
            "tgt_ix": "6-456_v1_152@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_153",
            "tgt_ix": "6-456_v1_153@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_154",
            "tgt_ix": "6-456_v1_154@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        },
        {
            "src_ix": "6-456_v1_155",
            "tgt_ix": "6-456_v1_155@0",
            "etype": "link",
            "meta": {
                "created_by": "IntertextSentenceSplitter_all"
            }
        }
    ],
    "prefix": "6-456_v1",
    "meta": {
        "parser": "F1000XMLParser",
        "intertext-graph": "N/A",
        "doi": "10.12688/f1000research.11332.1",
        "atype": "review",
        "license": "http://creativecommons.org/licenses/by/4.0/",
        "title": "Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions",
        "abstract": "There are more and more data concerning the role of cellular metabolism in innate immune cells, such as macrophages or conventional dendritic cells. However, few data are available currently concerning plasmacytoid dendritic cells (PDC), another type of innate immune cells. These cells are the main type I interferon (IFN) producing cells, but they also secrete other pro-inflammatory cytokines (e.g., tumor necrosis factor or interleukin [IL]-6) or immunomodulatory factors (e.g., IL-10 or transforming growth factor-\u03b2). Through these functions, PDC participate in antimicrobial responses or maintenance of immune tolerance, and have been implicated in the pathophysiology of several autoimmune diseases. Recent data support the idea that the glycolytic pathway (or glycolysis), as well as lipid metabolism (including both cholesterol and fatty acid metabolism) may impact some innate immune functions of PDC or may be involved in these functions after Toll-like receptor (TLR) 7/9 triggering. Some differences may be related to the origin of PDC (human versus mouse PDC or blood-sorted versus FLT3 ligand stimulated-bone marrow-sorted PDC). The kinetics of glycolysis may differ between human and murine PDC. In mouse PDC, metabolism changes promoted by TLR7/9 activation may depend on an autocrine/paracrine loop, implicating type I IFN and its receptor IFNAR, explaining a delayed glycolysis. Moreover, PDC functions can be modulated by the metabolism of cholesterol and fatty acids. This may occur via the production of lipid ligands that activate nuclear receptors (e.g., liver X receptor [LXR]) in PDC or through limiting intracellular cholesterol pool size (by statins or LXR agonists) in these cells. Finally, lipid-activated nuclear receptors ( i.e ., LXR or peroxisome proliferator activated receptor) may also directly interact with pro-inflammatory transcription factors, such as NF-\u03baB. Here, we discuss how glycolysis and lipid metabolism may modulate PDC functions and how this may be harnessed in pathological situations where PDC play a detrimental role.",
        "contributors": [
            {
                "surname": "Saas",
                "given-names": "Philippe"
            },
            {
                "surname": "Varin",
                "given-names": "Alexis"
            },
            {
                "surname": "Perruche",
                "given-names": "Sylvain"
            },
            {
                "surname": "Ceroi",
                "given-names": "Adam"
            }
        ],
        "url": "https://f1000research.com/articles/6-456/v1/",
        "doc_id": "6-456",
        "version": 1,
        "ix_counter": 744,
        "sentence_split_type": "HybridSplitterLessAndLong",
        "sentence_split_model": "HybridSplitterLessAndLong_SciSpacy+Spacy"
    }
}